30.10.2018 Views

Annual Report 2017-18 | Monash Health

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Annual</strong><br />

<strong>Report</strong><br />

<strong>2017</strong>-<strong>18</strong>


Our vision<br />

& values<br />

Vision<br />

Exceptional care, outstanding outcomes.<br />

Purpose<br />

To deliver quality, patient-centred healthcare and services<br />

that meet the needs of our diverse community<br />

Our Values<br />

(iCARE)<br />

• Integrity<br />

• Compassion<br />

• Accountability<br />

• Respect<br />

• Excellence<br />

2 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Contents<br />

Our care at a glance 4<br />

<strong>Report</strong> of the Chair of the Board<br />

and Chief Executive 6<br />

The Year in review 9<br />

Innovation12<br />

Capital works 16<br />

Our people 22<br />

Our community 27<br />

The <strong>Monash</strong> <strong>Health</strong> Foundation 28<br />

A journey starts with one small step 31<br />

Our sites, services and staff 32<br />

Operational structure 34<br />

Jessie McPherson Private Hospital 36<br />

Clinical governance report 39<br />

Environmental sustainability report 40<br />

Our Board of Directors 42<br />

Members of the Board of Directors 45<br />

Statutory compliance 48<br />

Disclosure index 50<br />

Attestations 52<br />

Statement of Priorities - Part A 53<br />

Statement of Priorities - Part B 56<br />

Statement of Priorities - Part C 60<br />

Financial summary 62<br />

Financial statements and explanatory notes 66<br />

3


Our care<br />

at a glance<br />

In <strong>2017</strong>-<strong>18</strong><br />

3,915,202 40,987<br />

Total Episodes of care*<br />

Paediatric Admissions<br />

(3.6m in 2016-17) (40,293 in 2016-17)<br />

1,043,936<br />

Pathology Tests<br />

(1m in 2016-17)<br />

259,958<br />

Total Hospital Admissions<br />

(260,786 in 2016-17)<br />

1,453,333<br />

Outpatient Services<br />

(1.2m in 2016-17)<br />

226,315<br />

Emergency presentations<br />

(220,913 in 2016-17)<br />

10,027<br />

Births<br />

(10,162 in 2016-17)<br />

287,624<br />

Mental health<br />

(224,460 in 2016-17)<br />

58,858<br />

Ambulance Arrivals<br />

(54,495 in 2016-17)<br />

*Excludes: Surgical Operations,<br />

Total Hospital Admissions,<br />

Babies, Ambulance arrivals,<br />

and Paediatric Admissions.<br />

4 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


<strong>Monash</strong> <strong>Health</strong> is<br />

proud to provide<br />

healthcare to<br />

one quarter of<br />

Melbourne’s<br />

population, across<br />

the entire life-span<br />

from newborn and<br />

children, to adults,<br />

the elderly, their<br />

families and carers.<br />

We improve the health of<br />

our community through:<br />

• Prevention and early intervention<br />

• Community-based treatment and rehabilitation<br />

• Highly specialised surgical and medical diagnosis,<br />

treatment and monitoring services<br />

• Hospital and community-based mental health services<br />

• Sub-acute, aged care and palliative care programs<br />

• Research, education and teaching the next generation<br />

of healthcare professionals<br />

• Regional and state-wide specialist services.<br />

5


<strong>Report</strong> of the<br />

Chair of the<br />

Board and Chief<br />

Executive<br />

Welcome to the <strong>Monash</strong> <strong>Health</strong> <strong>2017</strong>-<strong>18</strong> <strong>Annual</strong> <strong>Report</strong><br />

Providing exceptional care<br />

<strong>Monash</strong> <strong>Health</strong> provides care to a<br />

quarter of all Victorians at every stage<br />

of their life. With the health and wellbeing<br />

of so many people in our hands,<br />

we strive to provide excellence in<br />

patient care. Our Transforming Care<br />

Program has this exact goal in mind,<br />

and we made significant progress this<br />

year. We are working to ensure our<br />

systems and our people align at<br />

every stage.<br />

<strong>Monash</strong> <strong>Health</strong> successfully achieved<br />

accreditation in <strong>2017</strong>, against the<br />

National Safety and Quality <strong>Health</strong><br />

Service Standards. Surveyors<br />

acknowledged our achievements and<br />

continued growth.<br />

We celebrated the one year anniversary<br />

of the opening of the <strong>Monash</strong><br />

Children’s Hospital school reflecting<br />

our commitment to patient care<br />

beyond the healthcare environment,<br />

and recognising the essential role that<br />

education plays in our young peoples’<br />

lives. We are immensely proud that this<br />

initiative will help to keep our young<br />

consumers connected to learning<br />

opportunities and the social aspects<br />

of attending school.<br />

Translating research into<br />

better patient outcomes<br />

<strong>Monash</strong> has achieved significant<br />

progress in research during FY 17-<strong>18</strong>,<br />

with widespread recognition of our<br />

people and our achievements. The<br />

work of our researchers and clinicians<br />

in pursuit of improved patient<br />

outcomes, is possible through the<br />

many partnerships we have in place.<br />

The <strong>Monash</strong> <strong>Health</strong> Translational<br />

Precinct (MHTP), an alliance between<br />

<strong>Monash</strong> <strong>Health</strong>, <strong>Monash</strong> University and<br />

Hudson Institute of Medical Research,<br />

had 1135 active research projects in FY<br />

<strong>2017</strong>-<strong>18</strong>, with $15.3 million new funds<br />

from the National <strong>Health</strong> and Medical<br />

Research Council to ensure lifechanging<br />

medical research is brought<br />

to the bedside. Innovative projects,<br />

such as home-based cancer treatments<br />

and use of virtual reality to alleviate<br />

anxiety in our youngest consumers are<br />

just two examples of the new thinking<br />

fuelling our work.<br />

Growing to meet Victoria’s<br />

healthcare needs<br />

In FY <strong>2017</strong>-<strong>18</strong>, <strong>Monash</strong> <strong>Health</strong> achieved<br />

many Australian and Victorian firsts,<br />

providing the latest equipment,<br />

procedures and services to consumers.<br />

We are now one of only two 24-hour<br />

endovascular clot retrieval services in<br />

Victoria; providing stroke victims with<br />

a better chance of survival. The use of<br />

3D modelling and a new generation<br />

scanner to assess musculoskeletal<br />

disease are just some of the amazing<br />

innovations we made available to<br />

consumers this year. The treatment of<br />

breast cancer through intraoperative<br />

radiotherapy has significantly improved<br />

our patients’ experience.<br />

We are well underway with the<br />

implementation of an Electronic<br />

Medical Record, which is <strong>Monash</strong><br />

<strong>Health</strong>’s biggest technology-based<br />

transformation and due to “go live”<br />

early 2019. It will provide clinicians<br />

with access to timely information about<br />

the people they are caring for, and<br />

assist them in making decisions with<br />

better evidence. For consumers, this<br />

means safer, higher quality care.<br />

We also progressed our capital works<br />

projects substantially, as we continue<br />

to plan for Victoria’s changing and<br />

expanding healthcare needs. Design<br />

consultants began work on our<br />

Victorian Heart Hospital - Victoria’s<br />

first standalone heart hospital that will<br />

bring together clinical practice and<br />

research and innovation.<br />

We continue to deliver our Casey<br />

Hospital expansion project to<br />

schedule, with the main inpatient<br />

tower construction works progressing<br />

well; new theatres and Central Sterile<br />

Services Department on track for<br />

completion by the end of September<br />

2019 and the site’s new front entrance<br />

building will open in late 20<strong>18</strong>. A<br />

key focus of 20<strong>18</strong>-19 will be detailed<br />

operational and budget planning.<br />

Likewise, service and capital planning<br />

for the expansion of Pakenham <strong>Health</strong><br />

Centre commenced in <strong>2017</strong>-<strong>18</strong> and will<br />

continue in 20<strong>18</strong>-19, to ensure it is well<br />

placed to meet growing demand for<br />

community-based services in the south<br />

eastern growth corridor of Melbourne.<br />

Planning for the expansion of<br />

<strong>Monash</strong> Medical Centre’s emergency<br />

department commenced in <strong>2017</strong>-<strong>18</strong>.<br />

This will enable the establishment of<br />

dedicated children’s emergency and<br />

mental health areas and improve traffic<br />

flows at the main entrance, thereby<br />

improving access to the hospital.<br />

Construction will commence in 20<strong>18</strong>-19.<br />

6 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Barbara Yeoh AM<br />

Chair of the Board of Directors<br />

(to 30 June 20<strong>18</strong>)<br />

Andrew Stripp<br />

Chief Executive<br />

Dipak Sanghvi<br />

Chair of the Board of Directors<br />

A fond farewell for our<br />

Chair of the Board<br />

This year marked the final chapter of a<br />

longstanding relationship with <strong>Monash</strong><br />

<strong>Health</strong> for our Board Chair, Ms Barbara<br />

Yeoh AM.<br />

Barbara has been an outstanding<br />

leader at <strong>Monash</strong> <strong>Health</strong> since 2009,<br />

guiding the organisation with calm<br />

determination through significant<br />

periods of change and growth.<br />

Barbara’s leadership has inspired our<br />

Board and Executive to commit to<br />

patient-focussed care and an ethos of<br />

continuous improvement. Barbara has<br />

remained dedicated to providing strong<br />

governance, with a focus on quality<br />

and safety. She is a leader who inspires<br />

by example and who is generous with<br />

her personal and professional support.<br />

<strong>Monash</strong> <strong>Health</strong> wishes her all the very<br />

best for the future.<br />

Mr Dipak Sanghvi has taken up the<br />

role of Chair of the Board as of 1 July,<br />

having served on the Board for three<br />

years already.<br />

Engaging with<br />

our community<br />

This year, our Community Advisory<br />

Committee members co-designed<br />

an improvement project to enhance<br />

emergency department patient<br />

experience. Other initiatives, such<br />

as the introduction of our integrated<br />

model for responding to elder abuse,<br />

reflect our belief in extending care<br />

beyond hospital walls and working<br />

together with consumers and their<br />

families to achieve the best<br />

possible outcomes.<br />

Our Primary Care and Population<br />

<strong>Health</strong> Advisory Committee is likewise<br />

progressing <strong>Monash</strong> <strong>Health</strong>’s Chronic<br />

Disease Strategy Implementation<br />

Plan. Once complete, this strategy<br />

will support community health and<br />

community healthcare providers to<br />

deliver diabetes, oral health, and<br />

management of advanced chronic<br />

non-malignant disease and palliative<br />

care in our community.<br />

The development of an Equity and<br />

Inclusion strategy was completed in<br />

<strong>2017</strong>-<strong>18</strong> and sets out the principles<br />

and a program to promote and ensure<br />

respect for all individuals irrespective<br />

of their personal beliefs, identity and<br />

choice of expression. The supporting<br />

action plan will be implemented in<br />

20<strong>18</strong>-19.<br />

Defining our strategic<br />

direction<br />

In <strong>2017</strong>, we began the process of<br />

developing <strong>Monash</strong> <strong>Health</strong>’s 2023<br />

strategic plan. This is a critical time for<br />

the organisation, as we define and focus<br />

our efforts over the next five years.<br />

Throughout the past 12 months,<br />

we listened to our community, our<br />

employees and our partners to<br />

understand what matters most to them,<br />

and what they believe we should aspire<br />

to achieve.<br />

Our 2023 strategic plan, describes our<br />

commitment to the relentless pursuit<br />

of excellence in our care, teaching and<br />

research, as well as the core principles<br />

and priorities to achieve our shared<br />

vision for the future. The plan will be<br />

published in FY 20<strong>18</strong>-19.<br />

Acknowledgements<br />

<strong>Monash</strong> <strong>Health</strong> works with many<br />

organisations and individuals to provide<br />

excellence in care. We acknowledge<br />

and thank the Victorian Government,<br />

Department of <strong>Health</strong> and Human<br />

Services and Federal Government for<br />

supporting us to serve our diverse<br />

and growing community.<br />

We extend grateful thanks to our<br />

Board Members and Executive<br />

for their leadership. To all <strong>Monash</strong><br />

<strong>Health</strong> employees and volunteers,<br />

thank you for your work and the<br />

wonderful contribution you make<br />

every day to the health and well-being<br />

of consumers. And to our community,<br />

we thank you for your feedback<br />

which provides us with rich insights<br />

into how we can improve.<br />

Andrew Stripp<br />

Chief Executive<br />

Dipak Sanghvi<br />

Chair of the Board of Directors<br />

7


Journeys of Inspiration<br />

and Hope book and<br />

exhibition launch<br />

The stories and experiences of people affected by an acquired<br />

brain injury were shared at the launch of a new book and art<br />

exhibition Journeys of Inspiration and Hope in October.<br />

The book is a collation of stories from clients of the <strong>Monash</strong><br />

<strong>Health</strong> Acquired Brain Injury: Slow to Recover (ABI: STR)<br />

program, which has been providing care to clients for 21 years.<br />

ABI: STR Program client Scott<br />

Harris and his mother Marissa<br />

The event was held in the Art Space at <strong>Monash</strong> Medical Centre,<br />

with around 70 consumers and families in attendance. The event<br />

was opened by Chief Executive Andrew Stripp, who reported that<br />

the program was launched in 1996 to provide for the very specific<br />

needs of those with severe to profound head injuries.<br />

Over that time, the program has helped more than 400 people<br />

to meet their rehabilitation goals.<br />

8 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


The year<br />

in review<br />

Delivering exceptional patient care<br />

<strong>Monash</strong> <strong>Health</strong> shines<br />

in National Standards<br />

accreditation<br />

<strong>Monash</strong> <strong>Health</strong> successfully achieved<br />

accreditation in October, against the<br />

National Safety and Quality <strong>Health</strong><br />

Service Standards.<br />

Twenty-two Australian Council on<br />

<strong>Health</strong>care Standards surveyors<br />

travelled across our health service<br />

speaking with staff, consumers and<br />

families. Many areas of <strong>Monash</strong><br />

<strong>Health</strong> performed strongly and<br />

received particular commendation<br />

from surveyors. <strong>Monash</strong> <strong>Health</strong> is now<br />

accredited to October 2020.<br />

Ruth welcomes a baby girl<br />

Ruth Staniscia gave birth to a healthy<br />

baby girl at <strong>Monash</strong> <strong>Health</strong> in<br />

December, after being told her<br />

heart condition could make<br />

pregnancy very risky.<br />

Ruth learned in late 2016 she had a<br />

congenital heart defect, bicuspid valve<br />

disease. Her heart has two leaflets on<br />

her aortic valve, instead of three like<br />

most people. This valve controls the<br />

one-way flow of oxygen-rich blood<br />

from the heart back into the body. Her<br />

condition means her heart was working<br />

overtime and some blood was flowing<br />

the wrong way.<br />

Becoming pregnant could have<br />

resulted in an enlarged artery in her<br />

heart rupturing, threatening her life<br />

and her baby’s.<br />

“In Ruth’s case the valve was also leaky<br />

and of most concern was that her aorta<br />

— the main pipe that attaches that<br />

valve to the body — was a lot bigger<br />

than it should be.” said <strong>Monash</strong> Heart<br />

cardiologist Dr Siobhan Lockwood.<br />

At thirty eight weeks pregnant her<br />

obstetrician Dr Annie Kroushev, from<br />

Jessie McPherson Private Hospital<br />

induced her and in September Ruth<br />

finally gave birth to healthy baby Aeva.<br />

“Seeing this gorgeous healthy looking<br />

girl was just amazing,” Mrs Staniscia<br />

said. “Even though it was a difficult<br />

pregnancy we felt so well looked after.”<br />

From patient to work<br />

experience<br />

In <strong>2017</strong>, Ashlene had surgery at <strong>Monash</strong><br />

<strong>Health</strong> to fix a valve in her heart, after it<br />

was discovered she was suffering from a<br />

congenital heart condition where blood<br />

was leaking and going the wrong way.<br />

She celebrated her 14th birthday in<br />

hospital and was so impressed with<br />

the care she received that she has now<br />

changed her career aspirations and<br />

wants to be a paediatric nurse.<br />

“The experience was lovely, even<br />

though I was stuck at the hospital. Now<br />

I’m really enjoying seeing the other side<br />

of hospital life,” she said.<br />

In 20<strong>18</strong> Ashlene spent a week of work<br />

experience with the <strong>Monash</strong> Heart<br />

team, chatting to consumers, seeing<br />

what happens in a catheter lab, and<br />

helping out nurses on ward tours.<br />

Delirium and dementia<br />

initiative launched<br />

After months of careful planning, the<br />

<strong>Monash</strong> <strong>Health</strong> Delirium and Dementia<br />

Initiative was launched in the general<br />

medicine wards at <strong>Monash</strong> Medical<br />

Centre in July.<br />

The initiative is being introduced<br />

across <strong>Monash</strong> <strong>Health</strong> to provide<br />

high-quality care for consumers with<br />

cognitive impairment, and improve<br />

staff experience in supporting<br />

these consumers. The approach<br />

uses a tailored framework, focusing<br />

on a number of principles of care<br />

throughout the patient journey.<br />

A key resource for the initiative is<br />

<strong>Monash</strong> <strong>Health</strong>’s new Cognition<br />

Clinical Lead, Bri Walpole. Bri will be<br />

based on the wards, helping staff to<br />

implement the principles of care and<br />

problem-solving with the team to<br />

provide safe and high quality care for<br />

consumers with cognitive impairment.<br />

Staff are being asked to be alert to<br />

the risk of delirium and the risk factors<br />

that can precipitate or predispose it;<br />

be aware that consumers with<br />

cognitive impairment are at increased<br />

risk of harm (e.g. falls, pressure injuries)<br />

in hospital; partner with consumers,<br />

families and carers to provide<br />

person-centred care and attend<br />

education sessions.<br />

9


<strong>Monash</strong> <strong>Health</strong> safely<br />

welcomes quadruplets<br />

In January <strong>Monash</strong> <strong>Health</strong> safely<br />

delivered a set of quadruplets,<br />

following a 30-week and one day<br />

gestation period.<br />

Mariam Hussaini and her husband<br />

Mohammed had always dreamed<br />

of having a family, after moving to<br />

Australia from Afghanistan in 2012.<br />

Mariam has been under the care of our<br />

Women’s & Newborn program since<br />

she was three months pregnant, with<br />

the wellbeing of Mariam and babies<br />

carefully monitored by a team of staff.<br />

“Each of the four babies had their own<br />

team, and everyone knew which team<br />

they belonged to,” said <strong>Monash</strong> <strong>Health</strong><br />

Director of Neonatology Dr Charles<br />

Barfield.<br />

All four boys were delivered safely by<br />

caesarean section.<br />

Named Elyas and Almaas (identical<br />

twins) and Rayan and Shayan (fraternal<br />

twins), all four were born healthy and<br />

progressed so well that they were able<br />

to go home in early April.<br />

Kidsafe Victoria opens<br />

Community Centre at<br />

<strong>Monash</strong> Children’s Hospital<br />

The Victorian Minister for Families<br />

and Children, the Hon Jenny Mikakos<br />

MP opened Kidsafe Victoria’s new<br />

Community Centre at <strong>Monash</strong><br />

Children’s Hospital in August.<br />

<strong>Monash</strong> <strong>Health</strong> Chief Operating<br />

Officer, Martin Keogh said <strong>Monash</strong><br />

Children’s Hospital is proud to work<br />

alongside Kidsafe Victoria to support<br />

them in education and advocacy that<br />

prevents injuries to children.<br />

“We treat over 30,000 children every<br />

year at this hospital, and many of them<br />

are here because of unintentional<br />

injuries and accidents,” he said.<br />

“The Kidsafe Children’s Injury<br />

Prevention Hub will be an asset for<br />

<strong>Monash</strong> Children’s Hospital, for our<br />

staff, parents, consumers and visitors.”<br />

Erica Edmands, President of Kidsafe<br />

Victoria said the opening of the new<br />

Child Injury Prevention Centre was<br />

made possible by many sponsors and is<br />

a major milestone for Kidsafe Victoria.<br />

“The location at the <strong>Monash</strong> Children’s<br />

Hospital will provide parents, carers,<br />

hospital staff and early childhood<br />

services with central access to<br />

lifesaving information,” she said.<br />

“The new Centre will increase<br />

opportunities to expand Kidsafe<br />

Victoria’s interaction with the<br />

community, as well as facilitate injury<br />

prevention initiatives in partnership<br />

with <strong>Monash</strong> Children’s Hospital.”<br />

Cassy and Hayley celebrate<br />

a very special school formal<br />

For many teenagers, the school<br />

Formal is the biggest event of the<br />

social calendar.<br />

School friends, Cassy and Hayley were<br />

both devastated that they couldn’t<br />

attend their formal last week.<br />

<strong>Monash</strong> Children’s Hospital<br />

Occupational Therapist, Larissa said<br />

she didn’t want the girls to miss out on<br />

the important occasion.<br />

“When the girls told me they were<br />

missing out on their Formal I thought<br />

– why can’t we bring the Formal to<br />

them?” she said.<br />

Larissa and her team worked to pull<br />

together a celebration the girls would<br />

never forget. Cassy and Hayley had<br />

grins from ear to ear and enjoyed party<br />

food, beautiful outfits, dancing, great<br />

music, and most importantly, lots<br />

of friends.<br />

In the lead up to the event, Hayley had<br />

been in bed for almost a week after<br />

undergoing surgery and that day was<br />

her first out of bed.<br />

Hayley’s mum Sharlene said she was<br />

absolutely blown away by the effort<br />

everyone had gone to for the girls.<br />

“It’s so wonderful to see all of their<br />

school friends here, the staff made<br />

cakes and the Starlight Captains<br />

painted their nails,” she said,<br />

“thank you.”<br />

Starlight Express Room<br />

opens at <strong>Monash</strong> Children’s<br />

Hospital<br />

In October, <strong>Monash</strong> <strong>Health</strong> officially<br />

opened the Starlight Express Room at<br />

<strong>Monash</strong> Children’s Hospital.<br />

The Starlight Express Room and<br />

Starlight Captains play a vital role in<br />

bringing fun, happiness and laughter to<br />

consumers and their families every day.<br />

<strong>Monash</strong> <strong>Health</strong> Chief Executive<br />

Andrew Stripp said <strong>Monash</strong> Children’s<br />

Hospital has been a proud partner<br />

with Starlight for many years. “This<br />

is a space for children to forget that<br />

they’re in hospital; to be children, not<br />

consumers,” he said.<br />

“The Starlight Captains help to<br />

support children when they are<br />

in hospital, providing a range<br />

of activities and distractions to<br />

improve their experience.”<br />

We are incredibly grateful to the<br />

Starlight Captains, staff, volunteers,<br />

supporters and ambassadors to have<br />

this amazing space in our hospital.”<br />

10 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Baby Harry<br />

goes home<br />

after 176 days<br />

For first time parents Belinda and Ivan Campbell,<br />

it was concerning when their baby needed to<br />

come into the world extremely early on 28 March<br />

<strong>2017</strong> at just 27 weeks, weighing just 730 grams.<br />

As a nurse, Belinda knew it was essential to have<br />

her baby delivered in a hospital with a Neonatal<br />

Intensive Care Unit (NICU) after she was<br />

diagnosed with preeclampsia.<br />

Baby Harry has gone through a lot to survive his<br />

first six months of life.<br />

With severe lung complications, he had to spend<br />

many weeks on a ventilator on life support and<br />

later underwent surgery.<br />

But he proved to be a fighter.<br />

At the time <strong>Monash</strong> <strong>Health</strong>’s neonatologist,<br />

Dr Atul Malhotra said, “as one of the first,<br />

sickest and most delicate consumers to be<br />

moved into the new <strong>Monash</strong> Newborn service<br />

on 19 April, it took ten specially trained staff to<br />

move him across.”<br />

“Harry has done great in the last few months,<br />

he is a little trooper.”<br />

Belinda and Ivan have a unique perspective<br />

of NICU life, having spent time in the old unit<br />

before being part of the move.<br />

“The new NICU is light, spacious and so<br />

comfortable. We are so grateful to the wonderful<br />

care we have received at <strong>Monash</strong> Children’s<br />

Hospital,” said Belinda.<br />

We can report little Harry was able to leave<br />

hospital and go home in September.<br />

<strong>Monash</strong> Medical Centre<br />

celebrates 30 years<br />

Current and past staff came together<br />

to celebrate the 30th anniversary of<br />

<strong>Monash</strong> Medical Centre in September.<br />

Memories and stories of the hospital’s<br />

past were shared between the 200<br />

guests during the celebratory event<br />

with an historical exhibition on display.<br />

Among many great memories, the<br />

event reunited Jessica Bailey and her<br />

parents Susan and Michael with the<br />

doctor who delivered the first baby -<br />

Jessica - at <strong>Monash</strong> Medical Centre,<br />

Dr Paul Shekleton. Professor Richard<br />

Harper, interim Director <strong>Monash</strong>Heart<br />

and Emeritus Professor of Cardiology<br />

took the audience through the journey<br />

of creating a cardiology service for<br />

the south east, which has resulted<br />

in <strong>Monash</strong>Heart being the largest<br />

cardiovascular service provider in<br />

Victoria. Jennine Harbrow, Acting<br />

Operations Director <strong>Monash</strong> <strong>Health</strong><br />

Community, shared her experience as a<br />

senior nurse over this period.<br />

Since its inception <strong>Monash</strong> Medical<br />

Centre has cared for more than two<br />

million people, helped to deliver close<br />

to 120,000 babies and supported<br />

hundreds of thousands of Victorian<br />

families through difficult times.<br />

11


Innovation<br />

Symptom and urgent<br />

review clinic<br />

A symptom and urgent review clinic<br />

for oncology patients began at<br />

Dandenong Hospital.<br />

Funded with a Department of <strong>Health</strong><br />

and Human Services competitive grant,<br />

the clinic runs four days a week and<br />

consists of advanced practice nurse<br />

in oncology, Gurpreet Grewal, and<br />

experienced oncology pharmacist,<br />

Chihao La, with oncologists support.<br />

Supportive care clinics are a pillar<br />

of modern oncology services. The<br />

objective of the clinic is to provide<br />

practical support to consumers<br />

receiving cancer treatment so that<br />

toxicities can be identified early and<br />

effectively managed.<br />

It is expected that pre-emptive<br />

management will reduce emergency<br />

department and hospital presentations<br />

and allow consumers to maintain<br />

their independence and quality of life.<br />

Appropriate consumers are identified<br />

by clinicians including doctors, nurses,<br />

and allied health staff.<br />

3D printing an education<br />

tool for surgical trainees<br />

and medical students<br />

In May, a team at <strong>Monash</strong> <strong>Health</strong> and<br />

<strong>Monash</strong> University created the first<br />

3D printed model of a three-year-old<br />

patient’s abnormal biliary tree and<br />

choledochal cyst, to improve the<br />

planning and outcome of her corrective<br />

surgery. The technology has also<br />

enhanced the educational experience<br />

for medical staff and students.<br />

The novel project, led by <strong>Monash</strong><br />

<strong>Health</strong> Consultant Paediatric and<br />

Neonatal Surgeon, Mr Ram Nataraja,<br />

who is also Director of Surgical<br />

Simulation and a Senior Lecturer<br />

at <strong>Monash</strong> University, was also<br />

published in the Journal of<br />

Paediatrics and Child <strong>Health</strong>.<br />

Mr Nataraja’s team constructed a<br />

3D model of the patient’s cyst, a rare<br />

congenital enlargement of the bile<br />

ducts. Mr Nataraja said the child had<br />

a straight forward uncomplicated<br />

post-operative recovery with no<br />

operative complications and has<br />

remained well since her surgery.<br />

Transforming care across<br />

<strong>Monash</strong> <strong>Health</strong><br />

<strong>Monash</strong> <strong>Health</strong> is undergoing a whole<br />

of hospital transformation, to provide<br />

the best possible care and experience<br />

for consumers.<br />

In the <strong>2017</strong>/<strong>18</strong> financial year the<br />

Transforming Care program has:<br />

• Encouraged and supported all<br />

employees to speak up regarding any<br />

safety concerns.<br />

• Allocated $<strong>18</strong>.1m towards<br />

replacement of medical equipment.<br />

• Continued to embed clinicians<br />

as managers and leaders in the<br />

health service.<br />

• Invested $2.6m in nursing leadership,<br />

to ensure nurse managers were able<br />

to allocate their time in accordance<br />

with clinical and management<br />

priorities, rather than working within<br />

nurse ratios.<br />

• Commenced the organisation-wide<br />

multi-day bed reconfiguration; to<br />

assist patient flow, and reduce the<br />

moving of people once admitted to<br />

an inpatient ward.<br />

• Improved the ability of clinical teams<br />

to communicate patient-related task<br />

requests and evenly distribute<br />

workload over night by implementing<br />

the electronic Smartpage system.<br />

• Attracted $172,379 in competitive<br />

funding for the <strong>2017</strong> Victorian<br />

Telehealth Specialist Clinic Funding<br />

Project, to improve access to adult<br />

specialist clinics for regional and<br />

rural consumers in collaboration with<br />

Gippsland <strong>Health</strong> Services.<br />

• This enabled, for example, the<br />

first adult telehealth conference<br />

between Casey Haematology Clinic,<br />

a Gippsland patient and a local GP<br />

clinic; saving the patient a 14+ hour<br />

round trip. See story below.<br />

• Commenced roll out of an electronic<br />

referral triage system to replace paper<br />

processes and eliminate the risk of<br />

lost referrals in specialist clinics.<br />

• Commenced relocation of paediatric<br />

and high safety risk adult clinics to<br />

fit-for-purpose specialist consulting<br />

clinic space.<br />

• Implemented a specialist consulting<br />

data dashboard, to enable<br />

transparency and allow staff<br />

to make data-driven decisions.<br />

• Introduced multidisciplinary inpatient<br />

ward based leadership teams, to<br />

support local areas to support ward<br />

performance and deliver patient<br />

centred care at the local level.<br />

• Implemented prioritised patient<br />

care pathways and investigations<br />

framework, to enable safe and<br />

direct patient admissions from<br />

our emergency departments to<br />

inpatient wards.<br />

• Improved ambulance offload<br />

processes in our emergency<br />

departments. This saved over 250<br />

hours in ‘Ambulance Victoria in<br />

corridors time’ from November to<br />

December <strong>2017</strong>, which significantly<br />

decreased the time ambulances<br />

were off the road.<br />

12 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Telehealth pilot program<br />

saves John 14 hour commute<br />

Gippsland-based John Bailey was<br />

delighted with <strong>Monash</strong> <strong>Health</strong>’s pilot<br />

adult telehealth service, after he was<br />

invited to participate in the program<br />

in June.<br />

John’s specialist appointments<br />

previously required a time commitment<br />

of more than 14 hours, including travel<br />

to Casey Hospital and back from<br />

Bruthen, a small town 20 minutes’<br />

drive east of Bairnsdale.<br />

In the past, appointments have meant<br />

a 4:30am wakeup and the hassle of car,<br />

train, and bus travel.<br />

“People don’t really understand the<br />

stress and anxiety that causes, because<br />

you don’t know the bus lines, or the<br />

train might be delayed or you end up<br />

on the wrong line. And there’s only so<br />

many magazines you can read!”<br />

Often, John would end up getting back<br />

home to Bruthen after 10pm at night.<br />

During the consultation, John spoke<br />

to his specialist via a phone and web<br />

connection at his local medical clinic,<br />

and was able to be home again in just<br />

90 minutes.<br />

“It was fantastic,” John said. “It felt<br />

like I was sitting in the room, sitting<br />

across the table with the doctor.<br />

You could see his face and speak to<br />

him as if he was there. It was all very<br />

personable and easy.”<br />

John was able to travel to his local<br />

clinic in Bairnsdale, the Macleod<br />

Street Medical Centre.<br />

Practise Manager at the centre, Mr<br />

Wayne Howlett, liaised with <strong>Monash</strong><br />

<strong>Health</strong> to ensure a private consultation<br />

room and the technology required.<br />

“Wayne had everything ready to go,<br />

and the Macleod Street Medical Centre<br />

were really helpful,” John said.<br />

John was ‘virtually’ checked in as a<br />

<strong>Monash</strong> <strong>Health</strong> patient at the Casey<br />

Specialist Consulting Clinic. After<br />

a private consultation, including<br />

immediate pathology requests and<br />

blood samples taken locally, John<br />

was able to make the short drive<br />

home again.<br />

“For people in the region, this will save<br />

us hours and hours of travel just to see<br />

a specialist that we otherwise may not<br />

have access to,” John said.<br />

“It was really excellent; a 20 minute<br />

drive that I’m used to, and I even had<br />

time to get my shopping done!”<br />

John’s GP also received a detailed<br />

letter after the appointment for any<br />

follow-up.<br />

Geriatric oncology clinic<br />

now open<br />

<strong>Monash</strong> <strong>Health</strong> Department of<br />

Oncology, in collaboration with<br />

Southern Metropolitan Integrated<br />

Cancer Service, announced the opening<br />

of our first Geriatric Oncology Clinic at<br />

Dandenong Hospital in February.<br />

The clinic places the focus on the whole<br />

patient, and includes collaborative<br />

patient management by a geriatrician,<br />

an oncologist, and allied health<br />

professionals.<br />

Every patient undergoes a<br />

comprehensive geriatric assessment,<br />

which identifies otherwise hidden<br />

problems including malnutrition,<br />

cognitive impairment, frailty, and<br />

social vulnerability. The information<br />

allows clinicians, consumers and<br />

families to tailor cancer treatment in a<br />

way that allows elderly consumers to<br />

benefit from modern therapies, while<br />

protecting them from risks.<br />

Establishing key community links to<br />

support function is a vital aspect of<br />

this clinic. The clinic is staffed by Dr<br />

Ranjana Srivastava, an oncologist who<br />

trained at the University of Chicago’s<br />

award-winning geriatric oncology clinic<br />

and Dr Irene Wagner, a geriatrician<br />

with extensive experience in managing<br />

dementia, behavioural issues, and<br />

the broader community needs of the<br />

elderly. They are supported by a range<br />

of hospital-based and community allied<br />

health services.<br />

<strong>Monash</strong> Children’s Hospital<br />

School officially opened<br />

The Victorian Premier, the Hon Daniel<br />

Andrews MP and Minister for Education<br />

the Hon James Merlino MP officially<br />

opened the <strong>Monash</strong> Children’s Hospital<br />

School in October.<br />

Welcomed to <strong>Monash</strong> Children’s<br />

Hospital by school Principal, Colin<br />

Dobson, the Premier and Minister visited<br />

young people as they worked alongside<br />

teaching staff.<br />

The school is run by the Department<br />

of Education, with teachers delivering<br />

classes throughout the hospital,<br />

including at students’ bedsides,<br />

in small activity rooms, and in central<br />

ward areas. There will soon also be four<br />

purpose-designed classrooms and a<br />

specialist art room.<br />

Classrooms feature hot desk areas and<br />

are equipped with cameras and the<br />

latest technology to enable students<br />

to virtually connect with teachers and<br />

classmates at their regular school, and<br />

with their families at home.<br />

13


24/7 Endovascular Clot<br />

Retrieval service saving<br />

stroke patients<br />

Victorian stroke victims now have a<br />

better chance of survival, with a new<br />

clot retrieval service improving stroke<br />

survival rates.<br />

<strong>Monash</strong> Medical Centre joined The<br />

Royal Melbourne Hospital as the<br />

state’s only 24/7 Endovascular Clot<br />

Retrieval hospitals. The service enables<br />

consumers to be transported for rapid<br />

treatment no matter where the patient<br />

is located.<br />

In <strong>2017</strong>/20<strong>18</strong>, 112 patients received<br />

endovascular clot retrieval compare<br />

to 70 patients in 2016/<strong>2017</strong>. In <strong>2017</strong> we<br />

performed 91 retrievals. In the first<br />

seven months of 20<strong>18</strong> we had already<br />

performed 83 cases and we estimate<br />

about 130-150 cases will be performed<br />

in 20<strong>18</strong>.<br />

First published by Nine News,<br />

17 September <strong>2017</strong>.<br />

A 30-minute heart disease<br />

test is being trialled by<br />

<strong>Monash</strong>Heart doctors<br />

A 30-minute test for coronary<br />

artery disease aims to cut the<br />

number of invasive investigations<br />

consumers have to undergo to get<br />

their diagnosis confirmed.<br />

The single test, which uses a patient’s<br />

CT scan to make a 3D model of the<br />

heart arteries and simulate blood<br />

flow, is designed to be faster with<br />

less potential side effects than<br />

current techniques.<br />

<strong>Monash</strong>Heart Interventional Cardiology<br />

Fellow, Dr Abdul Rahman Ihdayhid<br />

said when a patient was suspected of<br />

having clogged arteries, they usually<br />

had a CT scan. While it could highlight<br />

narrowing in these small tubes, he said<br />

that without further invasive tests, the<br />

cardiac CT could not say how blood<br />

flow to the heart was affected.<br />

Not all clogged arteries require a stent<br />

or bypass surgery and in some cases<br />

medication is sufficient.<br />

“The current gold standard for<br />

measuring blood flow is an angiogram,”<br />

Dr Ihdayhid said.<br />

“It’s done in the catheter lab where<br />

we put a specialised pressure wire<br />

down someone’s coronary artery<br />

and measure the blood flow. It’s an<br />

invasive procedure associated with<br />

potential side effects, discomfort to<br />

the patient, and considerable cost<br />

to the health system.”<br />

New generation bone<br />

scanner first in Australia<br />

A new generation scanner to assess<br />

musculoskeletal disease was made<br />

available to <strong>Monash</strong> <strong>Health</strong> consumers<br />

in March.<br />

The XtremeCT-II measures bone<br />

density and quantifies the threedimensional<br />

microarchitecture<br />

of bones (including 3D bone<br />

microstructure, tendons, cartilage,<br />

joints, muscle, fat and vascular<br />

calcification) at the highest resolution<br />

and precision currently available.<br />

“The XtremeCT-II is the only one of its<br />

kind in Australia and will allow cutting<br />

edge musculoskeletal research both<br />

domestically and internationally,”<br />

Research Fellow, Dr Ayse Zengin said.<br />

There are only two of these scanners<br />

in the world—the other is in China.<br />

The XtremeCT-II will be available as<br />

a research platform for researchers,<br />

clinicians and surgeons, ensuring<br />

collaboration between health<br />

care professionals.<br />

Head, Department of Medicine, School<br />

of Clinical Sciences at <strong>Monash</strong> <strong>Health</strong>,<br />

Professor Peter Ebeling, AO, heads up<br />

the Bone and Muscle Research Group<br />

at <strong>Monash</strong> University. Prof Ebeling<br />

anticipates using a low-radiation<br />

method for high-resolution imaging of<br />

bone, muscle and joints will enhance<br />

understanding of musculoskeletal<br />

conditions, enabling effective<br />

preventative and treatment strategies.<br />

Virtual reality to distract<br />

children during medical<br />

procedures<br />

Clinicians at <strong>Monash</strong> Children’s Hospital<br />

and <strong>Monash</strong> University are conducting<br />

a research study using virtual reality<br />

— an interactive computer system that<br />

can be ‘seen’ when wearing a headset<br />

and smartphone — to help distract<br />

consumers from procedures in our<br />

pathology and emergency departments.<br />

Current pain management techniques,<br />

such as local anaesthetic cream or<br />

distraction is inadequate for some<br />

children and may result in the need for<br />

restraints and/or sedation.<br />

Young consumers can now explore a<br />

virtual ocean and interact with friendly<br />

sea life, all while a doctor is performing<br />

medical procedures, including<br />

venepuncture or the inserting an<br />

intravenous cannula. These procedures<br />

can often be upsetting for children and<br />

family members.<br />

14 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Trial provides<br />

treatment at home<br />

for cancer patients<br />

The Hospital in the Home program was involved in a trial of a new way<br />

of treating cancer patients deemed at low risk of febrile neutropenia, a<br />

complication of chemotherapy usually treated with antibiotics.<br />

Until recently, consumers were treated as inpatients with IV antibiotics.<br />

Consumers now have the option of being safely treated in their own<br />

environment; shown to have great benefits for consumers and carers,<br />

and efficiencies for healthcare providers.<br />

The project was first trialled at the Peter MacCallum Cancer Centre,<br />

where it found inpatient length of stay was reduced from four days to<br />

less than one day.<br />

The program brings together several departments at <strong>Monash</strong> <strong>Health</strong><br />

and collaboration and education among staff and departments is<br />

expected to provide great benefits to consumers.<br />

L-R: Andre Levak, Low Risk Febrile<br />

Neutropenia Coordinator, Rhonda and<br />

Vicki McLeod, Oncology Nurse Practitioner.<br />

15


Pet therapy puppy Abby visits a young<br />

patient at <strong>Monash</strong> Children’s Hospital.<br />

Capital works<br />

Moorabbin Hospital –<br />

refurbished imaging and<br />

outpatient areas<br />

We were delighted to welcome The<br />

Hon Jill Hennessy MP, Victorian<br />

Minister for <strong>Health</strong> and Ambulance<br />

Services, and Mr Nick Staikos MP,<br />

Member for Bentleigh, to Moorabbin<br />

Hospital in November, to visit newlyrefurbished<br />

diagnostic imaging and<br />

outpatient areas.<br />

The $16.2 million capital project has<br />

already made a significant difference<br />

to the way Moorabbin Hospital cares<br />

for consumers.<br />

A new MRI machine and PET CT<br />

scanning technology have begun<br />

to operate at the site, with enhanced<br />

facilities for the imaging team.<br />

The outpatients’ area has also been<br />

improved, with additional consultation<br />

suites and a naturally-lit, more<br />

open environment.<br />

Casey Hospital expansion<br />

progresses on schedule<br />

Casey Hospital is poised to deliver<br />

even more services to one of the<br />

fastest growing areas in Melbourne’s<br />

south-east. Funded by the Victorian<br />

Government, construction began<br />

in <strong>2017</strong>, in conjunction with the<br />

Department of <strong>Health</strong> and Human<br />

Services and Plenary Group, and<br />

the project has reached a number of<br />

milestones in FY <strong>2017</strong>-<strong>18</strong>.<br />

The main inpatient tower construction<br />

works are progressing well and will<br />

be handed over in stages. The new<br />

theatres and Central Sterilising<br />

Supply Department is a major project<br />

milestone and is on track for completion<br />

by the end of September 2019.<br />

A number of internal refurbishment<br />

works will commence over coming<br />

months to create a new pharmacy<br />

and expand pathology services. The<br />

site’s new front entrance building is<br />

due to open in September 20<strong>18</strong>. The<br />

front entrance building will provide<br />

new retail areas for the site and also<br />

accommodate <strong>Monash</strong> University.<br />

Expansion is needed to ensure that<br />

Casey Hospital has the capacity<br />

and services needed to provide the<br />

residents of Casey and Cardinia with<br />

quality care at their local facility, given<br />

the unprecedented growth in this area<br />

and the need for increased specialised<br />

services. Construction is expected to<br />

be completed in 2019.<br />

16 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Happy 1st birthday <strong>Monash</strong><br />

Children’s Hospital!<br />

On 19 April <strong>Monash</strong> <strong>Health</strong> celebrated the first birthday of <strong>Monash</strong> Children’s Hospital<br />

(MCH). Staff and consumers came together to join in activities and entertainment,<br />

including an animal farm, face painting and a teddy bear hospital.<br />

Channel 9 was there to capture all the fun, as <strong>Monash</strong> celebrated its first year of<br />

operations. The MCH is only the second dedicated paediatric tertiary hospital in<br />

Victoria, and focusses on providing state-of-the-art facilities and care in a childfriendly<br />

environment.<br />

Victorian Heart Hospital<br />

development $320m funding<br />

boost<br />

The Victorian Government announced<br />

in December it will invest an additional<br />

$320 million to build the Victorian<br />

Heart Hospital, Victoria’s first<br />

standalone heart hospital that will bring<br />

together clinical practice and research.<br />

In FY <strong>2017</strong>-<strong>18</strong> design consultants were<br />

appointed and design has commenced,<br />

with construction scheduled to<br />

commence later in 20<strong>18</strong>.<br />

The newest hospital for <strong>Monash</strong> <strong>Health</strong><br />

is due for completion in 2022. Project<br />

partners <strong>Monash</strong> University will have<br />

embedded researchers within the<br />

facility, allowing cutting-edge research<br />

to directly benefit consumers.<br />

The total project is projected to cost<br />

$543 million, and the new hospital will<br />

have 195 beds, with the capacity to<br />

provide 2000 cardiac surgeries each<br />

year, 13,500 cardiac catheterisation<br />

laboratory procedures and 108,000<br />

consultations and outpatient<br />

appointments.<br />

<strong>Monash</strong> Medical Centre<br />

opens new state-of-the-art<br />

angiography facility<br />

<strong>Monash</strong> Medical Centre now offers<br />

more consumer emergency treatment,<br />

after opening our new innovative,<br />

state-of-the-art treatment facility<br />

in June.<br />

Professor Timothy Buckenham,<br />

Interventional Radiologist said that<br />

in <strong>2017</strong>, <strong>Monash</strong> <strong>Health</strong> treated 2400<br />

consumers with a comprehensive<br />

range of procedures to diagnose or<br />

treat consumers with cerebrovascular<br />

disease, kidney disease, sepsis,<br />

bleeding, aneurysms, and cancer.<br />

The new Biplane Angiography Suite<br />

is equipped with a new-generation<br />

image-guided therapy platform,<br />

capable of performing a wide range<br />

of routine and minimally-invasive<br />

catheter-based procedures in the<br />

interventional lab.<br />

Neuro-Interventional Radiologist and<br />

Head of Endovascular Clot Retrieval,<br />

Professor Ronil Chandra said the new<br />

facility is a major improvement for<br />

patient care at <strong>Monash</strong> <strong>Health</strong> and will<br />

increase capacity to provide lifesaving<br />

treatment to consumers across the<br />

south east of Victoria.<br />

The new Azurion Biplane<br />

Angiography imaging platform is<br />

one of the first of its kind installed<br />

in Australia, featuring substantial<br />

hardware and software upgrades.<br />

17


Research and<br />

partnerships<br />

Our research vision<br />

To be a health service that integrates excellence in clinical<br />

services, education and research. <strong>Monash</strong> <strong>Health</strong> provides<br />

a supportive and dynamic environment for health care<br />

professionals to conduct world-class clinical and translational<br />

research that drives improved clinical practice.<br />

<strong>Monash</strong> <strong>Health</strong><br />

Translation Precinct<br />

The <strong>Monash</strong> <strong>Health</strong> Translation<br />

Precinct (MHTP) partnership aims to be<br />

a world leader in translational research,<br />

generating innovative scientific<br />

discoveries and revolutionising clinical<br />

care in a dynamic and collaborative<br />

environment.<br />

The MHTP is a partnership between<br />

<strong>Monash</strong> <strong>Health</strong>, Hudson Research<br />

Institute and <strong>Monash</strong> University. MHTP<br />

is also a critical component of <strong>Monash</strong><br />

Partners Academic <strong>Health</strong> Science<br />

Centre. Through these partnerships,<br />

leading researchers have direct access<br />

to clinicians and consumers, enabling<br />

scientific breakthroughs to reach<br />

the bedside more effectively than<br />

ever before.<br />

Areas of focus within the MHTP<br />

include:<br />

• Cancer<br />

• Neurosciences<br />

• Endocrinology<br />

• Inflammation<br />

• Women’s, Children’s, and<br />

Reproductive <strong>Health</strong>.<br />

Breast cancer: Single<br />

dose of radiation replaces<br />

daily treatment<br />

A single nine-minute dose of radiation<br />

therapy delivered during breast cancer<br />

surgery has replaced three to five<br />

weeks of daily treatment at <strong>Monash</strong><br />

<strong>Health</strong>. Intra-operative radiotherapy<br />

was trialled in <strong>2017</strong>-<strong>18</strong> at Moorabbin<br />

Hospital, together with Peter<br />

MacCallum Cancer Centre. The trial<br />

found if radiation was delivered at<br />

the time of surgery to remove the<br />

tumour, it was as effective as standard<br />

external radiation.<br />

The trial and introduction of the therapy<br />

into standard care practices, means<br />

Victorian women with early, low-risk<br />

breast cancer are among the first in<br />

the world to have access to intraoperative<br />

radiation therapy, which<br />

could revolutionise cancer treatment by<br />

allowing it to be completed in one day.<br />

Consumers previously required<br />

up to 25 hospital visits to complete<br />

their treatment.<br />

Intra-operative radiotherapy offers<br />

women with early stage breast cancers<br />

another therapeutic option, a better<br />

patient experience and a more rapid<br />

return to normal activity. The technique<br />

delivers radiation to a more targeted<br />

area through a balloon in the resection<br />

cavity, which spares organs and tissue<br />

from radiation.<br />

Aspirin and the mysteries of<br />

preeclampsia<br />

A <strong>Monash</strong> <strong>Health</strong> researcher involved<br />

in world-first research is spreading<br />

the word about a simple solution to a<br />

potentially-deadly condition.<br />

Dr Daniel Rolnik was part of a team of<br />

researchers whose ground-breaking<br />

research was published in June’s edition<br />

of the prestigious New England Journal<br />

of Medicine. The large study screened<br />

almost 27,000 women in six countries,<br />

revealing aspirin is an effective<br />

treatment for preventing preeclampsia.<br />

Preeclampsia is a major cause of<br />

maternal and infant death around the<br />

world. It is often unclear what causes<br />

preeclampsia, with treatment options<br />

often limited once the condition<br />

has developed.<br />

Dr Rolnik found improved screening<br />

and a simple daily dose of inexpensive<br />

aspirin could dramatically reduce the<br />

incidence and mortality numbers.<br />

He observed a 60 per cent reduction<br />

in the development of preterm<br />

preeclampsia in women taking a low<br />

dose of aspirin during pregnancy,<br />

compared to the placebo group, and<br />

more than 80 per cent reduction in<br />

preeclampsia requiring delivery before<br />

34 weeks.<br />

<strong>Monash</strong> <strong>Health</strong> doctors<br />

invent bidirectional cannula<br />

to save limbs and lives<br />

<strong>Monash</strong> <strong>Health</strong> clinicians led a<br />

collaboration of Australian organisations<br />

to solve a global medical problem that<br />

will save lives around the world.<br />

A ‘bidirectional cannula’ device was<br />

developed by three <strong>Monash</strong> <strong>Health</strong> and<br />

<strong>Monash</strong> University clinicians. It is likely<br />

to significantly reduce complication<br />

rates around the world during certain<br />

types of heart surgery procedures.<br />

<strong>18</strong> <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


In FY <strong>2017</strong>-<strong>18</strong>:<br />

470<br />

New research projects<br />

approved by <strong>Monash</strong><br />

<strong>Health</strong> Human Research<br />

Ethics Committee<br />

1,135<br />

Active research<br />

projects.<br />

In <strong>2017</strong>/<strong>18</strong>:<br />

$15.3+<br />

million<br />

In National <strong>Health</strong><br />

and Medical Research<br />

Council (NHMRC)<br />

funding awarded<br />

to <strong>Monash</strong> <strong>Health</strong><br />

and <strong>Monash</strong> <strong>Health</strong><br />

Translation Precinct<br />

partners.<br />

374<br />

Clinical drug<br />

or device trials<br />

implemented<br />

229<br />

Quality improvement<br />

and service activities<br />

registered<br />

In <strong>2017</strong>:<br />

$20+<br />

million<br />

In funding for<br />

commercially sponsored<br />

clinical trials by<br />

leading pharmaceutical<br />

and biotechnology<br />

companies for national<br />

and international<br />

clinical research.<br />

19


The device has been designed,<br />

engineered, and tested in Australia.<br />

The clinical trials of the device was<br />

made possible by a generous grant<br />

from the Victorian Government.<br />

The device is used to connect<br />

consumers to a heart-lung machine<br />

through a large artery at the top of<br />

the leg. Clinical trials of the device at<br />

the Alfred Hospital, led by Associate<br />

Professor Silvana Marasco, have<br />

yielded very favourable results.<br />

The new device has shown tremendous<br />

promise in reducing the risk of leg<br />

ischaemia (lack of oxygen supply), a<br />

potentially serious complication that<br />

can occur during heart surgery and in<br />

consumers requiring artificial cardiac<br />

support in intensive care units.<br />

A world-first treatment for<br />

pelvic organ prolapse<br />

<strong>Monash</strong> <strong>Health</strong> has collaborated with<br />

Hudson Institute of Medical Research<br />

on a world-first approach to treating<br />

pelvic organ prolapse.<br />

With lab research underway, clinical<br />

trials are expected to begin in the next<br />

three to five years.<br />

A new bio-construct created by<br />

combining stem cells from the lining<br />

of a woman’s own uterus will be used<br />

to restore quality of life to women with<br />

pelvic organ prolapse, and to prevent<br />

the condition from occurring<br />

in younger women.<br />

Pelvic organ prolapse is a lifelong,<br />

potentially debilitating condition,<br />

predominantly caused by the impact of<br />

childbirth. It affects an estimated one<br />

in four women, and around one in two<br />

women aged over 50.<br />

Associate Professor Anna Rosamilia,<br />

head of the Pelvic Floor Unit at<br />

<strong>Monash</strong> <strong>Health</strong> says “It’s exciting to<br />

be part of a research team looking<br />

at new treatment options for pelvic<br />

organ prolapse which use degradable<br />

scaffolds and the woman’s own<br />

mesenchymal endometrial stem cells.<br />

Theoretically this should translate into<br />

better healing than currently available<br />

options but the technology needs<br />

further vigorous testing to establish<br />

its place.”<br />

World’s largest clinical<br />

trial in follicular lymphoma<br />

providing hope<br />

An international collaborative study,<br />

including researchers at <strong>Monash</strong><br />

<strong>Health</strong> and <strong>Monash</strong> University, has<br />

shown that follicular lymphoma<br />

patients treated with a therapy known<br />

as obinutuzumab, in combination with<br />

chemotherapy, leads to significant<br />

improvements in how the disease<br />

is controlled.<br />

Published in the prestigious New<br />

England Journal of Medicine in<br />

October, the results from the largest<br />

ever follicular lymphoma clinical trial<br />

revealed that consumers treated with<br />

a combination of chemotherapy and<br />

obinutuzumab had their disease under<br />

control for one and a half times longer<br />

than the standard treatment with<br />

chemotherapy and rituximab.<br />

The Gallium study was the largest<br />

clinical trial ever conducted in<br />

follicular lymphoma, comparing<br />

the safety and effectiveness of two<br />

different anti-lymphoma antibodies<br />

(rituximab and obinutuzumab), in<br />

combination with chemotherapy for<br />

consumers with previously untreated<br />

follicular lymphoma.<br />

1202 consumers — including 30 at<br />

<strong>Monash</strong> <strong>Health</strong>, the largest recruitment<br />

site in Australia—were randomly<br />

selected to receive chemotherapy with<br />

rituximab or chemotherapy<br />

with obinutuzumab.<br />

It’s hoped this new technique will<br />

trick the body or modify its immune<br />

response to promote healing rather<br />

than scarring, which will help to repair<br />

the damage.<br />

20 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


<strong>Monash</strong>Heart and <strong>Monash</strong> University<br />

research wins trifecta of prizes<br />

<strong>Monash</strong>Heart interventional cardiology fellow and <strong>Monash</strong> University PhD candidate Dr Abdul Ihdayhid<br />

was recognised for his ground-breaking research into coronary artery disease, receiving two highly<br />

prestigious awards in Perth in August. The two awards follow on from Dr Ihdayhid’s Young Investigator<br />

Award in July, at the Society of Cardiovascular Computed Tomography in Washington D.C.<br />

Dr Ihdayhid was awarded the highly regarded Ralph Reader Prize at the annual scientific<br />

meeting of the Cardiac Society of Australia & New Zealand as well as the prestigious<br />

Geoff Mews Memorial Fellows’ Prize at the Australia & New Zealand Endovascular Therapies<br />

Meeting for his research into assessing the functional significance of coronary artery disease.<br />

21


Our people<br />

<strong>Monash</strong> <strong>Health</strong> farewells<br />

Board Chair Barbara Yeoh AM<br />

On 27 June, more than one hundred<br />

people from <strong>Monash</strong> <strong>Health</strong><br />

community came together to farewell<br />

our Board Chair, Barbara Yeoh AM.<br />

<strong>Monash</strong> <strong>Health</strong> Chief Executive<br />

Andrew Stripp said how extremely<br />

fortunate <strong>Monash</strong> <strong>Health</strong> has been to<br />

have Barbara guiding the organisation<br />

through so many changes over the<br />

past nine years.<br />

The event included a video, with<br />

special words from Chief Executive<br />

Andrew Stripp, Board Member Charles<br />

Gillies, Wurundjeri Elder Margaret<br />

Gardiner, Professor Euan Wallace AM,<br />

Moorabbin Hospital Ladies Auxiliary<br />

President Pat Huggins OAM, Director<br />

of Nursing Hospital in the Community,<br />

<strong>Monash</strong> <strong>Health</strong> Community and<br />

Allied <strong>Health</strong> Jennine Harbrow, and<br />

the Minister for <strong>Health</strong> the Hon. Jill<br />

Hennessy MP.<br />

Ms Hennessy said, “Barbara has done<br />

extraordinary things for <strong>Monash</strong> <strong>Health</strong><br />

and for the entire community. She’s a<br />

champion for patients, she’s a champion<br />

for diversity, and she’s a champion for<br />

the workforce. We have been so lucky<br />

to have had her service.”<br />

Andrew Stripp said, “Barbara has<br />

made an extraordinary commitment to<br />

health care, but I think one of her other<br />

achievements is her humanity and<br />

commitment to patient care<br />

and experience.”<br />

Concluding the event, Barbara took the<br />

time to say thank you and farewell. She<br />

shared a quote from Winnie the Pooh,<br />

“How lucky am I to have something that<br />

makes saying goodbye so hard.”<br />

Staff recognised at <strong>Monash</strong><br />

<strong>Health</strong> awards<br />

The <strong>Monash</strong> <strong>Health</strong> Awards is a<br />

chance to celebrate, recognise, and<br />

congratulate staff for outstanding<br />

work. Each year, nominations are<br />

received from across the organisation,<br />

in 12 award categories. Submissions<br />

exemplify excellence, innovation,<br />

quality, safety, and leadership.<br />

In FY <strong>2017</strong>-<strong>18</strong>, <strong>Monash</strong> <strong>Health</strong> hosted<br />

two separate award ceremonies; in<br />

August <strong>2017</strong> and June 20<strong>18</strong>.<br />

Aboriginal Graduate and<br />

Cadetship Program wins<br />

national awards<br />

Aboriginal Graduate and Cadetship<br />

Program Coordinator, Judy Clayton,<br />

and Aboriginal <strong>Health</strong> Midwife and<br />

Aboriginal Graduate and Cadet<br />

Congratulations to the winners<br />

of the <strong>2017</strong> and the 20<strong>18</strong> <strong>Monash</strong><br />

<strong>Health</strong> Awards:<br />

In <strong>2017</strong>: Associate Professor Peter Poon,<br />

Jeff Chen, Janelle Finn, Dr Ramini Shankumar,<br />

Michelle Ravesi, Jacquie McBride, Alyce Cuman,<br />

Katrina Clarke, Annette Bezzant, Associate<br />

Professor Ronil Chandra, Dr Hashrul Rashid,<br />

General Medicine Unit, Accountable Care team,<br />

Dandenong Hospital, Fiona McAlinden, and<br />

Helen Stubbs.<br />

In 20<strong>18</strong>: Jeff Chen, Dr Michael Gordon and<br />

the Early in Life Mental <strong>Health</strong> Service, Dr Atul<br />

Malhotra and The Stem Cell BPD Team, Associate<br />

Professor Peter Poon and The Supportive Chronic<br />

Conditions Care Team, Jacquie McBride, Kate<br />

Plowright, Dr Ramini Shankumar and The Dental<br />

<strong>Health</strong> Services team, Dr Christina Johnson and<br />

The <strong>Monash</strong> Doctors Education team, Dr Jacquie<br />

Taylor and The <strong>Monash</strong> Newborn Team, Anne<br />

Marie Hadley and the Patient eXperience Team,<br />

and Associate Professor Michelle Giles.<br />

22 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Support Officer, Tracey Stephens,<br />

recently attended the Congress of<br />

Aboriginal and Torres Strait Islander<br />

Nurses and Midwives (CATSINaM)<br />

conference on the Gold Coast to<br />

receive a partnership award and Sally<br />

Goold Award for individual excellence<br />

in nursing.<br />

The CATSINaM Partnership Award<br />

is presented to organisations<br />

that actively establish culturally<br />

respectful, committed, and successful<br />

partnerships between their members<br />

and other organisations. This was<br />

awarded to the <strong>Monash</strong> <strong>Health</strong><br />

Aboriginal Graduate and Cadetship<br />

program for its organisation-wide<br />

commitment to increasing the number<br />

of Aboriginal nurses and midwives<br />

employed within our service and for<br />

ensuring Aboriginal staff have access<br />

to a range of career development and<br />

employment opportunities.<br />

Tracey Stephens was also presented<br />

with the Sally Goold Award for<br />

individual nursing and/or midwifery<br />

excellence that recognises her<br />

achievements as an Aboriginal<br />

midwife who has made substantial<br />

contributions to the nursing and<br />

midwifery profession, and the health<br />

of Aboriginal and Torres Strait Islander<br />

Australians.<br />

Length of Service awards<br />

celebrate our staff and<br />

volunteers<br />

In November, <strong>Monash</strong> thanked our<br />

many staff and volunteers at the annual<br />

Length of Service Awards. Over 540<br />

certificates were presented throughout<br />

the day, a testament to our dedicated<br />

and passionate people.<br />

Staff completing 10, 15, 20, 25, 30,<br />

35, and 40 years of service were<br />

acknowledged, together with<br />

volunteers completing five years or<br />

more of service. One volunteer, Carlene<br />

Powell, was honoured for achieving<br />

an amazing 50 years of service with<br />

<strong>Monash</strong> <strong>Health</strong>.<br />

People Matter Survey results<br />

In <strong>2017</strong>, almost 3400 staff, or 31 per<br />

cent of our total employees, took the<br />

time to share their views as part of<br />

the People Matter Survey. In 20<strong>18</strong>, the<br />

response rate more than doubled to<br />

4 per cent.<br />

Release of the full 20<strong>18</strong> results is<br />

pending, however the <strong>2017</strong> results<br />

presented excellent feedback,<br />

including: most staff believe the<br />

work they do is important, more staff<br />

observed managers driving a safetycentred<br />

culture, where patient care<br />

errors are handled appropriately, and<br />

more people report that they work in<br />

a fair and inclusive workplace.<br />

Full results for <strong>2017</strong> were rolled<br />

out during the year at our People<br />

Matter Forums.<br />

Using creative strategies to<br />

enhance patient wellbeing<br />

As part of the <strong>Monash</strong> <strong>Health</strong> Delirium<br />

and Dementia Initiative, a dedicated<br />

group of medical, allied health and<br />

nursing staff found creative ways to<br />

support patient care in the acute general<br />

medical units at <strong>Monash</strong> Medical Centre.<br />

From left, Board member and in-coming<br />

Board Chair, Dipak Sanghvi, Board<br />

Member, Dandenong and District<br />

Aborigines Co-operative Ltd., Margaret<br />

Gardiner and Chief Executive Officer,<br />

Dandenong and District Aborigines<br />

Co-operative Ltd., Andrew Gardiner.<br />

23


People with dementia and delirium are<br />

more vulnerable to falls and pressure<br />

injuries. Hospitals are unfamiliar<br />

environments, which often disrupt usual<br />

routines and can be disorientating.<br />

To meet the challenge of providing<br />

meaningful activities and engagement<br />

for people with a cognitive impairment<br />

in hospital, the general medical teams<br />

developed a dementia and delirium<br />

resource library.<br />

A bake sale raised approximately<br />

$1300 to support patient wellbeing<br />

and engagement and helped to fund<br />

‘dementia-safe’ sensory and tactile<br />

resources such as gel mats, a ‘plumber’s<br />

mate’ and magnetic building blocks.<br />

Other resources include reminiscence<br />

cards and a toss-and-talk ball activity<br />

to build on person-centred care, which<br />

can foster social and physical skills and<br />

collaboration between consumers, their<br />

family and the multidisciplinary team.<br />

A range of ‘fidget blankets’ has also<br />

been created; used to provide sensory<br />

and tactile stimulation. People with<br />

dementia and other forms of cognitive<br />

impairment often find comfort in having<br />

something to keep their hands busy,<br />

especially those staying in an unfamiliar<br />

environment like a hospital. Fidget<br />

blankets can help people feel calm<br />

while keeping them occupied.<br />

<strong>Monash</strong> <strong>Health</strong> hosted first<br />

Schwartz Round (19 Oct)<br />

<strong>Monash</strong> <strong>Health</strong> hosted its first Schwartz<br />

Round in November. The Schwartz<br />

Rounds are a multidisciplinary forum,<br />

where clinical and non-clinical staff can<br />

discuss social and emotional issues that<br />

arise in caring for consumers.<br />

The program comes from The<br />

Schwartz Center for Compassionate<br />

<strong>Health</strong>care, an independent, nonprofit<br />

organisation with more than<br />

425 healthcare members in the US,<br />

Canada, Australia and New Zealand.<br />

The Centre was founded by Ken<br />

Schwartz, days before his death from<br />

cancer in 1995. His experience as a<br />

patient drove him to establish the<br />

organisation with the mission to promote<br />

compassionate care so that consumers<br />

and their caregivers relate to one<br />

another in a way that provides hope to<br />

the patient, support to caregivers and<br />

sustenance to the healing process.<br />

In <strong>2017</strong>, <strong>Monash</strong> <strong>Health</strong> became a<br />

member of the Schwartz Centre. A<br />

Schwartz Rounds Planning Committee,<br />

chaired by Associate Professor Andrew<br />

Block was then created to oversee all<br />

future rounds.<br />

Dr Anjali Dhulia, Director Medical<br />

Services, said the program provided an<br />

important opportunity for staff to reflect<br />

on their experiences as caregivers.<br />

“The Schwartz Rounds bring doctors,<br />

nurses and allied health caregivers as<br />

well as non-clinical staff together to<br />

discuss the human side of healthcare,” Dr<br />

Dhulia said.<br />

“The purpose of Rounds is to understand<br />

the challenges and rewards that are<br />

central to providing care, not to solve<br />

problems or to focus on the clinical<br />

aspects of patient care.”<br />

<strong>Monash</strong> <strong>Health</strong> recognised<br />

in the <strong>2017</strong> Victorian Public<br />

<strong>Health</strong>care Awards<br />

The Victorian Public <strong>Health</strong>care Awards<br />

recognise and celebrate excellence,<br />

dedication and innovation in public<br />

health, health services and service<br />

initiatives that deliver informed and<br />

effective health care. Areas that received<br />

acknowledgement included:<br />

Category: Excellence in CALD health<br />

The GP Engagement Initiative: Building<br />

capacity in primary healthcare to<br />

respond to refugee health needs –<br />

Highly Commended<br />

Category: Excellence in public sector<br />

aged care<br />

Residential in Reach: Thinking outside<br />

the box - Highly Commended<br />

Category: Secretary’s Award for<br />

improving integration of care for<br />

consumers with chronic and complex<br />

conditions<br />

Oncopain Clinic: Provision of<br />

multidisciplinary rapid access<br />

cancer pain assessment and<br />

management - Finalist .<br />

A new world for nursing<br />

recruitment at <strong>Monash</strong> <strong>Health</strong><br />

<strong>Monash</strong> <strong>Health</strong> began a six-month trial of<br />

a Centralised Recruitment Model (CRM)<br />

for all nursing and midwifery roles. With<br />

well over 7000 nursing and midwifery<br />

staff working at <strong>Monash</strong> <strong>Health</strong>, the<br />

CRM represents a collaborative new<br />

way of managing the recruitment of<br />

permanent and fixed-term nursing and<br />

midwifery roles. Clinical hiring managers<br />

have partnered with a dedicated<br />

recruitment specialist to support them in<br />

the end-to-end recruitment process.<br />

The CRM partnership has helped to<br />

ensure only the best talent is recruited;<br />

more quickly and at a lower cost. The<br />

model also gives back valuable time<br />

to our clinical nursing hiring managers<br />

to provide exceptional care and an<br />

enhanced patient experience<br />

Professors David Kissane, AC<br />

and Barbara Workman, AC<br />

recognised in Australia<br />

Day honours<br />

Professor David Kissane, Head of<br />

Department of Psychiatry, School of<br />

Clinical Sciences at <strong>Monash</strong> <strong>Health</strong> and<br />

Professor Barbara Workman Service<br />

Director for Rehabilitation and Aged<br />

Care at <strong>Monash</strong> <strong>Health</strong> were made<br />

Companions of the Order of Australia in<br />

the 20<strong>18</strong> Australia Day Awards.<br />

24 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Professor Barbara Workman received<br />

this award for her significant service<br />

to geriatric and rehabilitation medicine,<br />

as a clinician, academic and educator,<br />

and as a leader in the provision of aged<br />

care services.<br />

Professor Kissane received his honour<br />

in recognition for his contribution to<br />

psycho-oncology and palliative medicine,<br />

as an educator, researcher, author and<br />

clinician, and through executive roles<br />

with a range of national and international<br />

professional medical bodies.<br />

Diana Egerton-Warbuton<br />

inducted into Victorian<br />

Honour Roll of Women<br />

Associate Professor Diana Egerton-<br />

Warburton was inducted into the<br />

Victorian Honour Roll of Women in 20<strong>18</strong>.<br />

Currently the Director of Emergency<br />

Research and Innovation at <strong>Monash</strong><br />

<strong>Health</strong>, Diana has worked for almost<br />

three decades in Victorian emergency<br />

departments. She has trained and<br />

mentored a new generation of<br />

emergency medicine specialists and is<br />

passionate about developing women<br />

in leadership roles. She is Associate<br />

Professor with the School of Clinical<br />

Sciences at <strong>Monash</strong> University and<br />

the National Drug Research Institute<br />

at Curtin University. She has also<br />

advised Victorian and Commonwealth<br />

governments on alcohol and drug policy.<br />

Diana’s research has always focussed on<br />

patient needs, with a particular interest<br />

in reducing alcohol harm. Diana served<br />

as President of the Australasian Society<br />

for Emergency Medicine from 1997 to<br />

2000, where she was an advocate for the<br />

non-specialist workforce and recognised<br />

for her teaching, training, research, and<br />

public health achievements.<br />

25


26 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Our community<br />

Refugee Week 20<strong>18</strong><br />

In June we celebrated Refugee Week,<br />

which raises awareness about issues<br />

affecting refugees and recognises the<br />

valuable contribution refugees make to<br />

Australian society.<br />

The theme of this year’s Refugee Week<br />

is #WithRefugees.<br />

<strong>Monash</strong> <strong>Health</strong> has a long-standing<br />

commitment to improving the health<br />

of asylum seekers and refugees across<br />

Melbourne’s south-east. This is most<br />

strongly reflected in <strong>Monash</strong> <strong>Health</strong>’s<br />

multidisciplinary refugee service,<br />

Refugee <strong>Health</strong> and Wellbeing, located<br />

in Dandenong.<br />

After years of working closely with<br />

local refugee communities, Refugee<br />

<strong>Health</strong> and Wellbeing has become<br />

familiar with stories of the tragic<br />

circumstances that bring asylum<br />

seekers and refugees to Australia.<br />

However, we have also experienced the<br />

many ways that refugee communities<br />

embrace new opportunities with<br />

strength, resilience, and determination<br />

through countless stories of success.<br />

Refugee Week was a way for the<br />

organisation to reflect on the diverse<br />

journeys of others, consider our<br />

personal roles in creating a fair, just,<br />

and inclusive society, and celebrate the<br />

diversity that makes Australia a vibrant<br />

and culturally-rich nation.<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong><br />

General Meeting<br />

More than 100 people attended the<br />

<strong>2017</strong> <strong>Annual</strong> Meeting in November.<br />

<strong>Monash</strong> <strong>Health</strong> Board Chair Barbara<br />

Yeoh delivered the opening address,<br />

followed by a detailed account of<br />

the achievements and successes of<br />

the organisation presented by Chief<br />

Executive Andrew Stripp.<br />

Mr Stripp reported on the<br />

organisation’s clinical, operational,<br />

safety, capital and financial results,<br />

including <strong>Monash</strong> <strong>Health</strong> meeting all<br />

of its service delivery targets within its<br />

2016-17 operating budget of $1.7 billion.<br />

Mr Stripp also shared patient<br />

stories and our progress on<br />

organisational-wide priorities, such<br />

as patient experience, response to<br />

family violence, aboriginal health,<br />

sustainability initiatives, research<br />

and innovation. He also spoke about<br />

opportunities and guiding principles<br />

as <strong>Monash</strong> <strong>Health</strong> develops its new<br />

strategic plan.<br />

Keynote speaker was Dr Beth Wilson<br />

AM. A lawyer by training, Dr Wilson<br />

is an expert in mental health and a<br />

passionate consumer rights advocate.<br />

Dr Wilson spoke about <strong>Monash</strong><br />

<strong>Health</strong>’s duties to its consumers,<br />

including the recently produced<br />

‘Statutory duty of candour’, which<br />

recommends legislation which would<br />

ensure consumers and their families<br />

are told when and why things go wrong<br />

with their care.<br />

Committed volunteer goes<br />

above and beyond<br />

Dayawati Lal has been volunteering<br />

at Dandenong Hospital since 2013.<br />

Originally from Fiji, it is part of<br />

Dayawati’s culture and Hindu beliefs<br />

to give back to the community in<br />

which she lives.<br />

Dayawati is one of the first friendly<br />

faces you see when entering<br />

Dandenong Hospital, she provides<br />

important directions and guidance to<br />

consumers and their visitors. She also<br />

spreads hope and happiness with the<br />

delivery of flowers to the wards on<br />

Tuesday mornings.<br />

But Dayawati wanted to do even more<br />

for <strong>Monash</strong> <strong>Health</strong> consumers. She<br />

came to her shift one afternoon with<br />

the funds to purchase a wheelchair.<br />

“I wanted to give something useful<br />

to the people who need help moving<br />

around the hospital,” she said.<br />

We thank Dayawati and all of our<br />

committed volunteers who generously<br />

give their time to help consumers and<br />

their families.<br />

Integrated Model for<br />

Responding to Elder Abuse<br />

at <strong>Monash</strong> <strong>Health</strong><br />

In December, <strong>Monash</strong> <strong>Health</strong> launched<br />

a project to deliver an Integrated<br />

Model for Responding to Elder Abuse.<br />

The new model focusses on identifying<br />

and responding as part of a whole of<br />

health approach to elder abuse using<br />

a family centred approach, which<br />

engages both the person being abused<br />

and the person responsible.<br />

This new initiative is a 12-month project<br />

funded by the Department of <strong>Health</strong><br />

and Human Services through the Elder<br />

Abuse Prevention and Response Unit.<br />

The department has funded five trial<br />

sites throughout Victoria.<br />

The integrated model of care includes<br />

four key components: workforce<br />

training, an Elder Abuse Prevention<br />

Response liaison officer, counselling<br />

and mediation (including financial<br />

counselling), and an elder abuse<br />

prevention network. <strong>Monash</strong> <strong>Health</strong><br />

has partnered with like-minded<br />

organisations to help us achieve this,<br />

including St Vincent’s Hospital, the<br />

Bouverie Centre and FMC Mediation,<br />

and Counselling Victoria.<br />

27


The <strong>Monash</strong><br />

<strong>Health</strong> Foundation<br />

The <strong>Monash</strong> <strong>Health</strong> Foundation partners with the<br />

community through philanthropy to support the<br />

incredible work of <strong>Monash</strong> <strong>Health</strong>.<br />

Generous giving from individuals,<br />

organisations, and passionate fundraisers<br />

has enabled the purchase of state-of-theart<br />

equipment, investment in research<br />

and provided additional comfort and<br />

wellbeing programs for consumers and<br />

their families.<br />

Thank you to every person, family and<br />

organisation that has helped make a<br />

difference to our consumers through<br />

generous donations.<br />

20<strong>18</strong> has been a great year as we<br />

have built on the successful events<br />

of the past, forged new partnerships<br />

and strengthened our community of<br />

philanthropy. Through the launch of the<br />

Imagination Appeal we have reached new<br />

donors and inspired many to continue<br />

their support.<br />

We are particularly grateful to the people,<br />

groups and organisations who have<br />

supported <strong>Monash</strong> <strong>Health</strong> through direct<br />

gifts or by dedicating their time and<br />

energy to organising extraordinary events<br />

that have lasting impact:<br />

• The inaugural Premier’s Golf Day<br />

was held in support of the <strong>Monash</strong><br />

Children’s Hospital NICU. Over<br />

$400,000 was raised to purchase<br />

new equipment including a state-ofthe-art<br />

transportation cot. The event<br />

was supported by Victoria’s property<br />

development community and was<br />

attended by the Honourable Daniel<br />

Andrews MP, Premier of Victoria along<br />

with cricket legends Ian Botham and<br />

Dean Jones.<br />

• Bailey’s Golf Day has raised over $3<br />

million to fund paediatric oncology<br />

fellows at the <strong>Monash</strong> Children’s<br />

Hospital Cancer Centre.<br />

• The 2nd annual My Room Footy<br />

Show Telethon was held in August.<br />

Funds raised by My Room have<br />

been committed to support a<br />

Clinical Research Training program,<br />

Dietetics, Physiotherapy, a 3D<br />

pain distraction system, and<br />

patient families undergoing long<br />

term treatment.<br />

• Lincoln and Veronique Wulff and the<br />

Dandelion Wishes Gala Committee<br />

for their ongoing dedication and<br />

commitment to paediatric health,<br />

now in its third year, the annual gala<br />

has raised over $1.2 million for the<br />

<strong>Monash</strong> Children’s Hospital. Funds<br />

from this year’s event purchasing an<br />

echocardiograph for the Paediatric<br />

Intensive Care Unit.<br />

• The Friends of the Children Foundation<br />

who continue to support the <strong>Monash</strong><br />

Children’s Hospital through their<br />

fundraising and involvement in The<br />

Walk for <strong>Monash</strong> Children’s Hospital<br />

which raised nearly $200,000 this year.<br />

• Richard Lim and the Cambodian<br />

community came together to celebrate<br />

the inaugural Lim’s Pharmacy Charity<br />

Dinner Dance raising over $100,000<br />

for <strong>Monash</strong> <strong>Health</strong> and <strong>Monash</strong><br />

Children’s Hospital.<br />

• The annual <strong>Monash</strong> CF Foundation<br />

Charity Golf held at Cheltenham<br />

Golf Club, led by Felicity Stretch and<br />

her dedicated volunteers raised over<br />

$12,600. The funds support the Cystic<br />

Fibrosis service at <strong>Monash</strong> Children’s<br />

Hospital and <strong>Monash</strong> <strong>Health</strong> which<br />

treats over 230 kids & adults with<br />

Cystic Fibrosis.<br />

• Jennifer Herbert who is currently<br />

undergoing treatment for cancer,<br />

wanted consumers in the public health<br />

system to have the same options for<br />

treatment as those in private hospitals.<br />

Jennifer has inspired generosity<br />

from others and raised an amazing<br />

$81,000 to purchase two scalp cooling<br />

machines that preserve a patient’s hair<br />

during chemotherapy.<br />

28 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


29


Acknowledgment<br />

65km for Cystic Fibrosis Committee<br />

ALH Group Pty Ltd<br />

Amgen Australia Pty Ltd<br />

Anna Marsenovic<br />

Anna Wang<br />

Anthony Bellgrove<br />

Anthony Caligiuri Director –<br />

Mt Atkinson Holdings<br />

ANZAPP Vic<br />

ASL Real Estate<br />

Bailey’s Day<br />

BankVic<br />

Beletti Restaurant Cafe Bar<br />

Berwick Opportunity Shop<br />

Blueways Group<br />

BMF Construction<br />

Boston Scientific<br />

Brent and Jessica Cameron on behalf<br />

of Brooke Cameron<br />

Cambodian Community MCH<br />

Fundraising Event<br />

Camp Quality<br />

Cancer Council Victoria<br />

CEPIA – Cardiac Electrophysiology<br />

Institute of Australasia<br />

Chain Reaction<br />

Channel 9<br />

Children’s Cancer Foundation<br />

Chobani<br />

City of Casey<br />

Collier Charitable Fund<br />

Cystic Fibrosis Community Care<br />

Dandelion Wishes Gala Committee<br />

Effie Atkins’ Dr Hope<br />

Estate of Doris and Rupert Joseph<br />

Estate of EC Blackwood<br />

Estate of Ernest Finlay Burns<br />

Estate of John Frederick Wright<br />

Estate of John Lambrick<br />

Estate of Lindsay James Baldy<br />

Estate of Martin and Isobel McLoughlin<br />

Estate of Maxwell John Bradford<br />

Estate of Muriel Bradley<br />

Estate of Eva Tidswell<br />

Estate of William and Mary Levers &<br />

Sons Maintenance Fund<br />

Estate of William Macrow<br />

Exclusive Networks<br />

First State Super<br />

Freemasons Foundation Victoria<br />

Friends of the Children Foundation<br />

Giac Hoang Pagoda<br />

HESTA Superfund<br />

Indimax Productions<br />

INKA Surgical Instruments<br />

Jennifer Herbert<br />

John Kilpatrick<br />

John Plumridge – MAW Civil Pty Ltd<br />

Julie Biggar<br />

K Henzen<br />

KARL STORZ Endoscopy Australia<br />

Kaspersky Lab<br />

Kids with Cancer Foundation<br />

Australia<br />

Lady Marigold Southey AC<br />

Lim’s Parmacy<br />

Lincoln & Veronique Wulff<br />

Lions Club of Clarinda<br />

Lions Club of Dandenong Supper –<br />

District 201V5<br />

Lions Club of Waverley<br />

Lotus Oaks Development<br />

Louis and Lesley Nelken Trust Fund<br />

Mary MacKillop Foundation<br />

Maxxia<br />

Mazda Foundation<br />

McGrath Foundation<br />

Medical Indemnity Protection<br />

Society (MIPS)<br />

Medtronic Australasia Pty Ltd<br />

Melbourne Racing Club Foundation<br />

Mercedes-Benz Berwick<br />

Miei Fiori<br />

Moller Family Foundation<br />

<strong>Monash</strong> Cystic Fibrosis Foundation<br />

<strong>Monash</strong> Plastic &<br />

Reconstructive Surgery<br />

<strong>Monash</strong> University<br />

Moorabbin Hospital Ladies Auxiliary<br />

Moose Toys<br />

Mr Rolf Burggraaff<br />

My Room<br />

Paragon Financial Group<br />

Patterson Cheney<br />

Pellicano Property & Constructions<br />

Premier’s Golf Day<br />

Redkite<br />

Rombotis Event Trust<br />

Rotary Club of Endeavour Hills<br />

Rubbermaid (Newell Brands)<br />

Sam Polimeni<br />

Scleroderma Victoria Inc.<br />

Scottish Pacific<br />

Sparkling Car Wash<br />

Spicer Thoroughbreds<br />

Stihl Shop Ferntree Gully<br />

Stockwood Building Group<br />

Thai Hoa Long<br />

The Appu Family<br />

The Flinders Group (Tass & Tina Arhon<br />

and Steve Panopoulos)<br />

The Foundation for Aids Research (amfAR)<br />

The Garry White Foundation<br />

The Honda Foundation<br />

The Miranda Foundation<br />

The <strong>Monash</strong> Kids Support Group<br />

The Ricky Taylor Foundation Inc.<br />

The Teo Chew Chinese Assoc. of Vic.<br />

The Walt Disney Company<br />

The Wood Family<br />

Thi Ly<br />

Tom and Margo Hartley<br />

Unicharm Australasia<br />

Watsons<br />

Yan Wo Tong Chinese Medicine Centre<br />

Zagame Automotive Group.<br />

Thank you<br />

The <strong>Monash</strong> <strong>Health</strong> Foundation<br />

acknowledges the generosity of all<br />

the people who have supported the<br />

work of <strong>Monash</strong> <strong>Health</strong> throughout<br />

the year.<br />

In particular, we extend our gratitude<br />

to those who have raised funds in<br />

celebration of a special occasion<br />

or have given a gift in memory of<br />

a loved one.<br />

Our auxiliary members have, as<br />

always, worked tirelessly to raise<br />

funds for <strong>Monash</strong> <strong>Health</strong>. The<br />

extraordinary commitment from this<br />

wonderful group of people to support<br />

our <strong>Monash</strong> <strong>Health</strong> consumers<br />

continues to inspire generosity from<br />

our community.<br />

30 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


A journey starts<br />

with one small step<br />

Seven years ago, three mums decided to make a difference and<br />

raise funds to support vital research into cystic fibrosis (CF).<br />

After significant planning and<br />

organisation, Susan Biggar, Julie<br />

Noorman and Kathy Ryan, (all CF<br />

Mums) launched ‘65km for Cystic<br />

Fibrosis’ (www.65kmforcf.com.au),<br />

a 65km endurance walk to raise funds<br />

for research. The event exceeded their<br />

own expectations both in terms of<br />

participation and fundraising.<br />

As parents of children living with CF,<br />

these extraordinary mums know the<br />

value of research to improve the quality<br />

It is truly<br />

inspirational<br />

to witness and<br />

support such<br />

dedicated<br />

fundraisers.<br />

Matthew Hannan,<br />

<strong>Monash</strong> <strong>Health</strong> Foundation<br />

of life for their children. This was the<br />

driving factor and the motivation<br />

to work tirelessly to raise money to<br />

support research into CF.<br />

Cystic fibrosis is a complicated disease,<br />

it primarily effects the lungs and<br />

digestive system and there is currently<br />

no cure.<br />

<strong>Monash</strong> <strong>Health</strong> provides lifetime care<br />

for over 200 adults and children with<br />

cystic fibrosis. Every year, an average<br />

of eight newly diagnosed babies are<br />

referred to <strong>Monash</strong> <strong>Health</strong>’s Cystic<br />

Fibrosis clinic.<br />

Funds raised from the <strong>2017</strong> event have<br />

funded three research projects we<br />

hope will have a lasting impact on the<br />

lives of these consumers.<br />

• Studying the impact of DNase<br />

with early stage lung disease<br />

to decrease inflammation and<br />

infection. This project has the<br />

potential to improve the long-term<br />

outcome in children with CF<br />

• Investigating the effect of an<br />

innovative treatment to improve<br />

sinus symptoms, quality of life,<br />

and the amount of infections<br />

for people living with CF and<br />

sinus disease<br />

• Develop the optimal, patient-centred<br />

model of care for people with cystic<br />

fibrosis Related Diabetes.<br />

The small but amazing team continue<br />

their unwavering commitment to the<br />

cause, raising over $600k since 2013<br />

and funding more than 10 research<br />

projects.<br />

The team has now been joined by Sue<br />

Emery and Phil Ryan which has seen<br />

the event grow in its participation rates<br />

and success, remarkably raising over<br />

$147,000 in 20<strong>18</strong>. The Committee will<br />

work with health care professionals,<br />

researchers, and the CF community<br />

to determine priority projects for<br />

consideration with funding from this<br />

year’s event.<br />

In 2016, the team was awarded the<br />

Premier’s Volunteer of the Year, Dame<br />

Elisabeth Murdoch Award for Teamwork,<br />

for their inspiring contribution.<br />

‘65km for Cystic Fibrosis’ Committee<br />

members, from left, Julie Noorman,<br />

Susan Biggar, Kathy Ryan and Sue Emery.<br />

31


Our sites, services<br />

and staff<br />

Our sites<br />

<strong>Monash</strong> <strong>Health</strong> provides services to almost a quarter of metropolitan<br />

Melbourne’s population. We also play a significant role in providing<br />

regional and state-wide specialist services in Victoria.<br />

Casey Hospital<br />

Casey Hospital is a 273-bed hospital<br />

serving one of the fastest growing<br />

areas in Melbourne’s south-east.<br />

Services include an emergency<br />

department, general medical, mental<br />

health, rehabilitation, surgical and<br />

ambulatory care services, maternity,<br />

and a special care nursery. The hospital<br />

is a provider of paediatric services for<br />

<strong>Monash</strong> Children’s Hospital and gives<br />

access to the leading cardiac services<br />

of <strong>Monash</strong>Heart.<br />

Cranbourne Centre<br />

Cranbourne Centre provides a range<br />

of same-day acute and subacute<br />

services including surgery, renal<br />

dialysis, specialist consulting services,<br />

regional ophthalmology services and<br />

mental health services. It also provides<br />

the local community with access to<br />

community health services and a<br />

community rehabilitation centre.<br />

Dandenong Hospital<br />

Dandenong Hospital is a 573-bed<br />

acute hospital providing a wide range<br />

of health services to the people<br />

living and working in Dandenong and<br />

its surrounding areas. The hospital<br />

provides a number of general and<br />

specialist services. These services<br />

include general medical and surgical,<br />

an intensive care unit, <strong>Monash</strong>Heart<br />

cardiac care centre, rehabilitation<br />

and aged care services, pathology,<br />

radiology, maternity unit, special<br />

care nursery, children’s services,<br />

outpatients, day chemotherapy,<br />

home haemodialysis, mental health<br />

services, and allied health services.<br />

Dandenong Hospital also provides<br />

specialist services including<br />

orthopaedic, plastics, vascular,<br />

facio-maxillary, gynaecology,<br />

respiratory, and infectious diseases.<br />

Kingston Centre<br />

Kingston Centre is a 213-bed<br />

subacute facility specialising in<br />

high-quality rehabilitation, functional<br />

restoration, transitional care and aged<br />

mental health. The highly regarded<br />

rehabilitation program focuses on<br />

restoring function after illness or injury<br />

with the full range of allied health<br />

services provided to adults of all ages.<br />

The centre provides specialist services<br />

for older people including aged care<br />

assessment, cognitive dementia and<br />

memory services. It also offers a Falls<br />

and Balance Clinic, Pain Clinic, clinical<br />

gait analysis, and continence service.<br />

It is at the forefront of research into<br />

movement and gait disorders, aged<br />

mental health and geriatric medicine.<br />

<strong>Monash</strong> Medical Centre<br />

Clayton<br />

<strong>Monash</strong> Medical Centre Clayton is<br />

a 640-bed teaching and research<br />

hospital, providing a comprehensive<br />

range of specialist surgical, medical,<br />

allied health and mental health services<br />

to the community.<br />

Specialist units include coronary<br />

care, intensive care and neonatal<br />

intensive care.<br />

The hospital is designated a national<br />

provider of renal and pancreatic<br />

transplants, and statewide provider<br />

of Thalassemia and children’s<br />

cancer services.<br />

It is the base for <strong>Monash</strong>HEART,<br />

a centre of excellence in cardiac<br />

assessment, treatment and research;<br />

and <strong>Monash</strong> Children’s, Hospital.<br />

Uniquely offering maternity and<br />

newborn services integrated on the one<br />

site, <strong>Monash</strong> Medical Centre provides<br />

one of Victoria’s largest women’s health<br />

services. It is also renowned for men’s<br />

health services.<br />

Moorabbin Hospital<br />

Moorabbin Hospital is a 147-bed<br />

hospital incorporating <strong>Monash</strong> Cancer<br />

Centre, one of Victoria’s leading cancer<br />

treatment centres, and operating in<br />

partnership with Peter MacCallum<br />

Cancer Centre. The hospital also offers<br />

elective surgery, short-stay care and<br />

dialysis. Home to Victoria’s first Patient<br />

Simulation Centre, the hospital plays a<br />

major role in the education and training<br />

of undergraduate and postgraduate<br />

medical students, nurses, and allied<br />

health professionals. The hospital hosts<br />

the Southern Melbourne Integrated<br />

Cancer Services and is a centre for<br />

research, and in particular, a major<br />

contributor to cancer-related research.<br />

<strong>Monash</strong> Children’s Hospital<br />

<strong>Monash</strong> Children’s Hospital (MCH)<br />

is a network of paediatric healthcare<br />

services across three sites – the main<br />

Clayton campus (co-located with<br />

<strong>Monash</strong> Medical Centre), together<br />

with satellite sites at Dandenong<br />

and Casey Hospitals.<br />

MCH has Victoria’s largest Neonatal<br />

Intensive Care Unit and provides<br />

leading paediatric services in<br />

rehabilitation, oncology, paediatric<br />

intensive care unit, and palliative care.<br />

32 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Our services<br />

<strong>Monash</strong> <strong>Health</strong> provides more than 250 uniquely integrated<br />

community and hospital-based services focusing on improving<br />

the health of our community through:<br />

• Prevention<br />

• Early intervention<br />

• Community-based treatment and<br />

rehabilitation<br />

• Highly specialised surgical and<br />

medical diagnosis, treatment and<br />

monitoring services<br />

• Hospital and community based<br />

mental health services<br />

• Comprehensive aged care programs<br />

• Aged residential services<br />

• Palliative care.<br />

Aged residential care and<br />

targetted programs<br />

Aged residential care is provided<br />

at: Allambee Nursing Home; AG<br />

Eastwood Hostel; the Kingston Centre<br />

(Cheltenham); Chestnut Gardens Aged<br />

Care (Doveton); Yarraman Nursing<br />

Home (Noble Park); and Mooraleigh<br />

Hostel (East Bentleigh), collectively<br />

providing 249 aged and aged mental<br />

health residential beds. Comprehensive<br />

aged care programs are provided<br />

across our acute and community based<br />

services, including aged mental health,<br />

and our aged and community care<br />

program (Dandenong).<br />

Community-based<br />

rehabilitation services<br />

Community rehabilitation services<br />

are provided from centres at Kingston,<br />

Clayton, Doveton, Springvale,<br />

Dandenong, Cranbourne and<br />

Pakenham and in clients’ homes<br />

through the Rehabilitation in the<br />

Home services.<br />

Community services<br />

Community services are provided<br />

across the catchment. Our staff<br />

are located across 11 major sites<br />

(Cranbourne Centre and Mundaring<br />

Drive, Cockatoo, Doveton, Kingston,<br />

Berwick, Clayton, Pakenham, Parkdale,<br />

Springvale, and Thomas Street,<br />

Dandenong). A range of services<br />

are provided at each site by multidisciplinary<br />

teams of allied health<br />

workers including physiotherapists,<br />

podiatrists, occupational therapists,<br />

dieticians, our services counsellors,<br />

speech pathologists, nurses, health<br />

promotion practitioners, and exercise<br />

physiologists. Co-located services<br />

include dialysis, dental, pregnancy<br />

care clinics, and adult mental health.<br />

We also facilitate group programs to<br />

support respite, social inclusion, and<br />

improved health. Some of our services<br />

are targeted at specific populations<br />

in our community and are led by<br />

experienced staff in these fields. This<br />

includes aged care, Aboriginal health,<br />

refugee health, youth and other<br />

vulnerable groups. Self-management<br />

is central to our care - we aim to<br />

empower and prepare clients to<br />

manage their health and healthcare<br />

across all levels of the care continuum.<br />

Community Support Options provide<br />

personalised services to assist people<br />

who are aged or have a disability<br />

to remain in their own homes.<br />

Respite services are also provided<br />

to support carers.<br />

Hospital and<br />

community-based<br />

mental health services<br />

Mental health services are provided<br />

through hospital and community-based<br />

facilities. Our services for children,<br />

youth and adults experiencing mental<br />

health issues include: the <strong>Monash</strong><br />

<strong>Health</strong> Drug and Alcohol Service; a<br />

telephone psychiatric triage service;<br />

community and inpatient perinatal,<br />

child and youth services; crisis<br />

assessment and treatment teams<br />

and enhanced crisis assessment and<br />

treatment teams; consultation liaison<br />

psychiatry; psychological medicine;<br />

mental health Hospital in the Home,<br />

community care teams; mobile<br />

support and treatment services; acute<br />

inpatient care; secure extended care<br />

services; perinatal infant service<br />

including an inpatient unit; eating<br />

disorders services; gender dysphoria<br />

services, prevention and recovery care<br />

services; and community residential<br />

and rehabilitation services.<br />

Hospital in the Home<br />

Hospital in the Home operates a<br />

‘140-bed’ virtual acute ward from<br />

consumers’ homes or residential care<br />

facilities. In-home care is provided<br />

by medical and nurse practitioners<br />

to people who require acute care,<br />

but can safely receive it in their<br />

home environment.<br />

33


Operational<br />

structure<br />

Chief Executive<br />

Andrew Stripp<br />

Chief<br />

Operating<br />

Officer<br />

Martin Keogh<br />

Clinical Programs<br />

• Acute Medicine,<br />

Subacute &<br />

Community<br />

• Children’s<br />

• Mental <strong>Health</strong><br />

• Specialty<br />

Medicine, Cancer<br />

& Intensive Care<br />

• Surgery &<br />

Interventional<br />

Services<br />

• Women’s &<br />

Newborn<br />

Campuses<br />

• Casey Hospital<br />

• Community Sites<br />

• Cranbourne<br />

Centre<br />

• Dandenong<br />

Hospital<br />

• Kingston Centre<br />

• <strong>Monash</strong> Medical<br />

Centre & <strong>Monash</strong><br />

Children’s<br />

Hospital<br />

• Moorabbin<br />

Hospital<br />

Other<br />

• Emergency<br />

Management<br />

& Business<br />

Continuity<br />

• <strong>Health</strong><br />

Information<br />

Services<br />

• Patient Flow Unit<br />

Executive<br />

Director<br />

Innovation,<br />

Patient Safety<br />

& Experience /<br />

Chief Medical<br />

Officer<br />

Erwin Loh<br />

Clinical Programs<br />

• Pathology<br />

• Pharmacy<br />

• Radiology<br />

Other<br />

• Medical<br />

Workforce<br />

• Appointment<br />

• Credentialing<br />

• Medical<br />

Education<br />

• Library<br />

• Simulation<br />

Centre<br />

• Patient<br />

Experience Office<br />

• Patient Safety,<br />

Innovation &<br />

Strategy<br />

• Business<br />

Intelligence<br />

• Centre for<br />

Clinical<br />

Effectiveness<br />

• Clinical<br />

Analytics<br />

• Clinical<br />

Governance<br />

• Innovation &<br />

Redesign<br />

• Strategy &<br />

Planning<br />

Executive<br />

Director<br />

Residential<br />

Care &<br />

Support<br />

Services/<br />

Chief Nursing<br />

& Midwifery<br />

Officer<br />

Cheyne Chalmers<br />

Clinical Programs<br />

• Residential Care<br />

• Campuses<br />

• Hostels & Nursing<br />

Homes<br />

Other<br />

• <strong>Monash</strong> Bureau<br />

• Nursing &<br />

Midwifery<br />

• Education &<br />

Workforce<br />

• Security<br />

• Support Services<br />

Executive<br />

Director<br />

Research<br />

Strategy<br />

Erwin Loh<br />

(interim)<br />

Clinical Trials<br />

• <strong>Monash</strong> <strong>Health</strong><br />

• Translation<br />

Precinct (MHTP)<br />

• Research<br />

Governance<br />

• Research<br />

Strategy<br />

Executive<br />

Director<br />

Financial<br />

Services /<br />

Chief Financial<br />

Officer<br />

Stuart Donaldson<br />

• Budget<br />

• Clinical Costing<br />

• Finance<br />

• Payroll<br />

• Revenue<br />

34 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Office of the Chief Executive<br />

Stuart Cavill (Acting) – Chief Allied <strong>Health</strong> Officer<br />

Amanda Nolan – Executive Advisor Business<br />

Sara Golubenko – to June 20<strong>18</strong> – Reform: Executive Advisor Chief Executive<br />

Executive<br />

Director<br />

Information<br />

Development<br />

Emilio Pozo<br />

• Information<br />

Technology<br />

Services<br />

• Electronic<br />

Medical Record<br />

Executive<br />

Director<br />

People &<br />

Culture<br />

Karen Lowe<br />

• Diversity &<br />

Inclusion<br />

• Employee<br />

Development<br />

• Employee <strong>Health</strong><br />

& Wellbeing<br />

• Employee<br />

Relations<br />

• People & Culture<br />

• Recruitment &<br />

Retention<br />

• Occupational<br />

<strong>Health</strong> & Safety<br />

Executive<br />

Director<br />

Capital &<br />

Infrastructure<br />

Geoff McDonald<br />

• Biomedical<br />

Engineering<br />

• Capital<br />

• Engineering<br />

• Infrastructure<br />

• Property<br />

Executive<br />

Director<br />

Communications<br />

& Engagement<br />

Louise Kanis<br />

• Public Relations<br />

• Communications<br />

• Government<br />

& community<br />

relations<br />

• Media relations<br />

• Internal and<br />

corporate<br />

communications<br />

• Brand & marketing<br />

• Web and digital<br />

communication<br />

• Project<br />

communication<br />

Executive<br />

Director<br />

Corporate<br />

Services &<br />

Governance<br />

/ Chief Legal<br />

Officer<br />

Katherine Lorenz<br />

• Audit<br />

• Compliance<br />

• Corporate<br />

Governance<br />

• Fraud Control<br />

• Freedom of<br />

Information<br />

• Insurance<br />

• Legal Services<br />

• Medicolegal<br />

• Commercial<br />

• Employment<br />

• Procurement<br />

• Retail<br />

• Risk<br />

• <strong>Monash</strong> <strong>Health</strong><br />

Foundation<br />

35


Jessie McPherson<br />

Private Hospital<br />

Jessie McPherson Private Hospital is a 103-bed<br />

tertiary level private hospital and a subsidiary<br />

of <strong>Monash</strong> <strong>Health</strong>. The hospital is proud to have<br />

a team of highly skilled and dedicated staff<br />

and is equipped with some of the best medical<br />

facilities in Victoria.<br />

Jessie McPherson Private Hospital<br />

offers specialist services including<br />

cardiology, cardiothoracic surgery,<br />

neurosurgery, vascular, gastro-sciences,<br />

general medicine and respiratory, high<br />

acuity maternity and neonatal services.<br />

The co-location of the hospital<br />

with <strong>Monash</strong> Medical Centre provides<br />

consumers with access to a wide<br />

range of additional services and<br />

facilities such as pharmacy, pathology<br />

and diagnostic imaging.<br />

This affiliation also provides Jessie<br />

McPherson Private Hospital consumers<br />

access to world-renowned research<br />

and teaching facilities.<br />

Jessie McPherson Private Hospital<br />

provides quality healthcare for people<br />

in Melbourne, regional Victoria,<br />

interstate, and overseas. As one of<br />

only a few private hospitals to provide<br />

tertiary level services in Victoria,<br />

Jessie McPherson Private Hospital has<br />

preferred provider agreement status<br />

with all major health funds.<br />

Safe patient care is the number one<br />

priority at Jessie McPherson Private<br />

Hospital and processes are in place<br />

to provide the best patient outcomes.<br />

The hospital’s ‘Point of Care Goals’<br />

were developed following input from<br />

Jessie McPherson Private Hospital staff<br />

and consumers about what constitutes<br />

safe and quality care. These goals<br />

reflect what consumers’ value about<br />

healthcare access and delivery, and<br />

how this translates into exceptional<br />

care, for every patient, every time.<br />

Jessie McPherson<br />

Private Hospital is<br />

one of a select few<br />

private hospitals<br />

accredited as a TAVI<br />

Hospital, this means<br />

that we are able to offer<br />

an alternative to open<br />

heart surgery for aortic<br />

stenosis patients.<br />

36 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


After developing symptoms, Brendan’s<br />

doctor picked up on a problem<br />

with his heart and he was referred<br />

to <strong>Monash</strong>Heart Interventional<br />

Cardiologist, Dr Ben Dundon.<br />

A rapid recovery for Brendan<br />

Dr Dundon’s assessment confirmed<br />

Brendan required coronary angioplasty,<br />

and he then had a stent inserted at the<br />

<strong>Monash</strong>Heart Cath Lab followed by<br />

a stay on the Cardiac Ward at Jessie<br />

McPherson Private.<br />

Whilst the stent improved his<br />

symptoms, Dr Dundon informed<br />

Brendan his aortic valve was not<br />

functioning as it should and may<br />

require treatment in the near future.<br />

Over the course of <strong>2017</strong>, Brendan<br />

noticed his condition worsening, he<br />

was struggling to remain active,<br />

finding himself out of breath doing<br />

everyday tasks like walking up a hill.<br />

It became increasingly worse.<br />

Brendan was then considered for<br />

a TAVI procedure and admitted to<br />

Jessie McPherson Private Hospital in<br />

November <strong>2017</strong>. The procedure was<br />

carried out the following day in the<br />

<strong>Monash</strong>Heart Cath Lab and Brendan<br />

was home by Friday and back at work<br />

the following week.<br />

Brendan has since returned to all the<br />

activities he enjoys.<br />

37


Our staff<br />

Our staff continue to provide quality health care to our community.<br />

As an equal opportunity employer, <strong>Monash</strong> <strong>Health</strong> is<br />

committed to a fair and non-discriminatory workplace<br />

that maximises the talent, potential and contribution of all<br />

employees. We act with fairness, dignity and empathy for<br />

each other and for consumers.<br />

We value honesty, openness and taking responsibility for our<br />

performance. We aim for and recognise innovation, quality<br />

and professionalism. All our staff remain firmly committed<br />

to our iCare values: integrity, compassion, accountability,<br />

respect, and excellence.<br />

We are continuing our commitment to conducting safety<br />

inspections with participation from <strong>Health</strong> and Safety<br />

Representatives and management. We are working to ensure<br />

ongoing consultation and engagement at all levels of <strong>Monash</strong><br />

<strong>Health</strong> to continuously improve our occupational health and<br />

safety performance.<br />

Staff numbers<br />

Labour category<br />

June<br />

YTD**<br />

FTE*<br />

June<br />

Current month<br />

FTE*<br />

<strong>2017</strong> 20<strong>18</strong> <strong>2017</strong> 20<strong>18</strong><br />

Nursing Services 4,799 4,968 4,970 5,111<br />

Admin. & Clerical 1,624 1,698 1,681 1,771<br />

Medical Support Services 1,102 1,179 1,145 1,233<br />

Hotel & Allied Services 958 1,029 990 1,050<br />

Medical Officers <strong>18</strong>6 <strong>18</strong>8 191 192<br />

Hospital Medical Officer 978 1,054 1,015 1,079<br />

Sessional Med. Officers 324 348 330 373<br />

Ancilliary Support Serv. 948 1,016 987 1,042<br />

Grand Total 10,919 11,480 11,309 11,852<br />

*Full-time equivalent (FTE) staff at <strong>Monash</strong> <strong>Health</strong> and Jessie<br />

McPherson Private Hospital as at 30 June 20<strong>18</strong>.<br />

**Average monthly FTE for financial year.<br />

Occupational health and safety statement<br />

<strong>Monash</strong> <strong>Health</strong> is committed to providing a safe and healthy<br />

working environment for our employees, contractors,<br />

volunteers and the public and we take all reasonable steps<br />

to control hazards and minimise risk of injury.<br />

This year we have focused on the strategic approach of<br />

managing health and safety in the workplace with the<br />

development of our OHS Strategy 20<strong>18</strong> – 2023 and the<br />

Action Plan for 20<strong>18</strong>/2019. For the first time lead and lag<br />

OHS targets have been established for <strong>Monash</strong> <strong>Health</strong> and<br />

will be reported monthly to all levels of the organisation.<br />

<strong>Monash</strong> <strong>Health</strong> has continued with a proactive and<br />

supportive approach to occupational health and safety with<br />

a focus on support in the workplace. A series of eLearning<br />

modules have been developed for all staff and managers<br />

to increase awareness and provide guidance in completing<br />

tasks safely.<br />

We are continuing our commitment to conducting safety<br />

inspections with participation from HSRs and management<br />

to ensure consultation and engagement at all levels of<br />

<strong>Monash</strong> <strong>Health</strong>. All new initiatives seek to ensure <strong>Monash</strong><br />

<strong>Health</strong> continuously improves occupational health and<br />

safety performance.<br />

Occupational violence statistics<br />

WorkCover accepted claims with an<br />

occupational violence cause per 100<br />

FTE<br />

Number of accepted WorkCover<br />

claims with lost time injury with an<br />

occupational violence cause per<br />

1,000,000 hours worked<br />

Number of occupational violence<br />

incidents reported<br />

Number of occupational violence<br />

incidents reported per 100 FTE<br />

Percentage of occupational violence<br />

incidents resulting in a staff injury,<br />

illness or condition<br />

2016-17 <strong>2017</strong>-<strong>18</strong><br />

0.37 0.35<br />

2.17 1.71<br />

850 1327<br />

7.83 11.47<br />

4.71 38.43*<br />

*In previous years the percentage of occupational violence<br />

lost time injuries (LTIs) resulting in a staff injury, illness or<br />

condition were reported. This year the value includes all<br />

incidents not just LTIs.<br />

WorkCover claims<br />

Number of standard claims by year<br />

17<br />

-<strong>18</strong><br />

16<br />

-17<br />

15<br />

-16<br />

14<br />

-15<br />

13<br />

-14<br />

12<br />

-13<br />

11<br />

-12<br />

10<br />

-11<br />

09<br />

-10<br />

08<br />

-09<br />

07<br />

-08<br />

171 177 148 176 130 166 166 151 152 165 174<br />

Definitions<br />

For the purposes of the statistics the following<br />

definitions apply:<br />

Occupational violence – any incident where an employee is<br />

abused, threatened or assaulted in circumstances arising out<br />

of, or in the course of their employment;<br />

Incident – an event or circumstance that could have resulted<br />

in, or did result in, harm to staff;<br />

Accepted WorkCover claims – accepted WorkCover claims<br />

that were lodged in <strong>2017</strong>-<strong>18</strong>;<br />

Lost time – at least one shift lost due to a work related injury<br />

or illness;<br />

Injury, illness or condition – this includes all reported<br />

harm as a result of an incident, regardless of whether the<br />

employee required time off work or submitted a claim.<br />

38 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Clinical<br />

governance<br />

report<br />

<strong>Monash</strong> <strong>Health</strong> is a public health service; a body corporate<br />

established under Section 65P of the <strong>Health</strong> Services Act 1988,<br />

as amended in 2005 and listed in Schedule 5 of that Act.<br />

Excellence is our standard<br />

Our Clinical Governance Framework<br />

outlines the structure and processes,<br />

leadership, and culture that are in<br />

place and the outcomes monitored to<br />

ensure we provide accountable, safe,<br />

effective, efficient patient-centred care<br />

underpinned by continuous improvement.<br />

It is based on the Victorian Clinical<br />

Governance Framework (June <strong>2017</strong>)<br />

and the Australian Safety and<br />

Quality Framework for <strong>Health</strong>care<br />

(December 2010).<br />

Key quality indicators are available<br />

on dashboards customised for<br />

each ward, unit and program and<br />

prominently displayed on quality<br />

boards in all wards.<br />

The health service performance<br />

against pre-determined quality<br />

indicators are tracked and reported<br />

monthly to Clinical Council, <strong>Monash</strong><br />

<strong>Health</strong> Executive, and the <strong>Monash</strong><br />

<strong>Health</strong> Board.<br />

39


Environmental<br />

sustainability report<br />

<strong>Monash</strong> <strong>Health</strong> is committed to reducing our ecological<br />

footprint. Sustainability is one of the priorities of our<br />

20<strong>18</strong>-23 Strategic Plan.<br />

We recognise the compelling link<br />

between greenhouse gas emissions,<br />

climate change, and the resultant<br />

impact on our environment.<br />

<strong>Monash</strong> <strong>Health</strong> has committed<br />

to actively contribute to the<br />

implementation of the Victorian<br />

Government’s policy to be net zero<br />

carbon emissions by 2050 and improve<br />

environmental sustainability.<br />

Eco Champions Committee<br />

The <strong>Monash</strong> <strong>Health</strong> Eco Champions<br />

Committee has represented <strong>Monash</strong><br />

<strong>Health</strong> at the Victorian Green<br />

<strong>Health</strong> Round Table and Australian<br />

Nursing and Midwifery Federation<br />

Sustainability Conference.<br />

The Committee meets bimonthly<br />

with a comprehensive and growing<br />

representation inclusive of clinical and<br />

non-clinical staff.<br />

Their outcomes this year include:<br />

• Highlighting sustainability<br />

initiatives to encourage staff<br />

participation as well as to support<br />

sustainability messaging<br />

• Regular contributions to the<br />

internal staff newsletter, keeping<br />

communications contemporary<br />

and relevant<br />

• Development of training materials<br />

and displays to support staff<br />

education and promotion of<br />

environmental sustainability<br />

• Running Keep a Cup drives to<br />

further encourage staff to reduce the<br />

amount of disposable cups used in<br />

our facilities<br />

• Our retail providers continue to offer<br />

a discount to those staff who bring<br />

their own mug<br />

• Engineering continues to roll out our<br />

LED lighting program<br />

• Implementation of a building<br />

analytics program for <strong>Monash</strong><br />

Children’s Hospital to ensure early<br />

detection of any Heating, Ventilation<br />

and Air Conditioning faults<br />

• Employment of an energy<br />

performance management consultant<br />

to conduct a level 2 energy audit<br />

for <strong>Monash</strong> Medical Centre and<br />

Dandenong Hospital. This audit<br />

will identify any opportunities to<br />

improve our energy consumption<br />

for these facilities.<br />

The Minister<br />

for <strong>Health</strong> and<br />

Ambulance<br />

Services,<br />

The Hon Jill<br />

Hennessy<br />

MP, is the<br />

responsible<br />

Minister.<br />

40 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Bicycle Facilities<br />

<strong>Monash</strong> <strong>Health</strong> has invested to<br />

encourage our staff to ride to work by<br />

installing /maintaining a number of bike<br />

parking facilities and changing facilities.<br />

These include but are not limited to:<br />

• Undercover and secure bike<br />

parking for 78 bikes at <strong>Monash</strong><br />

Medical Centre<br />

• Curved hoops at Casey Hospital near<br />

the Emergency Department. These<br />

are also available for the public<br />

• Bike racks at Moorabbin and<br />

Dandenong Hospitals.<br />

Cleaning without chemicals<br />

Our Infection Control and Support<br />

Services team presented our ‘cleaning<br />

without chemicals’ approach to the New<br />

South Wales branch of the Australian<br />

Nursing and Midwifery Federation. The<br />

session provided nurses and midwifes<br />

with information on the program, how<br />

to make the change, and the benefits to<br />

using this system. The session received<br />

great feedback.<br />

Recycling initiatives<br />

<strong>Monash</strong> <strong>Health</strong> continues to explore<br />

opportunities to increase our recycling<br />

rate. Despite changes to the recycling<br />

waste industry <strong>Monash</strong> <strong>Health</strong> still<br />

managed to recycle 1,104 tonnes of<br />

waste. This is equates to around<br />

25% of all waste generated across<br />

<strong>Monash</strong> <strong>Health</strong>.<br />

In addition <strong>Monash</strong> <strong>Health</strong> utilizes<br />

reusable sharps containers which saves<br />

between 10-15 tonnes of plastic going<br />

into landfill per year.<br />

Our Dandenong and Clayton sites<br />

diverted 1.4 tonnes of single use<br />

instruments from our clinical waste<br />

stream. These are removed free of<br />

charge by a local metal recycler.<br />

Grass roots initiatives<br />

Passionate staff drive local sustainability<br />

efforts in their areas or sites to raise<br />

awareness and contribute to the<br />

reduction of our environmental impact.<br />

Some of the staff-led activities this<br />

year included:<br />

• Staff continuing to self-nominate to<br />

become sustainability champions in<br />

their own areas<br />

• Our theatres continue to review the<br />

content of their prepacked theatre<br />

packs to eliminate any unnecessary<br />

items and reduce waste. They have<br />

been successful in reducing the<br />

number of hand towels in each pack<br />

that were otherwise thrown out<br />

• Our Central Production Kitchen<br />

which produces over 7,500 meals per<br />

day, five days per week continued to<br />

work with their suppliers to reduce<br />

the amount of packaging coming into<br />

the facility switching from recyclable<br />

cardboard boxes to reusable plastic<br />

food crates for meat deliveries<br />

• Dandenong Theatre is now recycling<br />

their PVC – oxygen masks and<br />

plastic tubing<br />

• Paper reduction is supported by an<br />

ever expanding electronic access<br />

system to information/forms<br />

and learning materials. We have<br />

continued to roll QR readers for<br />

attendance records for training<br />

and meetings<br />

• The Asset Sales Program is now in its<br />

5th year. The program has recycled<br />

thousands of items, including<br />

kitchen, cleaning, workshop, audio<br />

visual, IT, medical and laboratory<br />

equipment that would otherwise have<br />

been waste disposed of in landfill.<br />

Installation of hand dryers<br />

An initiative to install hand dryers into<br />

high use public and staff toilets has<br />

commenced. These hand dryers are<br />

very energy efficient and result in a<br />

number of benefits including reducing<br />

the amount of paper hand towels<br />

used. This initiative also improves the<br />

presentation of our bathrooms with no<br />

hand towels being left on the floors,<br />

reducing slip hazards.<br />

Garden Maintenance<br />

The gardens at <strong>Monash</strong> <strong>Health</strong> are<br />

maintained by our engineering<br />

department to ensure consumers,<br />

visitors and staff are able to enjoy the<br />

beautiful and relaxing garden spaces.<br />

This year our engineering department<br />

has engaged an arborist to ensure our<br />

trees are well maintained.<br />

41


Our Board<br />

of Directors<br />

The Board of Directors of <strong>Monash</strong> <strong>Health</strong> is appointed by the Governor-<br />

In-Council on the recommendation of the Minister for <strong>Health</strong> and<br />

Ambulance Services in accordance with the <strong>Health</strong> Services Act 1988.<br />

Functions of the Board<br />

of Directors<br />

The functions of the Board are:<br />

• To monitor the performance of<br />

<strong>Monash</strong> <strong>Health</strong><br />

• To recommend the appointment<br />

of and determine the employment<br />

terms (including remuneration)<br />

of a Chief Executive<br />

• To oversee the management of<br />

<strong>Monash</strong> <strong>Health</strong> and monitor the<br />

performance of the Chief Executive<br />

• To develop statements of priorities<br />

and strategic plans for the operation<br />

of <strong>Monash</strong> <strong>Health</strong> and monitor<br />

their compliance<br />

• To develop financial and business<br />

plans, strategies and budgets to<br />

ensure accountable and efficient<br />

provision of health services by<br />

<strong>Monash</strong> <strong>Health</strong> and its long-term<br />

financial viability, as well as to<br />

ensure they are adhered to<br />

• To establish and maintain effective<br />

systems to ensure that health<br />

services meet the needs of the<br />

community served by <strong>Monash</strong><br />

<strong>Health</strong> and that the views of<br />

users and providers of health<br />

services are taken into account<br />

• To ensure that <strong>Monash</strong> <strong>Health</strong><br />

operates within its budget and that<br />

its systems accurately reflect its<br />

financial position and viability<br />

• To ensure effective and accountable<br />

systems are in place to monitor<br />

and improve the quality and<br />

effectiveness of health services<br />

provided by <strong>Monash</strong> <strong>Health</strong><br />

• To ensure any problems identified<br />

with the quality or effectiveness<br />

of the health services provided are<br />

addressed in a timely manner and<br />

that <strong>Monash</strong> <strong>Health</strong> continuously<br />

strives to improve the quality of the<br />

health services it provides and to<br />

foster innovation<br />

• To develop arrangements with<br />

other agencies and health service<br />

providers to enable effective and<br />

efficient service delivery and<br />

continuity of care<br />

• To establish the organisational<br />

structure, including the management<br />

structure, of <strong>Monash</strong> <strong>Health</strong><br />

• To establish and ensure the<br />

effectiveness of a Finance<br />

Committee, an Audit Committee,<br />

a Quality Committee, and other<br />

committees considered appropriate<br />

• To facilitate health research and<br />

education and any other functions<br />

conferred on the Board by or<br />

under the Act.<br />

Board committees<br />

The following committees support<br />

the functions of the Board of<br />

Directors:<br />

Quality Committee<br />

The purpose of the Quality Committee<br />

is to support the Board’s function<br />

of providing strategic leadership in<br />

relation to the clinical governance of<br />

quality and safety at <strong>Monash</strong> <strong>Health</strong>.<br />

It serves to ensure, on behalf of<br />

the Board, that the following broad<br />

objectives are fulfilled:<br />

• Effective and accountable systems<br />

are in place to monitor and improve<br />

the quality and effectiveness<br />

of health services provided by<br />

<strong>Monash</strong> <strong>Health</strong><br />

• Any problems identified with the<br />

quality or effectiveness of the health<br />

services provided are addressed in<br />

a timely manner<br />

• Ensure <strong>Monash</strong> <strong>Health</strong> continuously<br />

strives to improve the quality of the<br />

health services it provides and to<br />

foster innovation.<br />

Audit Committee<br />

The role of the Audit Committee is to<br />

advise the Board of Directors on audit<br />

matters and matters relating to the<br />

financial, accounting and legislative<br />

compliance, and the operational<br />

effectiveness and efficiency of<br />

<strong>Monash</strong> <strong>Health</strong>.<br />

The committee also advises the<br />

Board on the level of business risk or<br />

exposure to which <strong>Monash</strong> <strong>Health</strong><br />

might be subject and oversight of<br />

internal and external audit activities.<br />

Membership of the committee<br />

includes:<br />

• John Thomson Member 1 July 2016<br />

to 30 June 20<strong>18</strong><br />

• Charles Gillies Member 1 July 2016<br />

to 30 June 20<strong>18</strong><br />

• Sarah Ralph Member 2 March 2016<br />

to 30 June 20<strong>18</strong><br />

• Jorden Lam Member 2 March 2016<br />

to 30 June 20<strong>18</strong>.<br />

Remuneration Committee<br />

The principal role of the Remuneration<br />

Committee is to advise the Board<br />

of Directors on matters relating to<br />

the organisation’s remuneration<br />

policies and practices. In addition,<br />

the Remuneration Committee provides<br />

oversight with respect to succession<br />

planning for the Chief Executive and<br />

senior executive positions.<br />

42 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


43


Aboriginal <strong>Health</strong> Strategic<br />

Partnership Committee<br />

The Aboriginal <strong>Health</strong> Strategic<br />

Partnership Committee operates<br />

under the authority of the <strong>Monash</strong><br />

<strong>Health</strong> Board of Directors and the<br />

Dandenong and District Aborigines<br />

Co-operative Limited Board of<br />

Directors. The Aboriginal <strong>Health</strong><br />

Strategic Partnership Committee<br />

commenced in 2012 and was followed<br />

by a signing of the Statement of Intent<br />

and a Memorandum of Understanding<br />

between the two organisations.<br />

The purpose of the Aboriginal <strong>Health</strong><br />

Strategic Partnership Committee is<br />

to ensure a collaborative partnership<br />

between the Dandenong and District<br />

Aborigines Co-operative Limited and<br />

<strong>Monash</strong> <strong>Health</strong>.<br />

The intent is to ensure that by working<br />

closely together we are able to better<br />

meet the health and wellbeing needs<br />

of our local Aboriginal and Torres Strait<br />

Islander communities.<br />

The Aboriginal <strong>Health</strong> Strategic<br />

Partnership Committee shall:<br />

• Ensure accountability and leadership<br />

in relation to all Aboriginal and<br />

Torres Strait Islander health matters<br />

• Ensure a respectful and collaborative<br />

relationship between <strong>Monash</strong> <strong>Health</strong><br />

and the Aboriginal and Torres Strait<br />

Islander community<br />

• Oversee the implementation of<br />

the <strong>Monash</strong> <strong>Health</strong> Reconciliation<br />

Action Plan and Employment Plan<br />

• Identify shared strategic opportunities<br />

and projects<br />

• Monitor the <strong>Monash</strong> <strong>Health</strong> Aboriginal<br />

<strong>Health</strong> Data <strong>Report</strong> and relevant data<br />

from the Dandenong and District<br />

Aborigines Co-operative Limited<br />

• Support the Aboriginal <strong>Health</strong><br />

Working Group to achieve their goals.<br />

During FY <strong>2017</strong>-<strong>18</strong>, the committee<br />

has focussed on a few key priorities:<br />

Improving maternity and emergency<br />

care for Aboriginal and Torres Strait<br />

Islander people. Increasing Aboriginal<br />

employment at <strong>Monash</strong> <strong>Health</strong> has also<br />

been another key priority as we have a<br />

2 per cent Aboriginal and Torres Strait<br />

Islander employment target.<br />

Finance Committee<br />

The role of the Finance Committee<br />

is to advise the Board of Directors on<br />

financial matters and to assist in the<br />

oversight of financial performance.<br />

The Finance Committee reviews and<br />

makes recommendations to the Board<br />

regarding financial strategy, financial<br />

policies, annual operating and capital<br />

budgets, cash flow and business plans<br />

to ensure alignment with key strategic<br />

priorities and performance objectives.<br />

Community Advisory Committee<br />

The role of the Community Advisory<br />

Committee (CAC) is to provide<br />

direction and leadership to integrate<br />

consumer, carer, and community views<br />

into health services operations and<br />

strategic policy development; and<br />

to identify and advise the Board of<br />

Directors on priority areas and issues<br />

requiring a consumer, carer and/or<br />

community perspective.<br />

The last 12 months have been a period<br />

of change for the committee saying<br />

goodbye to a number of committee<br />

members including Peter McDonald,<br />

Halina Gwizdzil, Catherine Rampant,<br />

Reg Shelly, Judy Little, Peter Vant Hooft<br />

and Debbie Williams (Board member).<br />

We also welcomed a new chair<br />

Lynda Condon and new committee<br />

members Zuben Rustomjee, Julie<br />

Noorman, Shabnam Safa, and Emma<br />

Burt. Continuing on the committee<br />

are Sharon Harris, Pauline Hopkins and<br />

Betty Wilderman (Vice Chair). The<br />

CAC has appreciated the enormous<br />

support from the Board Chair Barbara<br />

Yeoh and her commitment to consumer<br />

engagement at <strong>Monash</strong> <strong>Health</strong>.<br />

Key Achievements<br />

• Successfully supported <strong>Monash</strong><br />

<strong>Health</strong> through the National<br />

Standards Accreditation process.<br />

Members were integral in National<br />

Standards planning, preparation<br />

and survey meeting with auditors<br />

to discuss the role and extent<br />

of consumer engagement and<br />

contributions to the many<br />

committees and working parties<br />

across the organisation<br />

• Engaged in the development of<br />

equity and inclusion definition for<br />

<strong>Monash</strong> <strong>Health</strong><br />

• Commenced work around the<br />

review of the consumer participation<br />

framework following engagement<br />

from Safer Care Victoria who<br />

is developing a new state-wide<br />

framework<br />

• Contributed to the strategic plan<br />

consultation process giving valuable<br />

feedback during key milestone<br />

points that have been incorporated<br />

into the plan<br />

• Providing feedback into the<br />

proposed <strong>Monash</strong> <strong>Health</strong> Volunteer<br />

Ward Ambassador program<br />

• Realignment of consumer<br />

representation on all of the<br />

organisations Clinical Governance<br />

Committees following the<br />

introduction of a new<br />

program structure.<br />

• Currently co designing an<br />

improvement project to enhance<br />

the experience of consumers in the<br />

Emergency Department<br />

• Completed CAC governance training<br />

• Drove the development of a new<br />

Consumer Advisor Orientation /<br />

On boarding program.<br />

Primary Care and Population<br />

<strong>Health</strong> Advisory Committee<br />

The Primary Care and Population<br />

<strong>Health</strong> Advisory Committee provides<br />

strategic advice to the Board of<br />

Directors on matters specific to the<br />

primary care and population health<br />

of our local community. Membership<br />

comprises primary care and academic<br />

partners in our region and members<br />

of the <strong>Monash</strong> <strong>Health</strong> Board and<br />

management.<br />

The committee has a particular focus<br />

on improving the health status of<br />

our community across focus areas<br />

such as the hospital primary care<br />

interface, models of care for high<br />

risk community members, health<br />

promotion, and, primary care research<br />

and education. In addition, there is a<br />

focus on the health and wellbeing of<br />

vulnerable groups such as refugees,<br />

Aboriginal and Torres Strait Islanders<br />

and culturally and linguistically diverse<br />

communities.<br />

The Primary Care and Population<br />

<strong>Health</strong> Advisory Committee<br />

has continued to provide strong<br />

leadership to the development<br />

and implementation of <strong>Monash</strong><br />

<strong>Health</strong>’s Chronic Disease Strategy<br />

Implementation Plan. This work builds<br />

on a foundation set in initial action<br />

areas of diabetes; chronic respiratory<br />

disease; management of advanced<br />

stage chronic disease; and oral health.<br />

Implementation of the strategy involves<br />

small collaborative cross-sector pilots<br />

in each area, bringing back key themes<br />

and learnings to inform initiatives to<br />

scale, and ultimately our healthcare<br />

system as a whole.<br />

44 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Members of the<br />

Board of Directors<br />

Ms Barbara Yeoh AM<br />

BSc (Hons), FAICD<br />

• Chair, <strong>Monash</strong> <strong>Health</strong> Board<br />

• Chair, Remuneration Committee<br />

• Member, Finance Committee<br />

• Chair, Board Quality Committee,<br />

June <strong>2017</strong><br />

• Member, Aboriginal <strong>Health</strong> Strategic<br />

Partnership Committee<br />

Term of appointment:<br />

July 2009 - 30 June 20<strong>18</strong>.<br />

Ms Barbara Yeoh has more than 30<br />

years experience as a director in both<br />

the public and private sectors across<br />

a broad range of industries. She is<br />

currently a Member of the AHPRA<br />

Agency Management Committee,<br />

Deputy Chair of the Victoria State<br />

Emergency Service and Deputy Chair of<br />

the Civil Aviation Safety Authority Audit<br />

Committee. Ms Yeoh is also a Principal<br />

Associate of Phillips KPA, specialist<br />

advisers to the education sector.<br />

In 2015, Ms Yeoh was inducted into<br />

the Victorian Honour Roll of Women<br />

and received the CEO Magazine<br />

Chairperson of the year award which<br />

encompasses the public, private and<br />

not for profit sectors.<br />

Mr Charles Gillies<br />

BSc/BA, MBA, SF Fin, GAICD<br />

• Chair, Finance Committee<br />

• Chair, Audit Committee<br />

• Member, Kitaya Holdings Board<br />

Pty Ltd*<br />

Term of appointment:<br />

July 2011 - current.<br />

Mr Charles Gillies is co-founder of<br />

Jolimont Global Mining Systems which<br />

specialises in investing in mining<br />

technology companies.<br />

These companies compete in fastmoving,<br />

highly competitive global<br />

technology markets. As an active<br />

investor himself his approach has been<br />

to work closely with management to<br />

develop a plan to create economic<br />

value. He has been Director and<br />

Chairman of a number of technology<br />

and investment companies and<br />

has worked closely with CEOs and<br />

management teams, developing<br />

strategies and setting objectives and<br />

performance targets.<br />

*Kitaya Holdings Pty Ltd operates Jessie<br />

McPherson Private Hospital.<br />

Ms Debbie Williams<br />

FAICD, MBA, ME, BCom, GradDip<br />

in <strong>Health</strong> Services Management<br />

• Chair, Primary Care and Population<br />

<strong>Health</strong> Advisory Committee<br />

• Member, Community Advisory<br />

Committee<br />

Term of appointment:<br />

July 2009 - June 20<strong>18</strong>.<br />

Ms Debbie Williams is a strategy<br />

consultant who brings extensive<br />

experience in healthcare management,<br />

corporate governance, business<br />

strategy development, mental<br />

health management and financial<br />

management. Ms Williams is President<br />

of Toy Libraries Australia.<br />

45


Mr Dipak Sanghvi<br />

• Member, Primary Care and<br />

Population <strong>Health</strong> Advisory<br />

Committee<br />

• Member, Finance Committee<br />

• Member, Kitaya Holdings Board Pty<br />

Ltd, March 20<strong>18</strong> to June 20<strong>18</strong><br />

Term of appointment:<br />

June 2016 - current.<br />

Mr Dipak Sanghvi is a pharmacist<br />

who owns five pharmacies in Victoria.<br />

He is currently Chair of Member<br />

Benefits Australia Pty Ltd. Previous<br />

positions held include: President of<br />

the Pharmacy Guild Victoria Branch<br />

during 2006-2011, Chair of Gold Cross<br />

Products and Services Pty Ltd, Chair of<br />

Return of Unwanted Medicines, being<br />

a Board member of Guild Insurance<br />

and Superannuation, and Meridian<br />

Lawyers; as well as several other board<br />

positions in the community<br />

and pharmaceutical industry.<br />

Ms Heather Cleland<br />

MBBS, FRACS (Plas)<br />

• Member, Quality Committee<br />

Term of appointment:<br />

July 2016 - current.<br />

Ms Heather Cleland is a Plastic<br />

Surgeon who is currently head of<br />

the state-wide Victorian Adult Burns<br />

Service at the Alfred Hospital. In<br />

addition to clinical practice and service<br />

development, she is actively involved<br />

in clinical education, training, and<br />

research. She has been instrumental in<br />

establishing the clinical quality Burns<br />

Registry of Australia and New Zealand,<br />

and chairs its steering committee. She<br />

is a Board member of the Australian<br />

and New Zealand Burns Association<br />

and Past President. She has served on<br />

various departmental and professional<br />

committees, and is a member of the<br />

Donor Tissue Bank Committee of<br />

the Victorian Institute of Forensic<br />

Medicine, member of the Court of<br />

Examiners of the Royal Australasian<br />

College of Surgeons and an Adjunct<br />

Senior Lecturer at <strong>Monash</strong> University.<br />

Ms Jorden Lam<br />

LLM, LLB, BCom, GradDipLP,<br />

GAICD, SA Fin.<br />

• Member, Audit Committee<br />

• Member, Community Advisory<br />

Committee<br />

Term of appointment:<br />

October 2016 - current.<br />

Ms Jorden Lam is the Company<br />

Secretary & General Counsel at HESTA<br />

Super Fund, and also serves on the<br />

Board of BreastScreen Victoria and<br />

the Policy Committee of Women<br />

in Super. She has also previously<br />

served on the Community Advisory<br />

Committee for Ambulance Victoria.<br />

She is experienced in the development<br />

and implementation of corporate<br />

governance frameworks, regularly<br />

advises on director and trustee duties<br />

and is passionate about achieving high<br />

standards of governance practice in<br />

organisations. Ms Lam has previously<br />

practiced as a commercial lawyer<br />

with several leading firms, advising<br />

corporations across a range of complex<br />

matters. In 2015 she was a recipient<br />

of the Australian Financial Review’s<br />

“Young Executive of the Year Award”.<br />

46 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Dr Misty Jenkins<br />

BSc (Hons), PhD, MAICD<br />

• Member, Quality Committee<br />

• Member, Aboriginal <strong>Health</strong> Strategic<br />

Partnership Committee<br />

Term of appointment:<br />

November 2016 - current.<br />

Dr Misty Jenkins is a NHMRC fellow,<br />

biomedical scientist and laboratory<br />

head at Walter and Eliza Hall Institute<br />

for Medical Research, where she<br />

researches cellular immunology<br />

and new immunotherapies for<br />

cancer. Dr Jenkins has previously<br />

held postdoctoral positions at The<br />

Universities of Cambridge and Oxford,<br />

and The Peter MacCallum Cancer<br />

Centre in Melbourne. Dr Jenkins was<br />

awarded the L’Oreal for Women in<br />

Science Fellowship (2013), was Tall<br />

Poppy of the year (2015) and won the<br />

Westpac/Australian Financial Review<br />

Top100 Women of Influence award<br />

(2016). In addition to her research<br />

career, Dr Jenkins brings experience in<br />

governance as a Director and Deputy<br />

Chair of The National Centre for<br />

Indigenous Genomics at ANU, previous<br />

Director of the Aurora Education<br />

Foundation, Ambassador for the<br />

Poche Centre for Indigenous <strong>Health</strong><br />

and Chair of NHMRC Project Grant<br />

Review Panels.<br />

Ms Sarah Ralph<br />

BA, LLB, LLM<br />

• Member, Audit Committee<br />

• Member, Primary Care and<br />

Population <strong>Health</strong> Advisory<br />

Committee<br />

Term of appointment:<br />

November 2016 - current.<br />

Ms Sarah Ralph is a partner of global<br />

law firm, Norton Rose Fulbright. Ms<br />

Ralph has practiced in employment<br />

and labour law for over 20 years and<br />

leads the firm’s national government<br />

practice. Ms Ralph regularly acts for<br />

public and private sector employers<br />

in complex employment matters<br />

including in the health sector. Ms<br />

Ralph’s experience includes working<br />

in government and the private sector<br />

in strategic and legal roles. Ms Ralph<br />

is a volunteer member of the Youth<br />

Support and Advocacy Service (YSAS)<br />

Risk and Audit Committee. Ms Ralph<br />

brings her experience in people<br />

management, corporate governance,<br />

and risk management to the Board.<br />

Emeritus Professor Hatem<br />

Salem AM<br />

MB, ChB (Mosul, Iraq), FRACP,<br />

FRCPA, MRCP (UK) MD (<strong>Monash</strong>),<br />

LRCP, MRCS.<br />

• Chair, Quality Committee<br />

Term of appointment:<br />

1 August <strong>2017</strong> - current.<br />

Hatem Salem is an Emeritus Professor<br />

at <strong>Monash</strong> University. Prior to this,<br />

Professor Salem was the Head of the<br />

Academic Department of Clinical<br />

Haematology at <strong>Monash</strong> University<br />

and the Head of Clinical Haematology<br />

at the Alfred Hospital. He served as<br />

President of Asia Pacific Society of<br />

Thrombosis and Haemostasis and past<br />

president and Executive Director of the<br />

Australasian Society of Thrombosis<br />

and Hemostasis. He is a senior<br />

Counsellor of the International Society<br />

of Thrombosis and Haemostasis.<br />

In 2005, his vision and ability to<br />

develop leading clinical and research<br />

programs was recognised by the<br />

Victorian Government’s Public<br />

<strong>Health</strong>care Award, where he<br />

was the recipient of the <strong>Health</strong><br />

Minister’s Award for Outstanding<br />

Individual Achievement.<br />

In 2010, Professor Hatem Salem was<br />

awarded the Member of the Order of<br />

Australia (AM) for service to medicine<br />

in the field of haematology as a<br />

clinician, educator and researcher and<br />

also through the establishment of the<br />

Australian Centre for Blood Diseases.<br />

47


Statutory<br />

compliance<br />

Carers Recognition Act 2012<br />

<strong>Monash</strong> <strong>Health</strong> is committed to<br />

partnering with and empowering<br />

our consumers.<br />

We understand that our consumers,<br />

their families and carers need to play<br />

an active role in their own healthcare<br />

and in helping us improve the quality<br />

and safety of our services.<br />

We take all practicable measures to<br />

ensure our employees and agents<br />

reflect the care relationship principles<br />

in developing, providing or evaluating<br />

support and assistance for persons in<br />

care relationships.<br />

The <strong>Monash</strong> <strong>Health</strong> Consumer and<br />

Community Participation Policy<br />

provides an organisation-wide<br />

framework describing our approach<br />

to embedding relationship centred<br />

care and partnerships in our culture,<br />

recognising that everyone in the<br />

organisation has an impact on patient,<br />

family, carer and consumer experience.<br />

Partnering with Consumers for an<br />

Exceptional Patient Experience<br />

education is mandatory for all new<br />

<strong>Monash</strong> <strong>Health</strong> staff both clinical and<br />

non-clinical. Our learning tools draw<br />

particular attention to the needs of<br />

carers and families.<br />

<strong>Monash</strong> <strong>Health</strong> reports on how we<br />

engage with our consumers, their<br />

families and carers in the annual<br />

Quality of Care <strong>Report</strong>. That report is<br />

available on our website: http://www.<br />

monashhealth.org/page/monash_<br />

health_quality_account<br />

There are no disclosures required to<br />

be made under the Carers Recognition<br />

Act 2012.<br />

Compliance with the<br />

Building Act 1993<br />

<strong>Monash</strong> <strong>Health</strong> facilities are managed<br />

through site inspections, risk<br />

assessments and audits. Contracts are<br />

in place to maintain Essential Safety<br />

Measures and annual compliance<br />

audited by independent Registered<br />

Building Surveyors.<br />

Building standards and<br />

condition assessments<br />

The condition of our buildings is<br />

assessed through site inspections<br />

and condition audits by architects<br />

and consultant engineers on an ‘as<br />

needed’ basis. Fire audits and risk<br />

assessments are undertaken by<br />

consultant fire engineers to comply<br />

with the Department of <strong>Health</strong> and<br />

Human Services Fire Risk Management<br />

Guidelines Series 7.<br />

Recommendations from fire audits are<br />

actioned through a series of projects<br />

developed in conjunction with the<br />

Department of <strong>Health</strong> and Human<br />

Services to maintain a high degree of<br />

fire safety. All bed-based facilities are<br />

audited on a five-yearly cycle.<br />

Fire safety audits<br />

The five-yearly fire safety audit of<br />

<strong>Monash</strong> <strong>Health</strong>’s 12 bed based facilities<br />

was completed in June 20<strong>18</strong>.<br />

Essential safety measures<br />

maintenance<br />

Contracts are in place to maintain all<br />

Essential Safety Measures elements at<br />

sites owned by <strong>Monash</strong> <strong>Health</strong>. Audits<br />

were performed at these sites by<br />

registered Building Surveyors to ensure<br />

compliance with Essential Safety<br />

Measures Maintenance regulations.<br />

Action plans to rectify defects<br />

identified during the audits<br />

are currently in place. In accordance<br />

with regulatory requirements, service<br />

and maintenance records are kept<br />

to enable completion of an annual<br />

Essential Safety Measures <strong>Report</strong> for<br />

all properties owned by <strong>Monash</strong><br />

<strong>Health</strong>. This provides confirmation<br />

that all Essential Safety Measures<br />

are operational at the required<br />

level of performance for the safety<br />

of these facilities.<br />

Risk assessment<br />

Victorian Managed Insurance Authority<br />

(VMIA) conducts site risk assessments<br />

(SRS) at <strong>Monash</strong> Medical Centre,<br />

Moorabbin Hospital, Kingston Centre,<br />

and Dandenong Hospital.<br />

Risk treatment options generated from<br />

the SRS are monitored through action<br />

plans until they are completed.<br />

Freedom of Information<br />

Act 1982<br />

Summary of requests received under<br />

the Act from 1 July <strong>2017</strong> to 30 June<br />

20<strong>18</strong>.<br />

Other (no documents found) 15<br />

Other (not proceeded with) 25<br />

Application fee not paid 0<br />

Not yet finalised 90<br />

Exemptions cited – total 230<br />

Clause:<br />

25 1<br />

25A(5) 3<br />

30(1) <strong>18</strong><br />

32(1) 6<br />

33(1) 119<br />

33(2)(A) 3<br />

33(4) 1<br />

33(4)(a) 0<br />

35(1)(a) 0<br />

35(1)(b) 56<br />

38 24<br />

48 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Fees and charges<br />

Application fees collected<br />

Application fees waived<br />

Copy charges collected<br />

$40,271.20<br />

$12,439.20<br />

$66,987.00<br />

Copy charges waived $7,640.30<br />

Initial decision makers<br />

Rachael Gillies, Release of Information<br />

Manager; Maija Dimits, <strong>Health</strong><br />

Information Manager; Elaine Elliott,<br />

<strong>Health</strong> Information Manager; Monika<br />

Bosnich, <strong>Health</strong> Information Manager;<br />

Tammy O’Connor, Senior Corporate<br />

Counsel; and Elle Bethune, Corporate<br />

Counsel.<br />

National Competition Policy<br />

<strong>Monash</strong> <strong>Health</strong> continued to comply<br />

with the Victorian Government’s<br />

Competitive Neutrality Policy. In<br />

addition, the Victorian Government’s<br />

Neutrality Pricing Principles for all<br />

relevant business activities have<br />

been applied by <strong>Monash</strong> <strong>Health</strong><br />

since 1 July 1988.<br />

Protected Disclosures<br />

Act 2012<br />

<strong>Monash</strong> <strong>Health</strong> has a procedure for<br />

protected disclosures and matters<br />

of this nature are referred to the<br />

Independent Broad-based Anti-<br />

Corruption Commission. Information<br />

is included in the ‘Patients & Visitors/<br />

Concerns and compliments’ section<br />

of the <strong>Monash</strong> <strong>Health</strong> Internet site<br />

for external parties and internally our<br />

staff policies and procedures provide<br />

direction for staff.<br />

Safe Patient Care Act 2015<br />

<strong>Monash</strong> <strong>Health</strong> has no matters to<br />

report in relation to its obligations<br />

under section 40 of the Safe Patient<br />

Care Act 2015.<br />

Victorian Industry<br />

Participation Policy Act 2003<br />

The following information for contracts<br />

commenced and/or completed in the<br />

financial year must be disclosed under<br />

the Victorian Industry Participation<br />

Policy (VIPP) Act 2003 (Refer to FRD<br />

25C Local Jobs First-Victorian Industry<br />

Participation Policy Disclosures in the<br />

<strong>Report</strong> of Operations):<br />

• Two contracts valued at $22M were<br />

commenced but not completed in<br />

the financial year for which a VIPP<br />

Plan was required;<br />

• Six contracts valued at $22.1M were<br />

commenced but not completed<br />

where a VIPP Plan was not required<br />

(due to nil to limited contestability)<br />

1. Four are local by nature; and<br />

2. Two are international by nature;<br />

• Eight conversations were held with<br />

the Industry Capability Network that<br />

correspond with the registration and<br />

issue of an Interaction Reference<br />

Number.<br />

Additional information<br />

available on request<br />

In accordance with FRD 22H, <strong>Monash</strong><br />

<strong>Health</strong> confirms the items listed below<br />

have been retained by <strong>Monash</strong> <strong>Health</strong><br />

and are available to the relevant<br />

Ministers, Members of Parliament and<br />

the public on request (subject to the<br />

freedom of information requirements,<br />

if applicable):<br />

a. Declarations of pecuniary interests<br />

have been duly completed by all<br />

relevant officers;<br />

b. Details of shares held by senior<br />

officers as nominee or held<br />

beneficially;<br />

c. Details of publications produced by<br />

the entity about itself, and how these<br />

can be obtained;<br />

d. Details of changes in prices, fees,<br />

charges, rates and levies charged by<br />

the <strong>Health</strong> Service;<br />

e. Details of any major external reviews<br />

carried out on the <strong>Health</strong> Service;<br />

f. Details of major research and<br />

development activities undertaken<br />

by the <strong>Health</strong> Service that are<br />

not otherwise covered either in<br />

the report of operations or in a<br />

document that contains the financial<br />

statements and report of operations;<br />

g. Details of overseas visits undertaken<br />

including a summary of the<br />

objectives and outcomes of each<br />

visit;<br />

h. Details of major promotional, public<br />

relations and marketing activities<br />

undertaken by the <strong>Health</strong> Service to<br />

develop community awareness of<br />

the <strong>Health</strong> Service and its services;<br />

i. Details of assessments and<br />

measures undertaken to improve the<br />

occupational health and safety of<br />

employees;<br />

j. A general statement on industrial<br />

relations within the <strong>Health</strong> Service<br />

and details of time lost through<br />

industrial accidents and disputes,<br />

which is not otherwise detailed in<br />

the report of operations;<br />

k. A list of major committees<br />

sponsored by the <strong>Health</strong> Service, the<br />

purposes of each committee and the<br />

extent to which those purposes have<br />

been achieved;<br />

l. Details of all consultancies and<br />

contractors including consultants/<br />

contractors engaged, services<br />

provided, and expenditure<br />

committed for each engagement.<br />

49


Disclosure index<br />

The <strong>Annual</strong> <strong>Report</strong> of <strong>Monash</strong> <strong>Health</strong> is prepared in accordance<br />

with all relevant Victorian legislation. This index has been prepared<br />

to facilitate identification of the Department’s compliance with<br />

statutory disclosure requirements.<br />

Legislation Requirement Page reference<br />

Charter and purpose<br />

FRD 22H Manner of establishment & relevant Ministers 39, 40<br />

FRD 22H Purpose, functions, powers and duties 2 & 5<br />

FRD 22H Initiatives and key achievements 6 & 7<br />

FRD 22H Nature and range of services provided 28<br />

Management and structure<br />

FRD 22H Organisational structure 34 & 35<br />

Financials and other information<br />

FRD 10A Disclosure index 50 & 51<br />

FRD 11A Disclosure of ex-gratia expenses 131<br />

FRD 21C Responsible person and executive officer disclosures 52<br />

FRD 22H Application and operation of Protected Disclosure 2012 49<br />

FRD 22H Application and operation of Carers Recognition Act 2012 48<br />

FRD 22H Application and operation of Freedom of Information Act 1982 48, 49<br />

FRD 22H<br />

Compliance with building and maintenance provisions of<br />

Building Act 1993<br />

48<br />

FRD 22H Details of consultancies over $10,000 63<br />

FRD 22H Details of consultancies under $10,000 63<br />

FRD 22H Employment and conduct principles 38<br />

FRD 22H Information and Communications Technology Expenditure 63<br />

FRD 22H Major changes or factors affecting performance 67<br />

FRD 22H Occupational violence 38<br />

FRD 22H<br />

Operational and budgetary objectives and performance<br />

against objectives<br />

56-57<br />

FRD 22H Summary of the entity’s environmental performance 40, 41<br />

FRD 22H Significant changes in financial position during the year 62<br />

50 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Legislation Requirement Page reference<br />

FRD 22H Statement on National Competition Policy 49<br />

FRD 22H Subsequent events 130<br />

FRD 22H Summary of the financial results for the year 62<br />

FRD 22H Additional information available on request 49<br />

FRD 22H<br />

Workforce Data Disclosures including a statement on the<br />

application of employment and conduct principles<br />

38<br />

FRD 25C Victorian Industry Participation Policy disclosures 49<br />

FRD 103F Non-Financial Physical Assets 94<br />

FRD 110A Cash flow statements 74<br />

FRD 112D Defined Benefit Superannuation Obligations 91<br />

SD 5.2.3 Declaration in report of operations 52<br />

SD 5.1.4 Financial Management Compliance Attestation 52<br />

Other requirements under Standing Directions 5.2<br />

SD 5.2.2 Declaration in financial statements 68<br />

SD 5.2.1(a)<br />

Compliance with Australian accounting standards and other<br />

authoritative pronouncements<br />

69-70<br />

SD 5.2.1(a) Compliance with Ministerial Directions 68<br />

Legislation<br />

Freedom of Information Act 1982 48 & 49<br />

Protected Disclosure Act 2012 49<br />

Carers Recognition Act 2012 48<br />

Victorian Industry Participation Policy Act 2003 49<br />

Building Act 1993 48<br />

Financial Management Act 1994 52<br />

Safe Patient Care Act 2015 49<br />

51


Attestations<br />

Data Integrity<br />

I, Andrew Stripp certify that <strong>Monash</strong><br />

<strong>Health</strong> has put in place appropriate<br />

internal controls and processes to<br />

ensure that reported data accurately<br />

reflects actual performance. <strong>Monash</strong><br />

<strong>Health</strong> has critically reviewed these<br />

controls and processes during the year.<br />

Andrew Stripp<br />

Chief Executive<br />

<strong>Monash</strong> <strong>Health</strong><br />

17 August 20<strong>18</strong><br />

Conflict of Interest<br />

I, Andrew Stripp, certify that <strong>Monash</strong><br />

<strong>Health</strong> has put in place appropriate<br />

internal controls and processes to<br />

ensure that it has complied with the<br />

requirements of hospital circular<br />

07/<strong>2017</strong> Compliance reporting in health<br />

portfolio entities (Revised) and has<br />

implemented a ‘Conflict of Interest’<br />

policy consistent with the minimum<br />

accountabilities required by the VPSC.<br />

Declaration of private interest forms<br />

have been completed by all executive<br />

staff within <strong>Monash</strong> <strong>Health</strong> and<br />

members of the board, and all declared<br />

conflicts have been addressed and are<br />

being managed. Conflict of interest is<br />

a standard agenda item for declaration<br />

and documenting at each executive<br />

board meeting.<br />

Compliance with <strong>Health</strong><br />

Purchasing Victoria (HPV)<br />

<strong>Health</strong> Purchasing Policies<br />

I, Andrew Stripp certify that <strong>Monash</strong><br />

<strong>Health</strong> has put in place appropriate<br />

internal controls and processes to<br />

ensure that it has complied with<br />

all requirements set out in the HPV<br />

<strong>Health</strong> Purchasing Policies including<br />

mandatory HPV collective agreements<br />

as required by the <strong>Health</strong> Services Act<br />

1988 (Vic) and has critically reviewed<br />

these controls and processes during<br />

the year.<br />

Andrew Stripp<br />

Chief Executive<br />

<strong>Monash</strong> <strong>Health</strong><br />

17 August 20<strong>18</strong><br />

Financial Management<br />

Compliance attestation<br />

I, Mr Dipak Sanghvi, on behalf of the<br />

Board certify that <strong>Monash</strong> <strong>Health</strong> has<br />

complied with the applicable Standing<br />

Directions of the Minister of Finance<br />

under the Financial Management Act<br />

1994 and Instructions.<br />

Mr Dipak Sanghvi<br />

Chair, Board of Directors<br />

Melbourne<br />

17 August 20<strong>18</strong><br />

Responsible bodies<br />

declarations<br />

In accordance with the Financial<br />

Management Act 1994, I am pleased<br />

to present the report of operations for<br />

<strong>Monash</strong> <strong>Health</strong> for the year ending 30<br />

June 20<strong>18</strong>.<br />

Mr Dipak Sanghvi<br />

Chair, Board of Directors<br />

Melbourne<br />

17 August 20<strong>18</strong><br />

Andrew Stripp<br />

Chief Executive<br />

<strong>Monash</strong> <strong>Health</strong><br />

17 August 20<strong>18</strong><br />

52 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Statement of<br />

Priorities - Part A<br />

<strong>Health</strong> Service Deliverables<br />

Help people stay healthy by completing the<br />

<strong>Monash</strong> <strong>Health</strong> Integrated <strong>Health</strong> Promotion<br />

Plan to improve alignment of health promotion<br />

activities, including our refugee health services<br />

and therefore health outcomes for disadvantaged<br />

population groups through improved collaboration<br />

of organisations across <strong>Monash</strong> <strong>Health</strong>’s<br />

catchment area.<br />

Build healthy neighbourhoods by establishing<br />

a regional Chronic Disease coalition with<br />

community partners including Primary <strong>Health</strong><br />

Networks, general practice, community health<br />

and consumers in line with the <strong>Monash</strong> <strong>Health</strong><br />

Chronic Disease Strategy.<br />

Target health gaps by continuing the<br />

implementation of <strong>Health</strong> Links – Chronic Care<br />

(<strong>Monash</strong> Watch) and evaluate to inform the future<br />

platform of service delivery.<br />

Reduce state-wide risks by implementing a Family<br />

Violence Education Plan in <strong>Monash</strong> <strong>Health</strong>’s<br />

emergency departments to improve support for<br />

victims of family violence; initially measured by<br />

the number of staff trained to respond.<br />

Ensure fair access by establishing a contemporary<br />

elective surgery model of care including<br />

implementing pre-procedural care that is<br />

standardised and transparent in delivery, reducing<br />

the number of consumers whom are: on the<br />

elective surgery waitlist; and, on the elective<br />

surgery waitlist longer than their clinically<br />

recommended time.<br />

Improve timely access to care by implementing a<br />

standardised model of care across <strong>Monash</strong> <strong>Health</strong><br />

emergency departments, focusing on upfront<br />

senior decision making and timely progression<br />

of care to improve the number of emergency<br />

consumers whom are: transferred from ambulance<br />

to emergency department within clinically<br />

recommended time; and, seen within the clinically<br />

recommended time.<br />

Status<br />

indicator<br />

Achieved<br />

Achieved<br />

Achieved<br />

Achieved<br />

In progress<br />

In progress<br />

Comment<br />

The Integrated <strong>Health</strong> Promotion Plan is<br />

complete and was submitted to the Department<br />

of <strong>Health</strong> and Human Services.<br />

In partnership with representatives of South<br />

Eastern Melbourne Primary Care Partnership and<br />

Southern <strong>Health</strong> Connect progress is underway<br />

against work plan milestones.<br />

The <strong>Health</strong> Links – Chronic Care (<strong>Monash</strong> Watch)<br />

evaluation report is complete.<br />

Development of a Victorian Integrated Care<br />

Model will be undertaken in consideration of the<br />

<strong>Health</strong> Care Home Trial in south east Melbourne,<br />

in partnership with the South Eastern Melbourne<br />

Primary <strong>Health</strong> Network.<br />

Family Violence Education Plan is implemented in<br />

<strong>Monash</strong> <strong>Health</strong>’s emergency departments.<br />

234 Emergency Department staff have received<br />

family violence education comprising 42<br />

registrars and 192 nurses. A comprehensive<br />

training program continues.<br />

The new peri-operative co-ordinator model<br />

practices consistently across all specialties<br />

and the Treatment in Turn and Prioritisation of<br />

Review work is complete. The time taken to treat<br />

consumers continues to decrease.<br />

The redesign program of work will continue in<br />

20<strong>18</strong>-19.<br />

The Prioritising Patient Care Pathway has<br />

been implemented and the Upfront Senior<br />

Decision Making model is in the process of<br />

implementation across all three emergency<br />

departments.<br />

Ambulance Victoria offload performance has<br />

progressively improved since the beginning of<br />

the year, as has the number of presentations seen<br />

within clinically recommended triage times.<br />

The redesign program of work will continue in<br />

20<strong>18</strong>-19.<br />

53


<strong>Health</strong> Service Deliverables<br />

Ensure fair access by developing and commencing<br />

implementation of a specialist consulting<br />

clinics redesign plan to ensure that clinics run<br />

efficiently and effectively, increasing the number<br />

of consumers who attend their first appointment<br />

within the recommended time.<br />

Improve access by enhancing partnerships with<br />

residential care facilities to provide optimal in<br />

home care with a view to provide better care and<br />

prevent unnecessary emergency department<br />

admissions.<br />

Plan and invest in the redesign of the <strong>Monash</strong><br />

Medical Centre emergency department to provide<br />

appropriate segregation for adult, paediatric and<br />

mental health patients.<br />

Plan and invest in commencing construction of<br />

the Casey Hospital expansion, in line with the<br />

construction program.<br />

Unlock innovation by implementing an emergency<br />

department interactive dashboard to increase<br />

visibility of patient flow across <strong>Monash</strong> <strong>Health</strong>.<br />

Unlock innovation by further developing the<br />

Mental <strong>Health</strong> Hospital In the Home service<br />

provided through Casey Hospital.<br />

Improve the traffic flows at Clayton through a<br />

redesign in collaboration with Vic Roads and local<br />

council.<br />

Unlock innovation by increasing access to care,<br />

teaching and research through the <strong>Monash</strong><br />

Children’s Telesurgery Service to regional<br />

operating theatres and emergency departments<br />

at Latrobe Regional Hospital, Central Gippsland<br />

<strong>Health</strong> Service and Bairnsdale Regional <strong>Health</strong><br />

Service.<br />

Strengthen the workforce by establishing<br />

interdisciplinary ward leadership teams to<br />

enhance local quality and safety improvement<br />

initiatives and the oversight of routine clinical<br />

practice.<br />

Status<br />

indicator<br />

In progress<br />

Achieved<br />

Achieved<br />

Achieved<br />

Achieved<br />

Achieved<br />

Achieved<br />

Achieved<br />

Achieved<br />

Comment<br />

Specialist Consulting redesign work is well<br />

underway, including: minimising risks associated<br />

with delays to care through redesigning e-referral<br />

management; clinic demand and capacity<br />

planning; improved data management and<br />

reporting; and, significant expansion of the<br />

telehealth specialist consulting program.<br />

The redesign program of work will continue in<br />

20<strong>18</strong>-19.<br />

In partnership with South Eastern Melbourne<br />

Primary <strong>Health</strong> Network a new model was<br />

implemented to coordinate aged care services<br />

between hospital and aged care facilities.<br />

<strong>Monash</strong> <strong>Health</strong> has increased its outreach<br />

services to residential aged care in alignment<br />

with Department of <strong>Health</strong> and Human Services<br />

mandatory reporting and HIP guidelines.<br />

The design is progressing on schedule for the<br />

construction work to be tendered in early 2019.<br />

Construction work is on track for the project<br />

to be completed in late 2019.<br />

The emergency department Power Business<br />

Intelligence interactive dashboard is operational<br />

across the three <strong>Monash</strong> <strong>Health</strong> emergency<br />

departments.<br />

Hospital in the Home activity for the Casey<br />

sector of <strong>Monash</strong> <strong>Health</strong> increased by greater<br />

than 25% in <strong>2017</strong>-<strong>18</strong>.<br />

The traffic redesign has been approved by<br />

VicRoads and the City of <strong>Monash</strong>. Design<br />

documentation is on schedule for tender in<br />

early 2019.<br />

The <strong>Monash</strong> Children’s telehealth service has<br />

increased access to care, teaching and research<br />

by increasing the number of telesurgery<br />

specialities, the number of consults, the number<br />

of calls to people’s homes, and the support<br />

provided in the Gippsland region by general<br />

practitioners, paediatricians, and allied health<br />

practitioners.<br />

The new ward governance model has<br />

commenced across <strong>Monash</strong> <strong>Health</strong> sites, with<br />

leadership teams formed, and program and ward<br />

quality and safety dashboards, available on both<br />

the quality boards in place in all wards and on<br />

the electronic quality and safety dashboards<br />

accessible via the intranet.<br />

54 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


<strong>Health</strong> Service Deliverables<br />

Strengthen the role and leadership of nurse<br />

managers through allocation of additional<br />

management time and education and training.<br />

Strengthen the workforce by developing a fivetier<br />

education strategy to address occupational<br />

violence and aggression incidents (and<br />

implement): online training for managers to<br />

address bullying and inappropriate behaviour;<br />

and, online training for all employees which<br />

includes processes for reporting patient and<br />

employee safety concerns and escalation.<br />

Prevent avoidable harm by developing and<br />

implementing a formal online training package to<br />

educate staff members that have patient contact<br />

on their obligations to report patient safety<br />

concerns, as measured by the number of staff<br />

trained and an increase in the number of reported<br />

incidents.<br />

Partner with consumers to put quality first by<br />

addressing priorities arising from the outcomes<br />

of the Victorian <strong>Health</strong>care Experience Survey:<br />

• Discharge planning:<br />

Transition hospital to home: Implement “My<br />

Passport” and Teach Back training across adult<br />

inpatient wards and paediatrics.<br />

• Environment: Implement redesigned ward<br />

upgrade and cleaning programs for adult<br />

inpatient wards at <strong>Monash</strong> Medical Centre.<br />

• Food services: Develop and implement a plan<br />

to address key drivers of the patient food<br />

experience, to commence implementation at<br />

<strong>Monash</strong> Medical Centre.<br />

Status<br />

indicator<br />

Achieved<br />

Achieved<br />

In progress<br />

In progress<br />

Achieved<br />

In progress<br />

Comment<br />

Nurse managers of 24 hour 7 day services have<br />

transitioned to full-time management positions.<br />

A new governance structure for all nurse<br />

managers is established and ongoing education<br />

and support is in place.<br />

The occupational violence and aggression<br />

strategy, work plan and training are developed<br />

and accessible to all employees.<br />

Implementation of the Department of <strong>Health</strong> and<br />

Human Services training is in progress, and will<br />

continue into 20<strong>18</strong>-19.<br />

The rollout of “My Passport” and Teach Back<br />

training was completed for 24 wards across<br />

<strong>Monash</strong> <strong>Health</strong>, and will continue into 20<strong>18</strong>-19.<br />

Redesigned ward upgrades and cleaning<br />

programs for adult inpatient wards at <strong>Monash</strong><br />

Medical Centre were completed.<br />

The plan is developed and implementation has<br />

commenced in accordance with the work plan.<br />

55


Statement of<br />

Priorities B<br />

High Quality and Safety indicator<br />

Target<br />

<strong>2017</strong>-20<strong>18</strong><br />

Result<br />

Accreditation<br />

Compliance with NSQHS Standard accreditation Full Compliance Achieved<br />

Infection prevention and control<br />

Compliance with Hand Hygiene Australia program >=80% 81%<br />

% of <strong>Health</strong> care worker immunised for influenza >=75% 78.0%<br />

Patient experience<br />

Victorian <strong>Health</strong>care Experience Survey - Percentage of positive patient<br />

experience reponses Quarter1<br />

Victorian <strong>Health</strong>care Experience Survey - Percentage of positive patient<br />

experience reponses Quarter2<br />

Victorian <strong>Health</strong>care Experience Survey - Percentage of positive patient<br />

experience reponses Quarter3<br />

Victorian <strong>Health</strong>care Experience Survey - Percentage of positive responses to<br />

questions on discharge care Quarter1<br />

Victorian <strong>Health</strong>care Experience Survey - Percentage of positive responses to<br />

questions on discharge care Quarter2<br />

Victorian <strong>Health</strong>care Experience Survey - Percentage of positive responses to<br />

questions on discharge care Quarter3<br />

Victorian <strong>Health</strong>care Experience Survey - Patients perception of cleanliness<br />

Quarter1<br />

Victorian <strong>Health</strong>care Experience Survey - Patients perception of cleanliness<br />

Quarter2<br />

Victorian <strong>Health</strong>care Experience Survey - Patients perception of cleanliness<br />

Quarter3<br />

>=95% 88.4%<br />

>=95% 89.6%<br />

>=95% 85.6%<br />

>= 75% 70.4%<br />

>= 75% 72.3%<br />

>= 75% 68.5%<br />

>= 70% 59.2%<br />

>= 70% 59.8%<br />

>= 70% 58.0%<br />

<strong>Health</strong>care associated infections<br />

Number of patients with surgical site infection No outliers Not Achieved<br />

ICU CLABSI (central line-associated blood stream infection) per 1000 line days -<br />

Clayton<br />

ICU CLABSI (central line-associated blood stream infection) per 1000 line days -<br />

Dandenong<br />

Nil 0.70<br />

Nil 0.00<br />

SAB rate (Occupied Bed days)


Target<br />

<strong>2017</strong>-20<strong>18</strong><br />

Result<br />

Adverse events<br />

Number of sentinel events Nil 10<br />

Mortality – number of deaths in low mortality DRGs2 Nil 0.02%<br />

Mental <strong>Health</strong><br />

Percentage of adult inpatients who are readmitted within 28 days of discharge =.65(Rehab) 0.79<br />

Governance, leadership and culture - % of Staff with positive response to questions<br />

Staff with an overall positive response to safety culture question >=80% 90%<br />

I am encouraged by my colleagues to report any patient safety concerns I may have >=80% 95%<br />

Patient care errors are handled appropriately in my work area >=80% 94%<br />

My suggestions about patient safety would be acted upon if I expressed them<br />

to my manager<br />

>=80% 91%<br />

The culture in my work area makes it easy to learn from the errors of others >=80% 87%<br />

Management is driving us to be a safety-centred organisation >=80% 93%<br />

This health service does a good job of training new and existing staff >=80% 82%<br />

Trainees in my discipline are adequately supervised >=80% 83%<br />

I would recommend a friend or relative to be treated as a patient here >=80% 91%<br />

57


Access and timelines<br />

Target<br />

<strong>2017</strong>-20<strong>18</strong><br />

Result<br />

Emergency Care<br />

Emergency - Casey Hospital<br />

Percentage of ambulance patients transferred within 40 minutes >=90% 76.0%<br />

Percentage of Triage Category 1 emergency patients seen immediately 100% 100.0%<br />

Percentage of Triage Categories 1-5 emergency patients seen within clinical<br />

recommended times<br />

>=80% 64.2%<br />

Percentage of emergency patients with length of stay less than 4 hours >=81% 70.8%<br />

Number of patients with a length of stay in the emergency department greater<br />

than 24 hours<br />

0 2<br />

Emergency - <strong>Monash</strong> Medical Centre<br />

Percentage of ambulance patients transferred within 40 minutes >=90% 72.0%<br />

Percentage of Triage Category 1 emergency patients seen immediately 100% 100.0%<br />

Percentage of Triage Categories 1-5 emergency patients seen within clinical<br />

recommended times<br />

>=80% 60.0%<br />

Percentage of emergency patients with length of stay less than 4 hours >=81% 58.1%<br />

Number of patients with a length of stay in the emergency department greater<br />

than 24 hours<br />

0 5<br />

Emergency - Dandenong Hospital<br />

Percentage of ambulance patients transferred within 40 minutes >=90% 72.5%<br />

Percentage of Triage Category 1 emergency patients seen immediately 100% 100.0%<br />

Percentage of Triage Categories 1-5 emergency patients seen within clinical<br />

recommended times<br />

>=80% 67.6%<br />

Percentage of emergency patients with length of stay less than 4 hours >=81% 64.2%<br />

Number of patients with a length of stay in the emergency department greater<br />

than 24 hours<br />

0 7<br />

Elective Surgery<br />

Percentage of Urgency Category 1 elective patients removed within 30 days 100% 100%<br />

Percentage of urgency category 1, 2 and 3 elective patients admitted within<br />

clinically recommended timeframes<br />

% patients on the waiting list who have waited longer than clinically<br />

recommended time for their respective triage category<br />

>=94% 86.4%<br />


Target<br />

<strong>2017</strong>-20<strong>18</strong><br />

Result<br />

Specialist Clinics<br />

Percentage of urgent patients referred by a GP or external specialist<br />

who attended a first appointment within 30 days<br />

Percentage of non-urgent patients referred by a GP or external specialist<br />

who attended a first appointment within 365 days<br />

100% 50.3%<br />

>=90% 96.5%<br />

Financial sustainability<br />

Target<br />

<strong>2017</strong>-20<strong>18</strong><br />

Result<br />

Finance<br />

YTD Operating Result ($m) $0.00 $0.04<br />

Trade creditors =14 days 11 days<br />

* GEM is Geriatric Evaluation and Management<br />

59


Statement of<br />

Priorities C<br />

Activity and Funding<br />

<strong>2017</strong>-<strong>18</strong> Activity<br />

Achievement<br />

Acute Admitted<br />

WIES Public 156,400<br />

WIES Private 15,975<br />

WIES (Public & Private) 172,375<br />

WIES DVA 579<br />

WIES TAC 740<br />

WIES TOTAL 173,694<br />

Acute Non-Admitted<br />

Home Enternal Nutrition 4,245<br />

Home Renal Dialysis - Home ABF 167<br />

Radiotherapy Non Admitted Shared Care 138<br />

Specialist Clinics - Public 223,703<br />

Home Perinatal Nutrition 157<br />

Subacute and Non-Acute Admitted<br />

Subacute WIES - Rehabilitation Public 2,678<br />

Subacute WIES - Rehabilitation Private/TAC/Workcover 442<br />

Subacute WIES - GEM Public 1,809<br />

Subacute WIES - GEM Private/TAC/Workcover 316<br />

Subacute WIES - Palliative Care Public 408<br />

Subacute WIES - Palliative Care Private 51<br />

Subacute WIES - DVA 60<br />

Transition Care - Occupied Bed days 17,331<br />

Transition Care - Home day 10,176<br />

60 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


<strong>2017</strong>-<strong>18</strong> Activity<br />

Achievement<br />

Subacute Non-Admited<br />

<strong>Health</strong> Independent Program - Public 194,152<br />

Aged Care<br />

Residential Aged Care 33,524<br />

HACC - Service Time Hours 51,594<br />

Mental <strong>Health</strong> ( Occupied Beddays) and Drug Services<br />

Mental <strong>Health</strong> Ambulatory 158,019<br />

Mental <strong>Health</strong> Inpatient - Available bed days 58,725<br />

Mental <strong>Health</strong> Inpatient - Secure Unit 16,384<br />

Mental <strong>Health</strong> Residential 44,984<br />

MH - Subacute 14,929<br />

Drug services 1,771<br />

Primary <strong>Health</strong><br />

Community <strong>Health</strong>/Primary Care Program -Service Time Hours 95,009<br />

Other<br />

NFC- Pancreas Transplants 14<br />

<strong>Health</strong> Workforce 562<br />

61


Summary of financial results<br />

20<strong>18</strong><br />

$’000<br />

<strong>2017</strong><br />

$’000<br />

2016<br />

$’000<br />

2015<br />

$’000<br />

2014<br />

$’000<br />

Total Revenue 1,882,391 1,850,870 1,751,695 1,512,402 1,450,332<br />

Total Expenses 1,877,401 1,754,104 1,647,800 1,528,277 1,428,992<br />

Net Result for the Year (inc. Capital<br />

and Specific Items)<br />

15 107,457 103,895 -15,875 21,340<br />

Retained Surplus/(Accumulate Deficit) 127,978 133,689 32,982 -67,073 -50,995<br />

Total Assets 1,813,045 1,715,387 1,591,476 1,420,199 1,405,432<br />

Total Liabilities 583,887 522,107 505,698 463,422 433,922<br />

Net Assets 1,229,158 1,193,280 1,085,778 956,777 971,510<br />

Total Equity 1,229,158 1,193,280 1,085,778 956,777 971,510<br />

Average collection days<br />

20<strong>18</strong> <strong>2017</strong> 2016 2015 2014<br />

Private 40 46 48 50 43<br />

Transport Accident Commission - - - - -<br />

Victorian WorkCover Authority (VWA) 67 98 96 127 117<br />

Nursing Home 41 38 37 28 26<br />

Inpatient debtors ageing<br />

90<br />

days<br />

<strong>2017</strong>-<br />

<strong>18</strong><br />

2016-<br />

17<br />

2015-<br />

16<br />

2014-<br />

15<br />

2013-<br />

14<br />

Private 1,839 675 67 238 2,8<strong>18</strong> 4,401 4,029 3,652 3,652<br />

Transport Accident<br />

Commission<br />

Victorian WorkCover<br />

Authority (VWA)<br />

- - - - - - - - -<br />

211 46 60 134 452 352 530 160 160<br />

Nursing Home 346 63 33 121 563 642 801 650 538<br />

Total 2,574 1,544 440 835 3,833 5,394 5,361 4,930 4,350<br />

62 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Disclosure<br />

Details of Information and Communication Technology (ICT) expenditure<br />

The total ICT expenditure incurred during <strong>2017</strong>-<strong>18</strong> is $54.6 million (excluding GST) with the details shown below:<br />

BAU ICT<br />

Expenditure<br />

Total (excluding<br />

GST)<br />

($’000)<br />

Non-BAU ICT<br />

Expenditure<br />

Total = A+B<br />

(Excluding GST)<br />

($’000)<br />

Operational<br />

Expenditure<br />

A (Excluding GST)<br />

($’000)<br />

Capital Expenditure<br />

B (Excluding GST)<br />

($’000)<br />

$30,135 $24,479 $241 $24,238<br />

<strong>2017</strong>-<strong>18</strong> Disclosure of Consultancy Expenditure<br />

Details of consultancies (under $10,000)<br />

In <strong>2017</strong>-<strong>18</strong>, there were 28 consultancies where the total fees payable to the consultants were less than $10,000.<br />

The total expenditure incurred during <strong>2017</strong>-<strong>18</strong> in relation to these consultancies is $117,288 (excluding GST).<br />

Details of consultancies (valued at $10,000 or greater)<br />

In <strong>2017</strong>-<strong>18</strong>, there were 23 consultancies where the total fees payable to the consultants were $10,000 or greater.<br />

The total expenditure incurred during <strong>2017</strong>-<strong>18</strong> in relation to these consultancies is $1,587,973 (excluding GST).<br />

Details of these consultancies are listed below.<br />

Consultants 20<strong>18</strong> <strong>2017</strong> 2016 2015 2014<br />

Consultants’ cost ($) 1,587,973 1,228,225 996,437 1,265,500 2,051,811<br />

Total number of consultants 51 107 140 80 115<br />

63


Consultant<br />

Purpose of<br />

Consultancy<br />

Start<br />

date<br />

End<br />

date<br />

Total<br />

approved<br />

project fee<br />

($’000)<br />

Expenditure<br />

<strong>2017</strong>-20<strong>18</strong><br />

($’000)<br />

Ernst & Young<br />

Internal Audit and FBT<br />

Services<br />

1/07/17 30/06/<strong>18</strong> 669 669<br />

Press Ganey Associates<br />

Pty Ltd<br />

Inpatient Surveying Consulting 1/07/17 30/06/<strong>18</strong> <strong>18</strong>7 <strong>18</strong>7<br />

Senateshj<br />

Information technology<br />

consulting<br />

1/07/17 30/06/<strong>18</strong> 88 88<br />

Pharmconsult Pty Ltd Consulting on Pharmacy 1/07/17 30/06/<strong>18</strong> 68 68<br />

Madison Cross Australia<br />

Pty Ltd<br />

<strong>Health</strong> Connexion<br />

Innovative Thinking It Unit<br />

Trust<br />

Consulting for Organisational<br />

Growth and Development<br />

Consulting for Transition<br />

Support Unit<br />

Information technology<br />

consulting<br />

1/07/17 30/06/<strong>18</strong> 58 58<br />

1/07/17 30/06/<strong>18</strong> 54 54<br />

1/07/17 30/06/<strong>18</strong> 52 52<br />

The Ideal Consultancy<br />

Pty Ltd<br />

Marketing Consulting 1/07/17 30/06/<strong>18</strong> 47 47<br />

Mkm <strong>Health</strong> Pty Limited<br />

Information technology<br />

consulting<br />

1/07/17 30/06/<strong>18</strong> 45 45<br />

Cetec Pty Ltd Workplace safety review 1/07/17 30/06/<strong>18</strong> 45 45<br />

Francis Group Consultants<br />

Aust Pty Ltd<br />

Project consulting 1/07/17 30/06/<strong>18</strong> 44 44<br />

Carney Associates Strategic Planning consulting 1/07/17 30/06/<strong>18</strong> 36 36<br />

Opturion Pty Ltd<br />

Pitcher Partners<br />

Information technology<br />

consulting<br />

Information technology<br />

consulting<br />

1/07/17 30/06/<strong>18</strong> 34 34<br />

1/07/17 30/06/<strong>18</strong> 30 30<br />

Aquaklar Analytical<br />

Supplies<br />

Workplace safety review 1/07/17 30/06/<strong>18</strong> 23 23<br />

Alison Evans Consulting Strategic Planning consulting 1/07/17 30/06/<strong>18</strong> <strong>18</strong> <strong>18</strong><br />

Simpply<br />

Information technology<br />

consulting<br />

1/07/17 30/06/<strong>18</strong> 16 16<br />

64 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Consultant<br />

Purpose of<br />

Consultancy<br />

Start<br />

date<br />

End<br />

date<br />

Total<br />

approved<br />

project fee<br />

($’000)<br />

Expenditure<br />

<strong>2017</strong>-20<strong>18</strong><br />

($’000)<br />

Hardes And Associates<br />

Consulting for Organisational<br />

Growth and Development<br />

1/07/17 30/06/<strong>18</strong> 15 15<br />

Novoture Pty Ltd Workplace Culture Review 1/07/17 30/06/<strong>18</strong> 14 14<br />

Margaret Charlton<br />

Consulting for Organisational<br />

Growth and Development<br />

1/07/17 30/06/<strong>18</strong> 13 13<br />

Disability Services<br />

Consulting<br />

Cwh Mediation<br />

& Workplace<br />

Insurance Scheme Review 1/07/17 30/06/<strong>18</strong> 13 13<br />

Workplace Review 1/07/17 30/06/<strong>18</strong> 10 10<br />

Hambleton Family Trust Workplace Review 1/07/17 30/06/<strong>18</strong> 10 10<br />

Advertising<br />

<strong>Monash</strong> <strong>Health</strong> made no expenditure in Government advertising.<br />

Car parking<br />

<strong>Monash</strong> <strong>Health</strong> complies with the Department of <strong>Health</strong> and Human Services hospital circular on car parking fees and details<br />

of car parking fees and concession benefits can be viewed at: https://www2.health.vic.gov.au/about/news-and-events/<br />

hospitalcirculars/circ0515<br />

<strong>Monash</strong> <strong>Health</strong>’s car parking fees and concession benefits can be found at: www.monashhealth.org<br />

65


Financial<br />

statements<br />

and explanatory<br />

notes<br />

66 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


67


68 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Independent Auditor’s <strong>Report</strong><br />

To the Board of <strong>Monash</strong> <strong>Health</strong><br />

Opinion<br />

I have audited the consolidated financial report of <strong>Monash</strong> <strong>Health</strong> (the health service) and its<br />

controlled entities (together the consolidated entity), which comprises the:<br />

• consolidated entity and health service balance sheet as at 30 June 20<strong>18</strong><br />

• consolidated entity and health service comprehensive operating statement for the year then<br />

ended<br />

• consolidated entity and health service statement of changes in equity for the year then ended<br />

• consolidated entity and health service cash flow statement for the year then ended<br />

• notes to the financial statements, including significant accounting policies<br />

• board member's, chief executive's and chief financial officer's declaration.<br />

In my opinion, the financial report presents fairly, in all material respects, the financial position of<br />

the consolidated entity and the health service as at 30 June 20<strong>18</strong> and their financial performance<br />

and cash flows for the year then ended in accordance with the financial reporting requirements of<br />

Part 7 of the Financial Management Act 1994 and applicable Australian Accounting Standards.<br />

Basis for<br />

Opinion<br />

I have conducted my audit in accordance with the Audit Act 1994 which incorporates the Australian<br />

Auditing Standards. I further describe my responsibilities under that Act and those standards in the<br />

Auditor’s Responsibilities for the Audit of the Financial <strong>Report</strong> section of my report.<br />

My independence is established by the Constitution Act 1975. My staff and I are independent of the<br />

health service and the consolidated entity in accordance with the ethical requirements of the<br />

Accounting Professional and Ethical Standards Board’s APES 110 Code of Ethics for Professional<br />

Accountants (the Code) that are relevant to my audit of the financial report in Victoria. My staff and<br />

I have also fulfilled our other ethical responsibilities in accordance with the Code.<br />

I believe that the audit evidence I have obtained is sufficient and appropriate to provide a basis for<br />

my opinion.<br />

Board’s<br />

responsibilities<br />

for the<br />

financial<br />

report<br />

The Board of the health service is responsible for the preparation and fair presentation of the<br />

financial report in accordance with Australian Accounting Standards and the Financial Management<br />

Act 1994, and for such internal control as the Board determines is necessary to enable the<br />

preparation and fair presentation of a financial report that is free from material misstatement,<br />

whether due to fraud or error.<br />

In preparing the financial report, the Board is responsible for assessing the health service and the<br />

consolidated entity’s ability to continue as a going concern, disclosing, as applicable, matters related<br />

to going concern and using the going concern basis of accounting unless it is inappropriate to do so.<br />

69


Auditor’s<br />

responsibilities<br />

for the audit<br />

of the financial<br />

report<br />

As required by the Audit Act 1994, my responsibility is to express an opinion on the financial report<br />

based on the audit. My objectives for the audit are to obtain reasonable assurance about whether<br />

the financial report as a whole is free from material misstatement, whether due to fraud or error,<br />

and to issue an auditor’s report that includes my opinion. Reasonable assurance is a high level of<br />

assurance, but is not a guarantee that an audit conducted in accordance with the Australian Auditing<br />

Standards will always detect a material misstatement when it exists. Misstatements can arise from<br />

fraud or error and are considered material if, individually or in the aggregate, they could reasonably<br />

be expected to influence the economic decisions of users taken on the basis of this financial report.<br />

As part of an audit in accordance with the Australian Auditing Standards, I exercise professional<br />

judgement and maintain professional scepticism throughout the audit. I also:<br />

• identify and assess the risks of material misstatement of the financial report, whether due to<br />

fraud or error, design and perform audit procedures responsive to those risks, and obtain<br />

audit evidence that is sufficient and appropriate to provide a basis for my opinion. The risk of<br />

not detecting a material misstatement resulting from fraud is higher than for one resulting<br />

from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations,<br />

or the override of internal control.<br />

• obtain an understanding of internal control relevant to the audit in order to design audit<br />

procedures that are appropriate in the circumstances, but not for the purpose of expressing<br />

an opinion on the effectiveness of the health service and the consolidated entity’s internal<br />

control<br />

• evaluate the appropriateness of accounting policies used and the reasonableness of<br />

accounting estimates and related disclosures made by the Board<br />

• conclude on the appropriateness of the Board's use of the going concern basis of accounting<br />

and, based on the audit evidence obtained, whether a material uncertainty exists related to<br />

events or conditions that may cast significant doubt on the health service and the<br />

consolidated entity’s ability to continue as a going concern. If I conclude that a material<br />

uncertainty exists, I am required to draw attention in my auditor’s report to the related<br />

disclosures in the financial report or, if such disclosures are inadequate, to modify my<br />

opinion. My conclusions are based on the audit evidence obtained up to the date of my<br />

auditor’s report. However, future events or conditions may cause the health service and the<br />

consolidated entity to cease to continue as a going concern.<br />

• evaluate the overall presentation, structure and content of the financial report, including the<br />

disclosures, and whether the financial report represents the underlying transactions and<br />

events in a manner that achieves fair presentation<br />

• obtain sufficient appropriate audit evidence regarding the financial information of the entities<br />

or business activities within the health service and consolidated entity to express an opinion<br />

on the financial report. I remain responsible for the direction, supervision and performance of<br />

the audit of the health service and the consolidated entity. I remain solely responsible for my<br />

audit opinion.<br />

I communicate with the Board regarding, among other matters, the planned scope and timing of the<br />

audit and significant audit findings, including any significant deficiencies in internal control that I<br />

identify during my audit.<br />

MELBOURNE<br />

20 August 20<strong>18</strong><br />

Ron Mak<br />

as delegate for the Auditor-General of Victoria<br />

70 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong><br />

2


<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

<strong>Monash</strong> <strong>Health</strong><br />

Comprehensive Operating Statement<br />

For the Financial Year Ended 30 June 20<strong>18</strong><br />

Note Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Revenue from operating activities 2.1 1,776,667 1,667,804<br />

Revenue from non-operating activities 2.1 3,709 2,759<br />

Employee expenses 3.1 (1,299,663) (1,210,884)<br />

Non salary labour costs 3.1 (19,151) (16,447)<br />

Supplies and consumables 3.1 (262,011) (268,549)<br />

Commercial activities 3.1 (62,215) (54,898)<br />

Other expenses 3.1 (137,384) (119,897)<br />

Share of net result of associates and joint ventures accounted for<br />

using the equity method 87 147<br />

Net result before capital and specific items 39 35<br />

Capital purpose income 2.1 101,928 <strong>18</strong>0,160<br />

Depreciation and amortisation 4.3 (77,310) (67,063)<br />

Specific expenses 3.3 (372) (667)<br />

Finance costs 3.4 (3,547) (3,739)<br />

Finance costs - self funded activity 3.4 (1,670) (1,734)<br />

Bad and doubtful debts expense 3.1 (2,762) -<br />

Expenditure using capital purpose income 3.1 (11,316) (10,226)<br />

4,951 96,731<br />

Net result after capital and specific items 4,990 96,766<br />

Other economic flows included in net result<br />

Revaluation of long service leave (4,975) 10,691<br />

Total other economic flows included in net result (4,975) 10,691<br />

Net result for the year 15 107,457<br />

Other comprehensive income<br />

Items that will not be reclassified to net result<br />

Changes in property, plant and equipment revaluation surplus 8.1a 35,000 -<br />

Total other comprehensive income 35,000 -<br />

Comprehensive result 35,015 107,457<br />

This Statement should be read in conjunction with the accompanying notes.<br />

71


<strong>Monash</strong> <strong>Health</strong><br />

Balance Sheet<br />

For the Financial Year Ended 30 June 20<strong>18</strong><br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Current assets<br />

Cash and cash equivalents 6.2 160,932 116,009<br />

Receivables 5.1 42,771 47,582<br />

Inventories 5.2 17,320 15,742<br />

Prepayments 2,087 2,893<br />

Total current assets 223,110 <strong>18</strong>2,226<br />

Non-current assets<br />

Receivables 5.1 90,917 81,717<br />

Investments accounted for using the equity method 4.1 4,099 4,012<br />

Property, plant and equipment 4.2 1,490,954 1,443,956<br />

Intangible assets 4.4 3,965 3,476<br />

Total non-current assets 1,589,935 1,533,161<br />

TOTAL ASSETS 1,813,045 1,715,387<br />

Current liabilities<br />

Payables 5.4 90,222 81,217<br />

Borrowings 6.1 7,781 6,161<br />

Provisions 3.5 320,839 279,912<br />

Other current liabilities 5.3 15,044 12,619<br />

Total current liabilities 433,887 379,909<br />

Non-current liabilities<br />

Borrowings 6.1 85,797 83,4<strong>18</strong><br />

Provisions 3.5 64,204 58,780<br />

Total non-current liabilities 150,001 142,198<br />

TOTAL LIABILITIES 583,887 522,107<br />

NET ASSETS 1,229,158 1,193,280<br />

EQUITY<br />

Property, plant and equipment revaluation surplus 8.1a 676,545 641,545<br />

Restricted specific purpose surplus 8.1a 20,715 14,953<br />

Contributed capital 8.1b 403,920 403,093<br />

Accumulated surpluses 8.1c 127,978 133,689<br />

TOTAL EQUITY 1,229,158 1,193,280<br />

This Statement should be read in conjunction with the accompanying notes.<br />

72 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


<strong>Monash</strong> <strong>Health</strong><br />

Statement of Changes in Equity<br />

For the Financial Year Ended 30 June 20<strong>18</strong><br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Consolidated Property, Plant<br />

& Equipment<br />

Revaluation<br />

Surplus<br />

Restricted<br />

Specific<br />

Purpose<br />

Surplus<br />

Contributed<br />

Capital<br />

Accumulated<br />

Surpluses<br />

Total<br />

Note $'000 $'000 $'000 $'000 $'000<br />

Balance at 1 July 2016 641,545 8,203 403,048 32,982 1,085,778<br />

Net result for the year 8.1c - - - 107,457 107,457<br />

Transfer (from)/to accumulated surpluses 8.1a,c - 6,750 - (6,750) -<br />

Contributed capital from the Victorian Government 8.1b - - 45 - 45<br />

Balance at 30 June <strong>2017</strong> 641,545 14,953 403,093 133,689 1,193,280<br />

Net result for the year 8.1c - - - 15 15<br />

Other comprehensive income for the year 8.1a 35,000 - - - 35,000<br />

Transfer (from)/to accumulated surpluses 8.1a,c - 5,762 - (5,762) -<br />

Prior year reclassification from subsidiary - - - 36 36<br />

Contributed capital from the Victorian Government - - 827 - 827<br />

Balance at 30 June 20<strong>18</strong> 676,545 20,715 403,920 127,978 1,229,158<br />

This Statement should be read in conjunction with the accompanying notes.<br />

73


<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

<strong>Monash</strong> <strong>Health</strong><br />

Cash Flow Statement<br />

For the Financial Year Ended 30 June 20<strong>18</strong><br />

Note Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

CASH FLOWS FROM OPERATING ACTIVITIES<br />

Operating grants from Government 1,528,862 1,441,631<br />

Capital grants from Government 52,966 1<strong>18</strong>,650<br />

Patient fees received 139,195 115,194<br />

Private hospital fees received 47,517 47,929<br />

Donations and bequests received 7,407 1,791<br />

GST received from ATO 35,101 38,016<br />

Recoupment from private practice for use of hospital facilities 12,987 11,696<br />

Interest and Investment income received 3,710 2,759<br />

Other receipts 36,178 53,102<br />

Total receipts 1,863,923 1,830,768<br />

Employee expenses paid (1,268,805) (1,213,970)<br />

Payments for supplies and consumables (282,833) (292,088)<br />

Finance costs (1,670) (1,734)<br />

Other payments (231,562) (211,354)<br />

Total payments (1,784,870) (1,719,146)<br />

NET CASH FLOW FROM OPERATING ACTIVITIES 8.2 79,053 111,622<br />

CASH FLOWS FROM INVESTING ACTIVITIES<br />

Purchase of intangibles, property, plant and equipment (44,908) (72,109)<br />

NET CASH FLOW USED IN INVESTING ACTIVITIES (44,908) (72,109)<br />

CASH FLOWS FROM FINANCING ACTIVITIES<br />

Repayment of car park loan (1,647) (1,048)<br />

Loan from government 10,000 -<br />

NET CASH FLOW USED IN FINANCING ACTIVITIES 8,353 (1,048)<br />

NET INCREASE IN CASH AND CASH EQUIVALENTS HELD 42,498 38,466<br />

Cash and cash equivalents at beginning of year 103,390 64,925<br />

CASH AND CASH EQUIVALENTS AT END OF FINANCIAL YEAR<br />

6.2 145,888 103,390<br />

This Statement should be read in conjunction with the accompanying notes.<br />

74 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 1: Summary of Significant Accounting Policies<br />

These annual financial statements represent the audited general purpose financial statements<br />

for <strong>Monash</strong> <strong>Health</strong> and its controlled entities for the year ended 30 June 20<strong>18</strong>. The report<br />

provides users with information about <strong>Monash</strong> <strong>Health</strong>’s stewardship of resources entrusted to it.<br />

(a) Statement of Compliance<br />

These financial statements are general purpose financial statements which have been prepared<br />

in accordance with the Financial Management Act 1994 and applicable AAS, which include<br />

interpretations issued by the Australian Accounting Standards Board (AASB). They are<br />

presented in a manner consistent with the requirements of AASB 101 Presentation of Financial<br />

Statements .<br />

The financial statements also comply with relevant Financial <strong>Report</strong>ing Directions (FRDs) issued<br />

by the Department of Treasury and Finance, and relevant Standing Directions (SDs) authorised<br />

by the Minister for Finance.<br />

<strong>Monash</strong> <strong>Health</strong> is a not-for-profit entity and therefore applies the additional paragraphs<br />

applicable to "not-for-profit" <strong>Health</strong> Services under the AASBs.<br />

The annual financial statements were authorised for issue by the Board of <strong>Monash</strong> <strong>Health</strong> on 17<br />

August 20<strong>18</strong>.<br />

(b) <strong>Report</strong>ing Entity<br />

The financial statements include all the controlled activities of <strong>Monash</strong> <strong>Health</strong>.<br />

Its principal address is:<br />

246 Clayton Road<br />

Clayton, Victoria 3168<br />

A description of the nature of <strong>Monash</strong> <strong>Health</strong>’s operations and its principal activities is included<br />

in the report of operations, which does not form part of these financial statements.<br />

Objectives and Funding<br />

<strong>Monash</strong> <strong>Health</strong>’s overall objective is to provide quality, patient-centred health care that meets<br />

the needs of the community through a vision of exceptional care, outstanding outcomes, key<br />

strategic goals of putting patients first, driving innovation, partnering strategically, leading in<br />

sustainable healthcare as well as to improve the quality of life for Victorians.<br />

<strong>Monash</strong> <strong>Health</strong> is predominantly funded by accrual based grant funding for the provision of<br />

services.<br />

(c) Basis of Accounting Preparation and Measurement<br />

These financial statements are presented in Australian dollars and the historical cost<br />

convention is used unless a different measurement basis is specifically disclosed in the note<br />

associated with the item measured on a different basis.<br />

The accounting policies have been applied in preparing the financial statements for the year<br />

ended 30 June 20<strong>18</strong>, and the comparative information presented in these financial statements<br />

for the year ended 30 June <strong>2017</strong>.<br />

Accounting policies are selected and applied in a manner which ensures that the resulting<br />

financial information satisfies the concepts of relevance and reliability, thereby ensuring that<br />

the substance of the underlying transactions or other events is reported.<br />

The financial statements are prepared on a going concern basis (refer to Note 8.11 Economic<br />

Dependency).<br />

All amounts shown in the financial statements have been rounded to the nearest thousand<br />

dollars, unless otherwise stated. Minor discrepancies in tables between totals and sum of<br />

components are due to rounding.<br />

75


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 1: Summary of Significant Accounting Policies (continued)<br />

(c) Basis of Accounting Preparation and Measurement (continued)<br />

Consistent with the requirements of AASB 1004 Contributions contributed capital and its<br />

repayment are treated as equity transactions and, therefore, do not form part of the income and<br />

expenses of <strong>Monash</strong> <strong>Health</strong>.<br />

Additions to net assets which have been designated as contributions by owners are recognised as<br />

contributed capital. Other transfers that are in the nature of contributions to or distributions by<br />

owners have also been designated as contributions by owners.<br />

<strong>Monash</strong> <strong>Health</strong> operates on a fund accounting basis and maintains three funds: Operating, Specific<br />

Purpose and Capital Funds. <strong>Monash</strong> <strong>Health</strong>'s Capital and Specific Purpose Funds include unspent<br />

donations and receipts from fund-raising activities conducted solely in respect of these funds.<br />

The financial statements, except for the cash flow statement, have been prepared using the accrual<br />

basis of accounting. Under the accrual basis, items are recognised as assets, liabilities, equity,<br />

income or expenses when they satisfy the definitions and recognition criteria for those items, that<br />

is, they are recognised in the reporting period to which they relate, regardless of when cash is<br />

received or paid.<br />

The financial statements are prepared in accordance with the historical cost convention, except for:<br />

● Non-current physical assets which, subsequent to acquisition, are measured at a revalued<br />

amount being their fair value at the date of the revaluation less any subsequent accumulated<br />

depreciation and subsequent impairment losses. Revaluations are made and are reassessed when<br />

the indices are published by the Valuer-General Victoria to ensure that the carrying amounts do not<br />

materially differ from their fair values;<br />

● The fair value of assets other than land is generally based on their depreciated replacement<br />

value.<br />

Judgements, estimates and assumptions are required to be made about the carrying values of<br />

assets and liabilities that are not readily apparent from other sources. The estimates and<br />

underlying assumptions are reviewed on an ongoing basis. The estimates and associated<br />

assumptions are based on professional judgements derived from historical experience and various<br />

other factors that are believed to be reasonable under the circumstances. Actual results may differ<br />

from these estimates.<br />

Revisions to accounting estimates are recognised in the period in which the estimate is revised and<br />

also in future periods that are affected by the revision. Judgements and assumptions made by<br />

management in the application of AAS that have significant effects on the financial statements and<br />

estimates relate to:<br />

● The fair value of land, buildings and plant and equipment (refer to Note 4.2 Property, Plant and<br />

Equipment);<br />

● Superannuation expense (refer to Note 3.6 Superannuation);<br />

● Employee benefit provisions are based on likely tenure of existing staff, patterns of leave claims,<br />

future salary movements and future discount rates (refer to Note 3.5 Employee Benefits in the<br />

Balance Sheet).<br />

Goods and Services Tax (GST)<br />

Income, expenses and assets are recognised net of the amount of associated GST, unless the GST<br />

incurred is not recoverable from the Australian Taxation Office (ATO). In this case the GST payable<br />

is recognised as part of the cost of acquisition of the asset or as part of the expense.<br />

Receivables and payables are stated inclusive of the amount of GST receivable or payable. The net<br />

amount of GST recoverable from, or payable to, the ATO is included with other receivables or<br />

payables in the Balance Sheet.<br />

Cash flows are presented on a gross basis. The GST components of cash flows arising from<br />

investing or financing activities which are recoverable from, or payable to the ATO, are presented<br />

as operating cash flow.<br />

Commitments and contingent assets and liabilities are presented on a gross basis.<br />

76 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 1: Summary of Significant Accounting Policies (continued)<br />

(d) Principles of Consolidation<br />

These statements are presented on a consolidated basis in accordance with AASB 10 Consolidated<br />

Financial Statements :<br />

• The consolidated financial statements of <strong>Monash</strong> <strong>Health</strong> includes all reporting entities controlled<br />

by <strong>Monash</strong> <strong>Health</strong> as at 30 June 20<strong>18</strong>.<br />

• Control exists when <strong>Monash</strong> <strong>Health</strong> has the power to govern the financial and operating policies of<br />

an organisation so as to obtain benefits from its activities. In assessing control, potential voting<br />

rights that presently are exercisable are taken into account. The consolidated financial statements<br />

include the audited financial statements of the controlled entities listed in Note 8.10 Controlled<br />

Entities.<br />

• The parent entity is not shown separately in the notes.<br />

Where control of an entity is obtained during the financial period, its results are included in the<br />

Comprehensive Operating Statement from the date on which control commenced. Where control<br />

ceases during a financial period, the entity’s results are included for that part of the period in which<br />

control existed. Where entities adopt dissimilar accounting policies and their effect is considered<br />

material, adjustments are made to ensure consistent policies are adopted in these financial<br />

statements.<br />

Entities consolidated into <strong>Monash</strong> <strong>Health</strong> reporting entity by virtue of the existence of congruent<br />

objectives, exposure to variable returns and significant management control include:<br />

● Kitaya Holdings Pty Ltd.<br />

Intersegment Transactions<br />

Transactions between segments within <strong>Monash</strong> <strong>Health</strong> have been eliminated to reflect the extent of<br />

<strong>Monash</strong> <strong>Health</strong>'s operations as a group.<br />

77


Note 2: Funding delivery of our services<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

<strong>Monash</strong> <strong>Health</strong>'s overall objective is to deliver programs and services that support and enhance<br />

the wellbeing of all Victorians.<br />

To enable <strong>Monash</strong> <strong>Health</strong> to fulfil its objective it receives income based on parliamentary<br />

appropriations. <strong>Monash</strong> <strong>Health</strong> also receives income from the supply of services.<br />

Structure<br />

2.1 Analysis of revenue by source<br />

2.2 Assets received free of charge or for nominal consideration<br />

78 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 2.1: Analysis of revenue by source<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Admitted<br />

Patients<br />

Non-<br />

Admitted EDs<br />

Aged Care Other i Total<br />

20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong><br />

Consolidated $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />

Mental<br />

<strong>Health</strong><br />

RAC (incl<br />

Mental<br />

<strong>Health</strong>)<br />

Primary<br />

<strong>Health</strong><br />

Government Grants 890,223 205,401 102,617 136,609 134,122 29,665 29,497 - 1,528,134<br />

Indirect Contributions by the Department of <strong>Health</strong> and<br />

Human Services 5,723 1,<strong>18</strong>9 803 906 414 179 <strong>18</strong>0 - 9,394<br />

Patient Fees 25,276 9,781 116 2,440 4,798 196 53 - 42,662<br />

Commercial Activities and Special Purpose Funds - - - - - - - 126,849 126,849<br />

Other Revenue from Operating Activities 69,628 69,628<br />

Total Revenue from Operating Activities 921,222 216,371 103,536 139,955 139,334 30,040 29,730 196,477 1,776,667<br />

Interest 3,709 3,709<br />

Total Revenue from Non-Operating Activities - - - - - - - 3,709 3,709<br />

Government Grants - - - - - - - 81,886 81,886<br />

Capital Purpose Income (excluding Interest) - - - - - - - 20,042 20,042<br />

Total Capital Purpose Income - - - - - - - 101,928 101,928<br />

Share of Net Result in Associates Accounted for using the<br />

Equity Method - - - - - - - 87 87<br />

Total Revenue 921,222 216,371 103,536 139,955 139,334 30,040 29,730 302,201 1,882,391<br />

Admitted<br />

Patients<br />

Non-<br />

Admitted EDs<br />

Aged Care Other i Total<br />

<strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong><br />

Consolidated $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />

Mental<br />

<strong>Health</strong><br />

RAC (incl<br />

Mental<br />

<strong>Health</strong>)<br />

Primary<br />

<strong>Health</strong><br />

Government Grants 879,938 200,794 101,079 104,070 99,847 21,957 22,466 - 1,430,150<br />

Indirect Contributions by the Department of <strong>Health</strong> and<br />

Human Services 6,996 1,453 981 1,108 506 2<strong>18</strong> 220 11,482<br />

Patient Fees 14,277 10,903 3,012 5,363 259 33 33,847<br />

Commercial Activities and Special Purpose Funds - - - - - - 125,342 125,342<br />

Other Revenue from Operating Activities 66,984 66,984<br />

Total Revenue from Operating Activities 901,211 213,149 102,060 108,190 105,716 22,434 22,719 192,326 1,667,804<br />

Interest - - - - - - - 2,759 2,759<br />

Total Revenue from Non-Operating Activities - - - - - - - 2,759 2,759<br />

Government Grants - - - - - - - 145,471 145,471<br />

Capital Purpose Income (excluding Interest) i - - - - - - - 34,689 34,689<br />

Total Capital Purpose Income - - - - - - - <strong>18</strong>0,160 <strong>18</strong>0,160<br />

Share of Net Result in Associates Accounted for using the<br />

Equity Method - - - - - - - 147 147<br />

Total Revenue 901,211 213,149 102,060 108,190 105,716 22,434 22,719 375,392 1,850,870<br />

i Other Programs include Commercial Activities, Special Purpose Funds and Capital.<br />

Revenue has been classified across programs as defined in the Agency Information Management System (AIMS) guidelines. For clinical support, infrastructure and corporate and diagnostic laboratory<br />

and medical services, Full Time Equivalent (FTE) has been used to allocate revenue across the programs.<br />

The Department of <strong>Health</strong> and Human Services makes certain payments on behalf of <strong>Monash</strong> <strong>Health</strong>. These amounts have been brought to account in determining the operating result for the year by<br />

recording them as revenue and expenses.<br />

79


Note 2.1: Analysis of revenue by source (continued)<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Revenue recognition<br />

Income is recognised in accordance with AASB 1<strong>18</strong> Revenue and is recognised as to the extent that it is probable<br />

that the economic benefits will flow to <strong>Monash</strong> <strong>Health</strong> and the income can be reliably measured at fair value.<br />

Unearned income at reporting date is reported as income received in advance. Amounts disclosed as revenue are<br />

where applicable, net of returns, allowances and duties and taxes.<br />

Government Grants and other transfers of income (other than contributions by owners)<br />

In accordance with AASB 1004 Contributions , government grants and other transfers of income (other than<br />

contributions by owners) are recognised as income when <strong>Monash</strong> <strong>Health</strong> gains control of the underlying assets<br />

irrespective of whether conditions are imposed on <strong>Monash</strong> <strong>Health</strong>’s use of the contributions. Contributions are<br />

deferred as income in advance when <strong>Monash</strong> <strong>Health</strong> has a present obligation to repay them and the present<br />

obligation can be reliably measured.<br />

Indirect contributions from the Department of <strong>Health</strong> and Human Services<br />

• Insurance is recognised as revenue following advice from the Department of <strong>Health</strong> and Human Services.<br />

• Long Service Leave (LSL) – Revenue is recognised upon finalisation of movements in LSL liability in line with<br />

the arrangements set out in the Department of <strong>Health</strong> and Human Services Hospital Circular 04/<strong>2017</strong>.<br />

Patient fees<br />

Patient fees are recognised as revenue on an accrual basis.<br />

Private practice fees<br />

Private practice fees are recognised as revenue at the time invoices are raised.<br />

Revenue from commercial activities<br />

Revenue from commercial activities such as car park and property rental income are recognised on an accrual<br />

basis and commercial laboratory medicine is recognised at the time invoices are raised.<br />

Donations and other bequests<br />

Donations and bequests are recognised as revenue when received. If donations are for a special purpose, they<br />

may be appropriated to a surplus, such as the specific restricted purpose surplus.<br />

Dividend revenue<br />

Dividend revenue is recognised when the right to receive payment is established. Dividends represents the<br />

income arising from <strong>Monash</strong> <strong>Health</strong>'s and its controlled entities' investments in financial assets.<br />

Interest revenue<br />

Interest revenue is recognised on a time proportionate basis that takes in account the effective yield of the<br />

financial asset, which allocates interest over the relevant period.<br />

Other income<br />

Other income includes recoveries for salaries and wages, non-property rental and external services provided.<br />

80 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 2.1: Analysis of revenue by source (continued)<br />

Category Groups<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

<strong>Monash</strong> <strong>Health</strong> has used the following category groups for reporting purposes for the current and previous<br />

financial years.<br />

Admitted Patient Services (Admitted Patients) comprises all acute and subacute admitted patient services,<br />

where services are delivered in public hospitals.<br />

Mental <strong>Health</strong> Services (Mental <strong>Health</strong>) comprises all specialised mental health services providing a range of<br />

inpatient, community based, residential, rehabilitation and ambulatory services which treat and support people<br />

with a mental illness and their families and carers. These services aim to identify mental illness early and seek to<br />

reduce its impact through providing timely acute care services and appropriate longer-term accommodation and<br />

support for those living with a mental illness.<br />

Non Admitted Services comprises acute and subacute non admitted services, where services are delivered in<br />

public hospital clinics and provide models of integrated community care, which significantly reduces the demand<br />

for hospital beds and supports the transition from hospital to home in a safe and timely manner.<br />

Emergency Department Services (EDs) comprises all emergency department services.<br />

Aged Care comprises a range of in home, specialist geriatric, residential care and community based programs<br />

and support services, such as Home and Community Care (HACC) that are targeted to older people, people with<br />

a disability, and their carers.<br />

Primary and Community <strong>Health</strong> comprises a range of home based, community based, primary health and<br />

dental services including health promotion and counselling, physiotherapy, speech therapy, podiatry and<br />

occupational therapy services.<br />

Residential Aged Care including Mental <strong>Health</strong> (RAC incl. Mental <strong>Health</strong>) referred to in the past as<br />

psychogeriatric residential services, comprises those Commonwealth-licensed residential aged care services in<br />

receipt of supplementary funding from the department under the mental health program. It excludes all other<br />

residential services funded under the mental health program, such as mental health funded community care units<br />

and secure extended care units.<br />

Other Services excluded from National <strong>Health</strong> Care Agreement (NHCA) (Other) comprises services not<br />

separately classified above, including: public health services such as laboratory testing, blood borne viruses /<br />

sexually transmitted infections clinical services, Kooris liaison officers, immunisation and screening services,<br />

drugs services including drug withdrawal, counselling and the needle and syringe program, disability services<br />

including aids and equipment and flexible support packages to people with a disability, community care programs<br />

including sexual assault support, early parenting services, parenting assessment and skills development, and<br />

various support services. <strong>Health</strong> and community initiatives also fall in this category group.<br />

81


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 2.2: Assets received free of charge or for nominal<br />

consideration<br />

During the reporting period, the fair value of assets<br />

received free of charge, was as follows:<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000 $'000<br />

Medical Equipment 136 713<br />

TOTAL 136 713<br />

Medical Equipment was gifted from various donors.<br />

The revenues and assets recognised as a result of such transactions shall be measured at the<br />

fair value of resources received.<br />

Fair value of assets and services received free of charge or for nominal consideration<br />

Resources received free of charge or for nominal consideration are recognised at their fair<br />

value when the transferee obtains control over them, irrespective of whether restrictions or<br />

conditions are imposed over the use of the contributions, unless received from another <strong>Health</strong><br />

Service or agency as a consequence of a restructuring of administrative arrangements. In the<br />

latter case, such transfer will be recognised at carrying amount. Contributions in the form of<br />

services are only recognised when a fair value can be reliably determined and the services<br />

would have been purchased if not received as a donation.<br />

82 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 3: The cost of delivering our services<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

This section provides an account of the expenses incurred by the hospital in delivering services and<br />

outputs. In Note 2, the funds that enable the provision of services were disclosed and in this note the<br />

cost associated with provision of services are recorded.<br />

Structure<br />

3.1 Analysis of expenses by source<br />

3.2 Analysis of expense and revenue by internally managed and restricted specific purpose funds<br />

3.3 Specific expenses<br />

3.4 Finance costs<br />

3.5 Employee benefits in the balance sheet<br />

3.6 Superannuation<br />

83


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 3.1: Analysis of Expenses by Source<br />

Admitted<br />

Patients<br />

Non-<br />

Admitted EDs<br />

RAC (incl<br />

Mental <strong>Health</strong> Mental<br />

<strong>Health</strong>) Aged Care<br />

Primary<br />

<strong>Health</strong> Other i Total<br />

20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong> 20<strong>18</strong><br />

Consolidated $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />

Employee Expenses 783,491 159,495 119,889 144,431 43,107 22,035 27,215 - 1,299,663<br />

Other Operating Expenses<br />

Non Salary Labour Costs 10,091 2,372 2,619 3,201 768 53 47 - 19,151<br />

Supplies and Consumables 168,699 34,334 <strong>18</strong>,728 22,510 7,943 6,490 3,307 - 262,011<br />

Medical Indemnity Insurance 15,833 3,287 2,220 2,507 1,145 494 497 - 25,983<br />

Fuel, Light, Power and Water 9,837 1,986 1,330 1,694 1,010 473 449 - 16,779<br />

Repairs and Maintenance 12,382 2,057 1,301 1,820 1,110 462 321 - 19,453<br />

Other Expenses 3,668 7,582 3,938 4,797 (129) 1,893 259 115,376 137,384<br />

Total Expenditure from Operating Activities 1,004,001 211,113 150,025 <strong>18</strong>0,960 54,954 31,900 32,095 115,376 1,780,424<br />

Finance Costs (refer Note 3.4) - - - - - - - 3,547 3,547<br />

Finance Costs - Self Funded Activity (refer Note 3.4) - - - - - - - 1,670 1,670<br />

Other Non-Operating Expenses<br />

Specific Expenses (refer Note 3.3) - - - - - - - 372 372<br />

Bad and Doubtful Debts Expense - - - - - - - 2,762 2,762<br />

Expenditure for Capital Purposes - - - - - - 11,316 11,316<br />

Depreciation (refer Note 4.3) 47,104 9,781 6,608 7,460 3,407 1,470 1,481 - 77,310<br />

Total Other Expenses 47,104 9,781 6,608 7,460 3,407 1,470 1,481 19,667 96,977<br />

Total Expenses 1,051,105 220,894 156,633 <strong>18</strong>8,420 58,361 33,370 33,576 135,043 1,877,401<br />

Admitted<br />

Patients<br />

Non-<br />

Admitted EDs<br />

RAC (incl<br />

Mental <strong>Health</strong> Mental<br />

<strong>Health</strong>) Aged Care<br />

Primary<br />

<strong>Health</strong> Other i Total<br />

<strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong> <strong>2017</strong><br />

Consolidated $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />

Employee Expenses 727,953 151,473 108,477 136,312 41,141 19,823 25,705 - 1,210,884<br />

Other Operating Expenses<br />

Non Salary Labour Costs 8,964 2,680 1,887 2,095 558 135 128 - 16,447<br />

Supplies and Consumables 174,780 34,211 <strong>18</strong>,766 22,919 8,<strong>18</strong>4 6,211 3,478 - 268,549<br />

Medical Indemnity Insurance 25,322 105 70 79 36 16 16 - 25,644<br />

Fuel, Light, Power and Water 6,089 1,230 821 1,092 640 277 284 - 10,433<br />

Repairs and Maintenance 11,949 1,965 1,<strong>18</strong>9 2,055 905 438 320 - <strong>18</strong>,821<br />

Other Expenses 1,871 7,037 3,024 4,673 61 2,969 160 100,102 119,897<br />

Total Expenditure from Operating Activities 956,928 198,701 134,234 169,225 51,525 29,869 30,091 100,102 1,670,675<br />

Finance Costs (refer Note 3.4) - - - - - - - 3,739 3,739<br />

Finance Costs - Self Funded Activity (refer Note 3.4) - - - - - - - 1,734 1,734<br />

Other Non-Operating Expenses<br />

Specific Expenses (refer Note 3.3) - - - - - - - 667 667<br />

Expenditure for Capital Purposes - - - - - - - 10,226 10,226<br />

Depreciation (refer Note 4.3) 40,861 8,485 5,732 6,471 2,955 1,275 1,285 - 67,063<br />

Total Other Expenses 40,861 8,485 5,732 6,471 2,955 1,275 1,285 16,365 83,429<br />

Total Expenses 997,789 207,<strong>18</strong>6 139,966 175,696 54,480 31,144 31,376 116,467 1,754,104<br />

Other Programs include Commercial Activities, Special Purpose Funds and Capital.<br />

Expenditure has been classified across programs as defined in the Agency Information Management System (AIMS) guidelines. For clinical support, infrastructure and corporate and diagnostic<br />

laboratory and medical services, FTE has been used to allocate expenditure across the programs.<br />

i<br />

84 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 3.1: Analysis of expenses by source<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Expenses are recognised as they are incurred and reported in the financial year to which they<br />

relate.<br />

Employee expenses<br />

Employee expenses include:<br />

• Wages and salaries;<br />

• Fringe benefits tax;<br />

• Leave entitlements;<br />

• Termination payments;<br />

• Workcover premiums; and<br />

• Superannuation expenses.<br />

Grants and other transfers<br />

These include transactions such as grants, subsidies and personal benefit payments made in cash<br />

to individuals.<br />

Other operating expenses<br />

Other operating expenses generally represent the day-to-day running costs incurred in normal<br />

operations and include:<br />

a) Supplies and consumables<br />

Supplies and services costs are recognised as an expense in the reporting period in which they are<br />

incurred. The carrying amounts of any inventories held for distribution are expensed when<br />

distributed.<br />

b) Fair value of assets, services and resources provided free of charge or for nominal<br />

consideration<br />

Contributions of resources provided free of charge or for nominal consideration are recognised at<br />

their fair value when the transferee obtains control over them.<br />

c) Borrowing costs of qualifying assets<br />

In accordance with the paragraphs of AASB 123 Borrowing Costs applicable to not-for-profit public<br />

sector entities, <strong>Monash</strong> <strong>Health</strong> continues to recognise borrowing costs immediately as an expense,<br />

to the extent that they are directly attributable to the acquisition, construction or production of a<br />

qualifying asset.<br />

Net gain/(loss) on non-financial assets<br />

Net gain/(loss) on non-financial assets and liabilities includes realised and unrealised gains and<br />

losses as follows:<br />

a) revaluation gains/(losses) of non-financial physical assets. (Refer to Note 4.2 Property,<br />

plant and equipment; and<br />

b) net gain/(loss) on disposal of non-financial assets.<br />

Any gain or loss on the disposal of non-financial assets is recognised in the period of disposal.<br />

85


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 3.1: Analysis of expenses by source (continued)<br />

Net gain/(loss) on financial instruments<br />

Net gain/(loss) on financial instruments includes:<br />

a) realised and unrealised gains and losses from revaluations of financial instruments at fair value;<br />

b) disposals of financial assets and derecognition of financial liabilities.<br />

Amortisation of non-produced intangible assets<br />

Intangible non-produced assets with finite lives are amortised as an ‘other economic flow’ on a<br />

systematic basis over the asset’s useful life. Amortisation begins when the asset is available for<br />

use that is when it is in the location and condition necessary for it to be capable of operating in the<br />

manner intended by management.<br />

Other gains/(losses) from other economic flows<br />

Other gains/(losses) include:<br />

a) the revaluation of the present value of the long service leave liability due to changes in the<br />

bond rate movements, inflation rate movements and the impact of changes in probability factors;<br />

and<br />

b) transfer of amounts from the reserves to accumulated surplus or net result due to disposal or<br />

derecognition or reclassification.<br />

De-recognition of financial liabilities<br />

A financial liability is derecognised when the obligation under the liability is discharged, cancelled<br />

or expires.<br />

86 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 3.2: Analysis of expense and revenue by internally managed and<br />

restricted specific purpose funds<br />

Expense<br />

Revenue<br />

Consolidated Consolidated Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong> 20<strong>18</strong> <strong>2017</strong><br />

$'000 $'000 $'000 $'000<br />

Commercial Activities<br />

Private Practice and Other Patient Activities 19,954 20,324 23,522 23,349<br />

Laboratory Medicine 2,289 2,195 2,289 2,300<br />

Diagnostic Imaging 12,149 12,159 12,227 12,163<br />

Property - - 119 116<br />

Other:<br />

-Bequests and Donations 1,478 1,014 2,530 1,789<br />

-Breastscreen service 4,466 4,<strong>18</strong>4 4,169 4,234<br />

-Cardiology 8,359 8,043 9,987 10,144<br />

-Special Purpose Funds 8,980 8,744 13,444 12,239<br />

Other Activities<br />

Fundraising and Community Support 217 768 107 470<br />

Research and Scholarship 8,425 5,766 8,720 7,452<br />

Other 3,344 1,701 3,248 3,145<br />

TOTAL 69,661 64,898 80,362 77,401<br />

87


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 3.3: Specific expenses<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Specific Expenses<br />

Voluntary Departure Packages 372 667<br />

Total Specific Expenses 372 667<br />

Note 3.4: Finance costs<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Finance Costs - Self Funded Activity 1,670 1,734<br />

Finance Charges - Finance Leases i 3,547 3,739<br />

Total Finance Costs 5,217 5,473<br />

i Construction and fit out of Casey Hospital was funded as a Public Private Partnership under a Project<br />

Agreement between the State of Victoria and Progress <strong>Health</strong> Pty Ltd. This amount represents the<br />

interest payments made during the financial year.<br />

Finance costs include:<br />

• interest on bank overdrafts and short-term and long-term borrowings (interest expense is<br />

recognised in the period in which it is incurred);<br />

• amortisation of discounts or premiums relating to borrowings;<br />

• amortisation of ancillary costs incurred in connection with the arrangement of borrowings; and<br />

• finance charges in respect of finance leases recognised in accordance with AASB 117 Leases .<br />

88 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 3.5: Employee benefits in the balance sheet<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000 $'000<br />

Current Provisions<br />

Employee Benefits i<br />

Accrued Days Off<br />

- unconditional and expected to be settled wholly within 12 months ii 4,326 3,895<br />

<strong>Annual</strong> Leave<br />

- unconditional and expected to be settled wholly within 12 months ii 77,929 69,393<br />

- unconditional and expected to be settled wholly after 12 months iii 13,154 11,527<br />

Long Service Leave<br />

- unconditional and expected to be settled wholly within 12 months ii 19,886 <strong>18</strong>,413<br />

- unconditional and expected to be settled wholly after 12 months iii 136,833 122,527<br />

Accrued wages and salaries 41,664 30,041<br />

293,792 255,796<br />

Provisions related to Employee Benefit On-Costs<br />

Unconditional and expected to be settled within 12 months ii 10,733 10,890<br />

Unconditional and expected to be settled after 12 months iii 16,314 13,226<br />

27,047 24,116<br />

Total Current Provisions 320,839 279,912<br />

Non-Current Provisions<br />

Employee benefits i 57,912 53,053<br />

Provisions related to employee benefit on-costs 6,292 5,727<br />

Total Non-Current Provisions 64,204 58,780<br />

Total Provisions 385,043 338,692<br />

(a) Employee Benefits and Related On-Costs<br />

Current Employee Benefits and related on-costs<br />

Unconditional long service leave entitlements 173,747 156,155<br />

<strong>Annual</strong> leave entitlements 101,102 89,821<br />

Accrued wages and salaries 41,664 30,041<br />

Accrued days off 4,326 3,895<br />

Non-Current Employee Benefits and related on-costs<br />

Conditional long service leave entitlements iii 64,204 58,780<br />

Total Employee Benefits and Related On-Costs 385,043 338,692<br />

Notes:<br />

i Employee benefits consist of amounts for accrued days off, annual leave and long service leave accrued by employees, not including oncosts.<br />

ii The amounts disclosed are nominal amounts.<br />

iii The amounts disclosed are discounted to present values.<br />

89


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 3.5: Employee benefits in the balance sheet (continued)<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

Movements in provisions $'000 $'000<br />

Movement in Long Service Leave:<br />

Balance at start of year 214,935 206,012<br />

Provision made during the year<br />

- Expense recognising employee service 41,379 25,204<br />

Settlement made during the year (<strong>18</strong>,363) (16,281)<br />

Balance at end of year 237,951 214,935<br />

Employee Benefit Recognition<br />

Provision is made for benefits accruing to employees in respect of wages and salaries, annual leave and long<br />

service leave for services rendered to the reporting date as expense during the period of the services are<br />

delivered.<br />

Provisions<br />

Provisions are recognised when <strong>Monash</strong> <strong>Health</strong> has a present obligation, the future sacrifice of economic<br />

benefits is probable, and the amount of the provision can be measured reliably.<br />

The amount recognised as a liability is the best estimate of the consideration required to settle the present<br />

obligation at reporting date, taking into account the risks and uncertainties surrounding the obligation.<br />

Salaries and Wages, <strong>Annual</strong> Leave and Accrued Days Off<br />

Liabilities for salaries and wages, annual leave and accrued days off are all recognised in the provision for<br />

employee benefits as ‘current liabilities’, because <strong>Monash</strong> <strong>Health</strong> does not have an unconditional right to defer<br />

settlements of these liabilities.<br />

Long Service Leave<br />

The liability for LSL is recognised in the provision for employee benefits.<br />

Unconditional LSL is disclosed in the notes to the financial statements as a current liability, even where the<br />

<strong>Monash</strong> <strong>Health</strong> Service does not expect to settle the liability within 12 months because it will not have the<br />

unconditional right to defer the settlement of the entitlement should an employee take leave within 12 months.<br />

An unconditional right arises after a qualifying period.<br />

The components of this current LSL liability are measured at:<br />

Undiscounted value – if the health service expects to wholly settle within 12 months; and<br />

Present value – where the health service does not expect to settle a component of this current liability<br />

within 12 months.<br />

Conditional LSL is disclosed as a non-current liability. Any gain or loss following revaluation of the present<br />

value of non-current LSL liability is recognised as a transaction, except to the extent that a gain or loss arises<br />

due to changes in estimations e.g. bond rate movements, inflation rate movements and changes in probability<br />

factors which are then recognised as other economic flows.<br />

Termination Benefits<br />

Termination benefits are payable when employment is terminated before the normal retirement date or when<br />

an employee decides to accept an offer of benefits in exchange for the termination of employment.<br />

On-Costs Related to Employee Expense<br />

Provision for on-costs, such as workers compensation and superannuation are recognised together with<br />

provisions for employee benefits.<br />

90 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 3.6: Superannuation<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Paid Contribution for the<br />

Year<br />

Contribution Outstanding<br />

at Year End<br />

Consolidated Consolidated Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong> 20<strong>18</strong> <strong>2017</strong><br />

$'000 $'000 $'000 $'000<br />

Defined benefit plans:<br />

State Superannuation Fund 550 539 39 60<br />

First State 3,417 3,290 237 365<br />

Unisuper 369 298 29 24<br />

Defined contribution plans:<br />

First State 54,447 46,453 4,266 5,246<br />

Hesta 48,348 36,963 3,763 4,734<br />

VicSuper and Other 2,087 1,606 335 198<br />

Total 109,2<strong>18</strong> 89,149 8,669 10,627<br />

Employees of <strong>Monash</strong> <strong>Health</strong> are entitled to receive superannuation benefits and <strong>Monash</strong> <strong>Health</strong><br />

contributes to both defined benefit and defined contribution plans. The defined benefit plans provides<br />

benefits based on years of service and final average salary.<br />

Defined contribution superannuation plans<br />

In relation to defined contribution (i.e. accumulation) superannuation plans, the associated expense is<br />

simply the employer contributions that are paid or payable in respect of employees who are members of<br />

these plans during the reporting period. Contributions to defined contribution superannuation plans are<br />

expensed when incurred.<br />

Defined benefit superannuation plans<br />

The amount charged to the Comprehensive Operating Statement in respect of defined benefit<br />

superannuation plans represents the contributions made by <strong>Monash</strong> <strong>Health</strong> to the superannuation plans<br />

in respect of the services of current <strong>Monash</strong> <strong>Health</strong> staff during the reporting period. Superannuation<br />

contributions are made to the plans based on the relevant rules of each plan, and are based upon<br />

actuarial advice.<br />

<strong>Monash</strong> <strong>Health</strong> Services does not recognise any unfunded defined benefit liability in respect of the plans<br />

because the hospital has no legal or constructive obligation to pay future benefits relating to its<br />

employees; its only obligation is to pay superannuation contributions as they fall due. The Department of<br />

Treasury and Finance discloses the State's defined benefits liabilities in its disclosure for administered<br />

items.<br />

Superannuation contributions paid or payable for the reporting period are included as part of employee<br />

benefits in the Comprehensive Operating Statement of <strong>Monash</strong> <strong>Health</strong>.<br />

The name, details and amounts expensed in relation to the major employee superannuation funds and<br />

contributions made by <strong>Monash</strong> <strong>Health</strong> are disclosed above.<br />

91


Note 4: Key Assets to support service delivery<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

The hospital controls infrastructure and other investments that are utilised in fulfilling its<br />

objectives and conducting its activities. They represent the key resources that have been<br />

entrusted to the hospital to be utilised for delivery of those outputs.<br />

Structure<br />

4.1 Investments accounted for using the equity method<br />

4.2 Property, plant and equipment<br />

4.3 Depreciation and amortisation<br />

4.4 Intangible assets<br />

92 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 4.1: Investments accounted for using the equity method<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Ownership Interest Published Fair Value<br />

Principal Country of 20<strong>18</strong> <strong>2017</strong> 20<strong>18</strong> <strong>2017</strong><br />

Name of Entity Activity Incorporation % % $'000 $'000<br />

Associates<br />

<strong>Monash</strong> <strong>Health</strong> Research Precinct Pty Ltd<br />

Property<br />

Investment Australia 20.33 20.33 4,099 4,012<br />

(a) As at 30 June 20<strong>18</strong>, the fair value of <strong>Monash</strong> <strong>Health</strong>'s interest in <strong>Monash</strong> <strong>Health</strong> Research Precinct Pty Ltd was based on its<br />

share of the company's net assets which is a level 3 input in terms of AASB 13 Fair Value Measurement.<br />

(b) The financial year end date of <strong>Monash</strong> <strong>Health</strong> Research Precinct Pty Ltd is 31 December. This was the reporting date established<br />

when that company was incorporated. For the purpose of applying the equity method of accounting, the financial statements of<br />

<strong>Monash</strong> <strong>Health</strong> Research Precinct Pty Ltd have been used, and appropriate adjustments have been made for the effects of<br />

significant transactions between that date and 30 June 20<strong>18</strong>.<br />

93


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 4.2: Property, plant and equipment<br />

(a) Gross carrying amount and accumulated depreciation<br />

Consolidated<br />

Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Land<br />

- Land at Fair Value 222,022 <strong>18</strong>7,022<br />

Total Land 222,022 <strong>18</strong>7,022<br />

Buildings<br />

- Buildings at Fair Value 676,088 676,088<br />

Less Accumulated Depreciation (120,453) (94,463)<br />

555,635 581,625<br />

- Buildings at Cost 461,591 429,989<br />

Less Accumulated Depreciation (49,291) (30,350)<br />

412,300 399,639<br />

Total Buildings 967,935 981,264<br />

Plant and Equipment<br />

- Plant and Equipment at Fair Value 57,559 43,092<br />

Less Accumulated Depreciation (23,814) (<strong>18</strong>,440)<br />

Total Plant and Equipment 33,745 24,652<br />

Medical Equipment<br />

- Medical Equipment at Fair Value 160,752 146,511<br />

Less Accumulated Depreciation (94,766) (82,683)<br />

Total Medical Equipment 65,987 63,828<br />

Computers and Communication Equipment<br />

- Computers and Communication Equipment at Fair Value 20,089 16,746<br />

Less Accumulated Depreciation (16,681) (13,685)<br />

Total Computers and Communication Equipment 3,408 3,061<br />

Furniture and Fittings<br />

- Furniture and Fittings at Fair Value 11,766 3,619<br />

Less Accumulated Depreciation (2,750) (1,402)<br />

Total Furniture and Fittings 9,016 2,217<br />

Motor Vehicles<br />

- Motor Vehicles at Fair Value 2,219 2,366<br />

Less Accumulated Depreciation (2,213) (2,353)<br />

Total Motor Vehicles 6 13<br />

Cultural Assets<br />

- Cultural Assets at Fair Value 2,792 2,792<br />

Total Cultural Assets 2,792 2,792<br />

94 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

(a) Gross carrying amount and accumulated depreciation (continued)<br />

Consolidated<br />

Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Assets Under Construction<br />

Assets Under Construction at Cost 55,820 60,379<br />

Software Under Construction at Cost 31,217 12,364<br />

Total Assets Under Construction 87,037 72,743<br />

Leased Assets Contracted under PPP Agreement<br />

- Leased Buildings at Fair Value 154,011 154,011<br />

Less Accumulated Depreciation (58,632) (52,136)<br />

95,379 101,875<br />

- Leasehold Improvements at Cost 1,448 1,448<br />

Less Accumulated Depreciation (547) (511)<br />

901 937<br />

- Leased Motor Vehicles 6,583 5,799<br />

Less Accumulated Depreciation (3,858) (2,248)<br />

2,725 3,551<br />

- Plant and Equipment at Fair Value 164 164<br />

Less Accumulated Depreciation (164) (164)<br />

- -<br />

- Medical Equipment at Fair Value 6,495 6,555<br />

Less Accumulated Depreciation (6,495) (6,555)<br />

- -<br />

- Computers and Communication Equipment at Fair Value 305 305<br />

Less Accumulated Depreciation (305) (305)<br />

- -<br />

- Furniture and Fittings at Fair Value 12 12<br />

Less Accumulated Depreciation (12) (12)<br />

- -<br />

Total Leased Assets 99,005 106,363<br />

TOTAL PROPERTY, PLANT AND EQUIPMENT 1,490,954 1,443,956<br />

(i) Casey Hospital commenced operation during the year of 30 June 2005. Construction and fit out of Casey Hospital was<br />

funded as a Public Private Partnership under a Project Agreement between the State of Victoria and Progress <strong>Health</strong> Pty Ltd.<br />

<strong>Monash</strong> <strong>Health</strong> is responsible for operating Casey Hospital and has recognised the leased asset and associated interest<br />

bearing liabilities (Note 6.1). The State of Victoria is obligated to fund quarterly service payments due to the Project<br />

Agreement for the life of that agreement, a period of up to 25 years.<br />

95


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 4.2: (b) Reconciliations of the carrying amounts of each class of asset<br />

Land Buildings Plant & Medical Computers and Furniture Motor Cultural Assets Under Leased Total<br />

Equipment Equipment Communication and Vehicles Assets Construction Assets<br />

Fittings<br />

$'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />

Balance at 1 July 2016 <strong>18</strong>7,022 797,490 <strong>18</strong>,121 47,458 2,408 2,004 21 2,793 206,272 112,207 1,375,797<br />

Additions - 1,200 9,227 27,644 1,884 514 - - 91,128 2,035 133,632<br />

Disposals - - (77) (609) - (16) - (1) - (38) (741)<br />

Net Transfers between Classes - 222,467 948 654 588 - - - (224,657) - -<br />

Depreciation (Note 4.3) - (39,893) (3,567) (11,319) (1,819) (285) (8) - - (7,841) (64,732)<br />

Balance at 1 July <strong>2017</strong> <strong>18</strong>7,022 981,264 24,652 63,828 3,061 2,217 13 2,792 72,743 106,363 1,443,956<br />

Additions - 212 2,602 14,814 1,067 278 - - 66,335 817 86,126<br />

Disposals - (<strong>18</strong>9) (11) (16) - - - - - (14) (229)<br />

Revaluation Increments 35,000 - - - - - - - - - 35,000<br />

Net Transfers between Classes - 29,720 11,962 192 2,296 7,872 - - (52,042) - 0<br />

Depreciation (Note 4.3) - (43,072) (5,460) (12,831) (3,017) (1,351) (7) - - (8,161) (73,899)<br />

Balance at 30 June 20<strong>18</strong> 222,022 967,935 33,745 65,987 3,408 9,017 6 2,792 87,037 99,005 1,490,954<br />

Land and buildings carried at valuation<br />

The Valuer-General Victoria undertook to re-value all of <strong>Monash</strong> <strong>Health</strong>'s owned and leased land and buildings to determine their fair value. The valuation, which conforms to Australian Valuation<br />

Standards, was determined by reference to the amounts for which assets could be exchanged between knowledgeable willing parties in an arm's length transaction. The valuation was based on<br />

independent assessments. The effective date of the valuation is 30 June 2014.<br />

In compliance with FRD 103F, in the year ended 30 June 20<strong>18</strong>, <strong>Monash</strong> <strong>Health</strong>'s management conducted an annual assessment of the fair value of land and buildings and leased buildings. To facilitate<br />

this, management obtained from the Department of Treasury and Finance the Valuer General Victoria indices for the financial year ended 30 June 20<strong>18</strong>.<br />

The fair value of the land had been adjusted by a managerial revaluation in 2016. The indexed value was then compared to individual assets written down book value as at 30 June 20<strong>18</strong> to determine<br />

the change in their fair values. The latest indices required a further managerial revaluation in 20<strong>18</strong>. The Department of <strong>Health</strong> and Human Services approved a managerial revaluation of the land asset<br />

class of $35m ($0 in <strong>2017</strong>).<br />

There was no material financial impact on change in fair value of buildings and leased buildings.<br />

96 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 4.2: (c) Fair value measurement hierarchy for assets<br />

Carrying Fair value measurement at end<br />

amount as of reporting period using:<br />

at 30 June<br />

Balance at 30 June 20<strong>18</strong> 20<strong>18</strong> Level 1 (i) Level 2 (i) Level 3 (i)<br />

Land at fair value<br />

- Non-Specialised Land 47,085 47,085<br />

- Specialised Land 174,937 174,937<br />

Total Land at Fair Value 222,022 47,085 174,937<br />

Buildings at fair value<br />

- Specialised Buildings 555,635 - 555,635<br />

Total Buildings at Fair Value 555,635 - 555,635<br />

Plant and Equipment at Fair Value 33,745 - 33,745<br />

Medical Equipment at Fair Value 65,987 - 65,987<br />

Computers and Communication Equipment at<br />

Fair Value 3,408 - 3,408<br />

Furniture and Fittings at Fair Value 9,016 - 9,016<br />

Cultural Assets at Fair Value 2,792 2,792 -<br />

Motor Vehicles at Fair Value 6 - 6<br />

Total Property, Plant and Equipment 892,611 - 49,877 842,734<br />

Fair value measurement at end<br />

Carrying of reporting period using:<br />

amount as<br />

at 30 June<br />

Balance at 30 June <strong>2017</strong> <strong>2017</strong> Level 1 (i) Level 2 (i) Level 3 (i)<br />

Land at fair value<br />

- Non-Specialised Land 39,514 39,514 -<br />

- Specialised Land 147,508 147,508<br />

Total Land at Fair Value <strong>18</strong>7,022 39,514 147,508<br />

Buildings at fair value<br />

- Specialised Buildings 581,625 - 581,625<br />

Total Building at Fair Value 581,625 - 581,625<br />

Plant and Equipment at Fair Value 24,652 - 24,652<br />

Medical Equipment at Fair Value 63,828 - 63,828<br />

Computers and Communication Equipment at<br />

Fair Value 3,061 - 3,061<br />

Furniture and Fittings at Fair Value 2,217 - 2,217<br />

Cultural Assets at Fair Value 2,792 2,792<br />

Motor Vehicles at Fair Value 13 13<br />

Total Property, Plant and Equipment 865,211 - 42,306 822,905<br />

Note<br />

i Classified in accordance with the fair value hierarchy<br />

97


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 4.2: (d) Reconciliation of level 3 Fair Value<br />

Plant and<br />

equipment<br />

Medical<br />

equipment<br />

Computers<br />

and<br />

Communic<br />

ations<br />

Furniture &<br />

Fittings<br />

Motor<br />

Vehicles<br />

Land Buildings<br />

$'000 $'000 $'000 $'000 $'000 $'000 $'000<br />

Consolidated<br />

Balance at 1 July <strong>2017</strong> 147,509 581,625 24,652 63,828 3,061 2,217 13<br />

Additions/(Disposals) - - 14,553 14,990 3,363 8,150 -<br />

Gains/(Losses) recognised in net result<br />

- Depreciation and amortisation - (25,990) (5,460) (12,831) (3,017) (1,351) (7)<br />

Items recognised in other comprehensive income<br />

- Revaluation 27,428 - - - - - -<br />

Balance at 30 June 20<strong>18</strong> 174,937 555,635 33,745 65,987 3,408 9,016 6<br />

98 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 4.2: (d) Reconciliation of level 3 Fair Value (continued)<br />

Plant and<br />

equipment<br />

Medical<br />

equipment<br />

Computers<br />

and<br />

Communica<br />

tions<br />

Furniture &<br />

Fittings<br />

Motor<br />

Vehicles<br />

Land Buildings<br />

$'000 $'000 $'000 $'000 $'000 $'000 $'000<br />

Consolidated<br />

Balance at 1 July 2016 147,509 609,271 <strong>18</strong>,142 47,458 2,408 2,004 21<br />

Additions - - 10,098 27,689 2,472 498 -<br />

Gains/(Losses) recognised in Net Result<br />

- Depreciation and Amortisation - (27,646) (3,575) (11,319) (1,819) (285) (8)<br />

Balance at 30 June <strong>2017</strong> 147,509 581,625 24,665 63,828 3,061 2,217 13<br />

99


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 4.2 (e): Fair value determination<br />

Asset class<br />

Types of assets<br />

In areas where there is an active<br />

market:<br />

Expected fair<br />

value level<br />

Likely valuation<br />

approach<br />

Non-specialised Land<br />

- Vacant Land<br />

Level 2 Market approach n.a.<br />

- Land not subject to restrictions as to<br />

use or sale<br />

Specialised Land<br />

Land subject to restriction as to use<br />

Level 3<br />

Specialised buildings (a)<br />

Vehicles<br />

Plant and equipment (a)<br />

Specialised buildings with limited<br />

alternative uses and/or substantial<br />

customisation<br />

Active resale market available Level 2 Market approach n.a.<br />

No active resale market available Level 3<br />

Specialised items with limited<br />

alternative uses and/or substantial<br />

customisation<br />

Level 3<br />

Level 3<br />

Specialised items with limited<br />

Medical equipment (a) alternative uses and/or substantial Level 3<br />

customisation<br />

Computers and<br />

Communication Equipment Any type Level 3<br />

(a)<br />

Furniture and Fittings Any type Level 3<br />

Market approach<br />

Depreciated<br />

replacement cost<br />

approach<br />

Depreciated<br />

replacement cost<br />

approach<br />

Depreciated<br />

replacement cost<br />

approach<br />

Depreciated<br />

replacement cost<br />

approach<br />

Depreciated<br />

replacement cost<br />

approach<br />

Depreciated<br />

replacement cost<br />

approach<br />

Significant inputs (Level 3<br />

only) (c)<br />

Community Service<br />

Obligations Adjustments<br />

- Cost per square metre<br />

- Useful life<br />

- Cost per square metre<br />

- Useful life<br />

- Cost per square metre<br />

- Useful life<br />

- Cost per unit<br />

- Useful life<br />

- Cost per square metre<br />

- Useful life<br />

- Cost per unit<br />

- Useful life<br />

(a) Newly built/acquired assets could be categorised as Level 2 assets as depreciation would not be a significant unobservable input (based on the 10 per cent<br />

materiality threshold).<br />

(b) AASB 13 Fair Value Measurement provides an exemption for not for profit public sector entities from disclosing the sensitivity analysis relating to ‘unrealised<br />

gains/(losses) on non-financial assets’ if the assets are held primarily for their current service potential rather than to generate net cash inflows.<br />

There were no changes in valuation techniques throughout the period to 30 June 20<strong>18</strong>.<br />

Initial Recognition<br />

Items of property, plant and equipment are measured initially at cost and subsequently revalued at fair value less accumulated depreciation and<br />

impairment loss. Where an asset is acquired for no or nominal cost, the cost is its fair value at the date of acquisition. Assets transferred as part of<br />

a merger are transferred at their carrying amounts.<br />

The cost of a leasehold improvement is capitalised as an asset and depreciated over the shorter of the remaining term of the lease or the estimated<br />

useful life of the improvements.<br />

Theoretical opportunities that may be available in relation to assets are not taken into account until it is virtually certain that any restrictions will no<br />

longer apply. Therefore, unless otherwise disclosed, the current use of these non-financial physical assets will be their highest and best uses.<br />

Land and buildings are recognised initially at cost and subsequently measured at fair value less accumulated depreciation and accumulated<br />

impairment loss.<br />

Subsequent Measurement<br />

Consistent with AASB 13 Fair Value Measurement , <strong>Monash</strong> <strong>Health</strong> determines the policies and procedures for recurring property, plant and<br />

equipment fair value measurements, in accordance with the requirements of AASB 13 and the relevant FRDs.<br />

All property, plant and equipment for which fair value is measured or disclosed in the financial statements are categorised within the fair value<br />

hierarchy.<br />

For the purpose of fair value disclosures, <strong>Monash</strong> <strong>Health</strong> has determined classes of assets on the basis of the nature, characteristics and risks of the<br />

asset and the level of the fair value hierarchy as explained above.<br />

In addition, <strong>Monash</strong> <strong>Health</strong> determines whether transfers have occurred between levels in the hierarchy by reassessing categorisation (based on the<br />

lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting period.<br />

For the purpose of fair value disclosures, <strong>Monash</strong> <strong>Health</strong> has determined classes of assets and liabilities on the basis of the nature, characteristics<br />

and risks of the asset or liability and the level of the fair value hierarchy as explained above.<br />

The Valuer-General Victoria (VGV) is <strong>Monash</strong> <strong>Health</strong>’s independent valuation agency.<br />

The estimates and underlying assumptions are reviewed on an ongoing basis.<br />

100 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 4.2 (e): Fair value determination (continued)<br />

Fair value measurement<br />

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market<br />

participants at the measurement date.<br />

Consideration of highest and best use (HBU) for non‐financial physical assets<br />

Judgements about highest and best use must take into account the characteristics of the assets concerned, including restrictions on the<br />

use and disposal of assets arising from the asset’s physical nature and any applicable legislative/contractual arrangements.<br />

In accordance with paragraph AASB 13.29, <strong>Monash</strong> <strong>Health</strong> assumes the current use of a non-financial physical asset is its HBU unless<br />

market or other factors suggest that a different use by market participants would maximise the value of the asset.<br />

Therefore, an assessment of the HBU will be required when the indicators are triggered within a reporting period which suggest the<br />

market participants would have perceived an alternative use of an asset that can generate maximum value. Once identified, <strong>Monash</strong><br />

<strong>Health</strong> engages with VGV or other independent valuers for formal HBU assessment.<br />

These indicators, as a minimum, include:<br />

External factors:<br />

• Changed acts, regulations, local law or such instrument which affects or may affect the use or development of the asset;<br />

• Changes in planning scheme, including zones, reservations, overlays that would affect or remove the restrictions imposed on the asset’s<br />

use from its past use;<br />

• Evidence that suggests the current use of an asset is no longer core to requirements to deliver <strong>Monash</strong> <strong>Health</strong>’s service obligation; and<br />

• Evidence that suggests that the asset might be sold or demolished at reaching the late stage of an asset’s life cycle.<br />

Valuation hierarchy<br />

<strong>Monash</strong> <strong>Health</strong> uses valuation techniques that are appropriate for the circumstances and where there is sufficient data available to<br />

measure fair value, maximising the use of relevant observable inputs and minimising the use of unobservable inputs.<br />

All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorised within the fair value<br />

hierarchy.<br />

Identifying unobservable inputs (level 3) fair value measurements<br />

Level 3 fair value inputs are unobservable valuation inputs for an asset or liability. These inputs require significant judgement and<br />

assumptions in deriving fair value for both financial and non-financial assets.<br />

Unobservable inputs are used to measure fair value to the extent that relevant observable inputs are not available, thereby allowing for<br />

situations in which there is little, if any, market activity for the asset or liability at the measurement date. However, the fair value<br />

measurement objective remains the same, i.e., an exit price at the measurement date from the perspective of a market participant that<br />

holds the asset or owes the liability. Therefore, unobservable inputs shall reflect the assumptions that market participants would use<br />

when pricing the asset or liability, including assumptions about risk.<br />

Assumptions about risk include the inherent risk in a particular valuation technique used to measure fair value (such as a pricing risk<br />

model) and the risk inherent in the inputs to the valuation technique. A measurement that does not include an adjustment for risk<br />

would not represent a fair value measurement if market participants would include one when pricing the asset or liability i.e., it might<br />

be necessary to include a risk adjustment when there is significant measurement uncertainty. For example, when there has been a<br />

significant decrease in the volume or level of activity when compared with normal market activity for the asset or liability or similar<br />

assets or liabilities, and <strong>Monash</strong> <strong>Health</strong> has determined that the transaction price or quoted price does not represent fair value.<br />

<strong>Monash</strong> <strong>Health</strong> develops unobservable inputs using the best information available in the circumstances which includes its own data. In<br />

developing unobservable inputs, <strong>Monash</strong> <strong>Health</strong> begins with its own data and makes adjustments to this data if reasonably available<br />

information indicates that other market participants would use different data or data unique to <strong>Monash</strong> <strong>Health</strong> exists that is not available<br />

to other market participants.<br />

Non‐Specialised Land, Non‐Specialised Buildings and Cultural Assets<br />

Non-specialised land, non-specialised buildings and cultural assets are valued using the market approach. Under this valuation method,<br />

the assets are compared to recent comparable sales or sales of comparable assets which are considered to have nominal or no added<br />

improvement value.<br />

For non-specialised land and non-specialised buildings, an independent valuation was performed by the Valuer-General Victoria to<br />

determine the fair value using the market approach. Valuation of the assets was determined by analysing comparable sales and allowing<br />

for share, size, topography, location and other relevant factors specific to the asset being valued. An appropriate rate per square metre<br />

has been applied to the subject asset. The effective date of the valuation is 30 June 2014.<br />

101


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 4.2 (e): Fair value determination (continued)<br />

Specialised Land and Specialised Buildings<br />

Specialised land includes Crown Land which is measured at fair value with regard to the property’s highest and best use<br />

after due consideration is made for any legal or physical restrictions imposed on the asset, public announcements or<br />

commitments made in relation to the intended use of the asset. Theoretical opportunities that may be available in relation<br />

to the assets are not taken into account until it is virtually certain that any restrictions will no longer apply. Therefore,<br />

unless otherwise disclosed, the current use of these non-financial physical assets will be their highest and best use.<br />

The market approach is used for specialised land and specialised buildings although it is adjusted for the community<br />

service obligation (CSO) to reflect the specialised nature of the assets being valued. Specialised assets contain significant,<br />

unobservable adjustments; therefore these assets are classified as Level 3 under the market based direct comparison<br />

approach.<br />

The CSO adjustment is a reflection of the valuer’s assessment of the impact of restrictions associated with an asset to the<br />

extent that is also equally applicable to market participants. This approach is in light of the highest and best use<br />

consideration required for fair value measurement, and takes into account the use of the asset that is physically possible,<br />

legally permissible and financially feasible. As adjustments of CSO are considered as significant unobservable inputs,<br />

specialised land would be classified as Level 3 assets.<br />

For <strong>Monash</strong> <strong>Health</strong>, the depreciated replacement cost method is used for the majority of specialised buildings, adjusting for<br />

the associated depreciation. As depreciation adjustments are considered as significant and unobservable inputs in nature,<br />

specialised buildings are classified as Level 3 for fair value measurements.<br />

An independent valuation of <strong>Monash</strong> <strong>Health</strong> ’s specialised land and specialised buildings was performed by the Valuer-<br />

General Victoria. The valuation was performed using the market approach adjusted for CSO. The effective date of the<br />

valuation is 30 June 2014.<br />

In June 20<strong>18</strong> a managerial valuation was carried out in accordance with FRD 103F to revalue the land to its fair value.<br />

Plant and Equipment<br />

Plant and equipment (including medical equipment, computers and communication equipment and furniture and fittings are<br />

held at carrying amount (depreciated cost). When plant and equipment is specialised in use, such that it is rarely sold other<br />

than as part of a going concern, the depreciated replacement cost is used to estimate the fair value. Unless there is market<br />

evidence that current replacement costs are significantly different from the original acquisition cost, it is considered<br />

unlikely that depreciated replacement cost will be materially different from the existing carrying amount.<br />

There were no changes in valuation techniques throughout the period to 30 June 20<strong>18</strong>.<br />

For all assets measured at fair value, the current use is considered the highest and best use.<br />

Revaluations of Non‐Current Physical Assets<br />

Non-current physical assets are measured at fair value and are revalued in accordance with FRD 103F Non-Current<br />

Physical Assets . This revaluation process normally occurs every five years, based upon the asset's Government<br />

Purpose Classification, but may occur more frequently if fair value assessments indicate material changes in<br />

values. Independent valuers are used to conduct these scheduled revaluations and any interim revaluations are<br />

determined in accordance with the requirements of the FRDs. Revaluation increments or decrements arise from<br />

differences between an asset’s carrying value and fair value.<br />

Revaluation increments are recognised in ‘Other Comprehensive Income’ and are credited directly to the asset revaluation<br />

surplus, except that, to the extent that an increment reverses a revaluation decrement in respect of that same class of<br />

asset previously recognised as an expense in net result, the increment is recognised as income in the net result.<br />

Revaluation decrements are recognised in ‘Other Comprehensive Income’ to the extent that a credit balance exists in the<br />

asset revaluation surplus in respect of the same class of property, plant and equipment.<br />

Revaluation increases and revaluation decreases relating to individual assets within an asset class are offset against one<br />

another within that class but are not offset in respect of assets in different classes.<br />

Revaluation surplus is not transferred to accumulated funds on de-recognition of the relevant asset, except where an asset<br />

is transferred via contributed capital.<br />

In accordance with FRD 103F, <strong>Monash</strong> <strong>Health</strong>'s non-current physical assets were assessed to determine whether<br />

revaluation of the non-current physical assets was required.<br />

102 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 4.3: Depreciation and amortisation<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000 $'000<br />

Depreciation<br />

Buildings 43,072 39,893<br />

Plant & Equipment 5,460 3,567<br />

Medical Equipment 12,831 11,319<br />

Computers and Communication Equipment 3,017 1,819<br />

Furniture and Fittings 1,351 285<br />

Motor Vehicles 7 8<br />

Leased Assets i 8,161 7,841<br />

Total Depreciation 73,899 64,732<br />

Amortisation<br />

Intangible Assets 3,411 2,331<br />

Total Amortisation 3,411 2,331<br />

Total Depreciation and Amortisation 77,310 67,063<br />

(i) Of the balance disclosed under 'Depreciation Leased Assets', $6.5m ($6.5m <strong>2017</strong>) relates to leased buildings<br />

contracted under a PPP arrangement.<br />

All buildings, plant and equipment and intangible produced assets that have finite useful lives are<br />

depreciated. Depreciation begins when the asset is available for use, which is when it is in the location<br />

and condition necessary for it to be capable of operating in a manner intended by management.<br />

Depreciation is generally calculated on a straight line basis, at a rate that allocates the asset value, less<br />

any estimated residual value over its estimated useful life. Estimates of the remaining useful lives and<br />

depreciation method for all assets are reviewed at least annually, and adjustments made where<br />

appropriate. This depreciation charge is not funded by the Department of <strong>Health</strong> and Human Services.<br />

Assets with a cost in excess of $1,000 are capitalised and depreciation has been provided on<br />

depreciable assets so as to allocate their cost or valuation over their estimated useful lives.<br />

Intangible produced assets with finite lives are depreciated as an expense on a systematic basis over<br />

the asset’s useful life.<br />

The following table indicates the expected useful lives of non-current assets on which the depreciation<br />

charges are based.<br />

20<strong>18</strong> <strong>2017</strong><br />

Buildings<br />

– Structure Shell Building Fabric 45 to 70 45 to 70 years<br />

– Site Engineering Services and Central Plant 22 to 30 22 to 30 years<br />

– Fit Out 22 to 30 22 to 30 years<br />

– Trunk Reticulated Building Systems 22 to 30 22 to 30 years<br />

Plant & Equipment 3 to 10 years 3 to 10 years<br />

Medical Equipment 3 to 10 years 3 to 10 years<br />

Computers and Communication 3 years 3 years<br />

Furniture and Fitting Up to 10 Up to 10 years<br />

Motor Vehicles 4 years 4 years<br />

Leased Buildings 45 Years 45 Years<br />

Intangible Assets 5 years 5 years<br />

As part of the building valuation, building values were separated into components and each component<br />

assessed for its useful life which is represented above.<br />

103


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 4.4: Intangible assets<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Intangible Produced Assets - Software 34,088 30,<strong>18</strong>8<br />

Less Accumulated Amortisation (30,123) (26,712)<br />

Total Intangible Assets 3,965 3,476<br />

Reconciliation of the carrying amounts of intangible assets at the beginning and end of the previous<br />

and current financial year:<br />

Consolidated<br />

$'000<br />

Balance at 1 July 2016 4,912<br />

Additions 895<br />

Amortisation (refer Note 4.3) (2,331)<br />

Balance at 1 July <strong>2017</strong> 3,476<br />

Additions 3,900<br />

Amortisation (refer Note 4.3) (3,411)<br />

Balance at 30 June 20<strong>18</strong> 3,965<br />

Intangible assets represent identifiable non-monetary assets without physical substance such as<br />

computer software.<br />

Intangible assets are initially recognised at cost. Subsequently, intangible assets with finite useful<br />

lives are carried at cost less accumulated amortisation and accumulated impairment losses. Costs<br />

incurred subsequent to initial acquisition are capitalised when it is expected that additional future<br />

economic benefits will flow to <strong>Monash</strong> <strong>Health</strong>.<br />

Expenditure on research activities is recognised as an expense in the period in which it is incurred.<br />

104 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 5: Other assets and liabilities<br />

This section sets out those assets and liabilities that arose from the <strong>Monash</strong> <strong>Health</strong>'s operations.<br />

Structure<br />

5.1 Receivables<br />

5.2 Inventories<br />

5.3 Other liabilities<br />

5.4 Payables<br />

105


Note 5.1: Receivables<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000 $'000<br />

CURRENT<br />

Contractual<br />

Inter Hospital Debtors 1,799 1,698<br />

Trade Debtors 5,708 5,807<br />

Patient Fees <strong>18</strong>,914 22,259<br />

Accrued Revenue - Other 16,789 10,597<br />

Amounts Receivable from Governments and Agencies i - 6,394<br />

Less Allowance for Doubtful Debts<br />

Trade Debtors (2<strong>18</strong>) (308)<br />

Patient Fees (3,071) (2,448)<br />

39,921 43,999<br />

Statutory<br />

GST Receivable 2,850 3,583<br />

2,850 3,583<br />

TOTAL CURRENT RECEIVABLES 42,771 47,582<br />

NON CURRENT<br />

Statutory<br />

Long Service Leave - Department of <strong>Health</strong> and Human<br />

Services 90,917 81,717<br />

TOTAL NON-CURRENT RECEIVABLES 90,917 81,717<br />

TOTAL RECEIVABLES 133,688 129,299<br />

i Terms and conditions of amounts receivable from the Department of <strong>Health</strong> and Human Services vary according to the<br />

particular agreement with the Department.<br />

(a) Movement in the Allowance for doubtful debts<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000 $'000<br />

Balance at beginning of year 2,756 2,550<br />

Increase in allowance recognised in net result 533 206<br />

Balance at end of year 3,289 2,756<br />

(b) Nature and extent of risk arising from receivables<br />

Refer to Note 7.1(a) for the nature and extent of credit risk arising from contractual receivables.<br />

106 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 5.1: Receivables (continued)<br />

Receivables consist of:<br />

• Contractual receivables, which includes mainly debtors in relation to goods and services, loans to<br />

third parties, accrued investment income, and finance lease receivables; and<br />

• Statutory receivables, which includes predominantly amounts owing from the Victorian<br />

Government and Goods and Services Tax (GST) input tax credits recoverable.<br />

Receivables that are contractual are classified as financial instruments and categorised as loans and<br />

receivables. Statutory receivables are recognised and measured similarly to contractual receivables<br />

(except for impairment), but are not classified as financial instruments because they do not arise<br />

from a contract.<br />

Receivables are recognised initially at fair value and subsequently measured at amortised cost less<br />

any accumulated impairment. Trade debtors are carried at nominal amounts due and are due for<br />

settlement within 30 days from the date of recognition.<br />

In assessing impairment of statutory (non-contractual) financial assets, which are not financial<br />

instruments, professional judgement is applied in assessing materiality using estimates, averages<br />

and other computational methods in accordance with AASB 136 Impairment of Assets .<br />

Trade debtors are carried at nominal amounts due and are due for settlement within 30 days from<br />

the date of recognition. Collectability of debts is reviewed on an ongoing basis, and debts which are<br />

known to be uncollectible are written off. A provision for doubtful debts is recognised when there is<br />

objective evidence that the debts may not be collected and bad debts are written off when<br />

identified.<br />

107


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 5.2: Inventories<br />

At Cost:<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Pharmaceuticals 7,961 6,160<br />

Medical and Surgical Consumables 7,336 7,939<br />

General Stores 559 525<br />

Pathology 1,464 1,1<strong>18</strong><br />

TOTAL INVENTORIES 17,320 15,742<br />

Inventories include goods and other property held either for sale, consumption or for<br />

distribution at no or nominal cost in the ordinary course of business operations. It includes<br />

land held for sale and excludes depreciable assets.<br />

Inventories held for distribution are measured at weighted average cost, adjusted for any<br />

loss of service potential. All other inventories are measured at the lower of cost and net<br />

realisable value.<br />

Inventories acquired at no cost or for nominal consideration are measured at current<br />

replacement cost at the date of acquisition.<br />

The bases used in assessing loss of service potential for inventories held for distribution<br />

include current replacement cost and technical or functional obsolescence.<br />

Cost is assigned to high value, low volume inventory items on a specific identification of cost<br />

basis.<br />

108 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 5.3: Other liabilities<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

CURRENT<br />

Monies Held in Trust<br />

- Patient Monies Held in Trust 219 211<br />

- Accommodation Bonds (Refundable Entrance Fees) 14,825 12,408<br />

Total Other Liabilities 15,044 12,619<br />

Represented by the following assets:<br />

Cash Assets 15,044 12,619<br />

TOTAL 15,044 12,619<br />

109


Note 5.4: Payables<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000 $'000<br />

CURRENT<br />

Contractual<br />

Trade Creditors 30,323 29,604<br />

Accrued Expenses 31,562 24,311<br />

Amounts payable to doctors 544 544<br />

Superannuation Accrual 8,669 10,566<br />

Prepaid revenue - Department of <strong>Health</strong> and Human<br />

Services 5,608 -<br />

Other 13,516 16,192<br />

TOTAL PAYABLES 90,222 81,217<br />

Payables consist of:<br />

• Contractual payables which consist predominantly of accounts payable representing<br />

liabilities for goods and services provided to <strong>Monash</strong> <strong>Health</strong> prior to the end of the financial<br />

year that are unpaid, and arise when <strong>Monash</strong> <strong>Health</strong> becomes obliged to make future<br />

payments in respect of the purchase of those goods and services. The normal credit terms<br />

for accounts payable are usually nett 30 - 35 days.<br />

Contractual payables are classified as financial instruments and are initially recognised at<br />

fair value, and then subsequently carried at amortised cost. Statutory payables are<br />

recognised and measured similarly to contractual payables, but are not classified as<br />

financial instruments and not included in the category of financial liabilities at amortised<br />

cost, because they do not arise from a contract.<br />

110 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 5.4 (a): Payables and borrowings maturity analysis<br />

The following table discloses the contractual maturity analysis for <strong>Monash</strong> <strong>Health</strong>'s financial liabilities.<br />

Maturity analysis of Financial Liabilities as at 30 June<br />

Carrying<br />

Amount<br />

Nominal<br />

Amount<br />

Less than 1<br />

Month<br />

1-3 Months 3 months -<br />

1 Year<br />

1 - 5 Years Over 5<br />

Years<br />

20<strong>18</strong> $'000 $'000 $'000 $'000 $'000 $'000 $'000<br />

Financial Liabilities<br />

Maturity Dates<br />

At amortised cost<br />

Payables 90,222 90,222 45,822 44,400<br />

Borrowings 93,578 93,578 1,648 858 8,544 36,499 46,030<br />

Other Financial Liabilities i<br />

- Accommodation Bonds 14,825 14,825 - 667 14,159 - -<br />

- Other 219 219 219 - - - -<br />

Total Financial Liabilities 198,844 198,844 47,689 45,925 22,703 36,499 46,030<br />

<strong>2017</strong><br />

Financial Liabilities<br />

At amortised cost<br />

Payables 81,217 81,217 56,757 24,460 - - -<br />

Borrowings 89,579 89,579 - 2,438 7,236 35,524 44,381<br />

Other Financial Liabilities i<br />

- Accommodation Bonds 12,408 12,408 - 1,625 10,783 - -<br />

- Other 211 211 211 - - - -<br />

Total Financial Liabilities <strong>18</strong>3,415 <strong>18</strong>3,415 56,968 28,523 <strong>18</strong>,019 35,524 44,381<br />

Ageing analysis of financial liabilities excludes the types of statutory financial liabilities (i.e. GST payable)<br />

i<br />

111


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 6: How we finance our operations<br />

This section provides information on the sources of finance utilised by <strong>Monash</strong> <strong>Health</strong> during its<br />

operations, along with interest expenses (the cost of borrowings) and other information related to<br />

financing activities of <strong>Monash</strong> <strong>Health</strong>.<br />

This section includes disclosures of balances that are financial instruments (such as borrowings and<br />

cash balances). Note: 7.1 provides additional, specific financial instrument disclosures.<br />

Structure<br />

6.1 Borrowings<br />

6.2 Cash and cash equivalents<br />

6.3 Commitments for expenditure<br />

112 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 6.1: Borrowings<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

CURRENT<br />

Australian Dollar Borrowings<br />

– Finance Lease Liability i 5,600 5,048<br />

– TCV Loan ii 1,<strong>18</strong>1 1,113<br />

– Advances from Government iii 1,000 -<br />

Total Australian Dollars Borrowings 7,781 6,161<br />

Total Current 7,781 6,161<br />

NON CURRENT<br />

Australian Dollar Borrowings<br />

– Finance Lease Liability i 51,945 56,229<br />

– TCV Loan ii 26,008 27,<strong>18</strong>9<br />

– Advances from Government iii 7,844 -<br />

Total Australian Dollars Borrowings 85,797 83,4<strong>18</strong><br />

Total Non-Current 85,797 83,4<strong>18</strong><br />

Total Borrowings 93,578 89,579<br />

i During the year ended 30 June 2005, Casey Hospital commenced operation. Construction and fit out of Casey Hospital was<br />

funded as Public Private Partnership under a Project Agreement between the State of Victoria and Progress <strong>Health</strong> Pty Ltd.<br />

<strong>Monash</strong> <strong>Health</strong> is responsible for operating Casey Hospital and has recognised the leased asset (Note 4.2) and associated<br />

interest bearing liabilities. The State of Victoria is obligated to fund quarterly service payments due under the Project<br />

Agreement for the life of that agreement, a period of up to 25 years.<br />

ii During the year ended 30 June 2010, <strong>Monash</strong> <strong>Health</strong> entered into a loan agreement with the Treasury Corporation of<br />

Victoria to fund $19.6m improvements required to the car park at the Clayton site. The loan is repayable over 22 years with<br />

repayments being made quarterly.<br />

During the year ended 30 June 2014, <strong>Monash</strong> <strong>Health</strong> made a further drawdown under the existing loan arrangement with the<br />

Treasury Corporation of Victoria to fund $13.5m improvements required to the car park at the Clayton site. The loan is<br />

repayable over 20 years with repayments being made quarterly.<br />

iii During the year ended 30 June 20<strong>18</strong>, the Department of <strong>Health</strong> and Human Services granted an interest free loan of $10m<br />

to <strong>Monash</strong> <strong>Health</strong>. The loan is repayable over 10 years with repayments being made annually.<br />

(a) Maturity analysis of borrowings<br />

Please refer to Note 5.4 for the ageing analysis of borrowings.<br />

(b) Defaults and breaches<br />

During the current and prior year, there were no defaults and breaches of any of the borrowings.<br />

113


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 6.1 Borrowings (continued)<br />

(c) Finance lease liabilities<br />

Minimum future lease<br />

payments (i)<br />

Present value of<br />

minimum future lease<br />

payments<br />

20<strong>18</strong> <strong>2017</strong> 20<strong>18</strong> <strong>2017</strong><br />

Finance leases $'000 $'000 $'000 $'000<br />

Casey Hospital Public Private Partnership Lease<br />

Repayments in relation to finance leases are payable as follows:<br />

Not later than one year 6,592 6,592 3,399 3,199<br />

Later than one year but not later than 5 years 26,370 26,370 15,871 14,933<br />

Later than 5 years 41,752 48,345 34,553 38,891<br />

Other finance lease liabilities payable i<br />

Not later than one year 2,276 1,969 2,201 1,849<br />

Later than one year but not later than 5 years 1,555 2,475 1,521 2,405<br />

Minimum lease payments ii 78,546 85,751 57,545 61,277<br />

Less future finance charges (21,001) (24,474) - -<br />

TOTAL 57,545 61,277 57,545 61,277<br />

Included in the financial statements as:<br />

Current borrowings lease liabilities 5,600 5,048<br />

Non-current borrowing lease liabilities 51,945 56,229<br />

57,545 61,277<br />

The weighted average interest rate implicit in the finance lease is 6.07% (<strong>2017</strong>: 6.07%).<br />

i Other finance lease liabilities include obligations that are recognised on the Balance Sheet.<br />

ii Minimum future lease payments include the aggregate of all base payments and any guaranteed residual.<br />

A lease is a right to use an asset for an agreed period of time in exchange for payment. Leases are classified at their<br />

inception as either operating or finance leases based on the economic substance of the agreement so as to reflect the risks<br />

and rewards incidental to ownership.<br />

Leases of property, plant and equipment are classified as finance leases whenever the terms of the lease transfer<br />

substantially all the risks and rewards of ownership to the lessee. All other leases are classified as operating leases, in the<br />

manner described in Note 6.3 Commitments for expenditure.<br />

Finance Leases<br />

Entity as lessor<br />

<strong>Monash</strong> <strong>Health</strong> does not hold any finance lease arrangements with other parties.<br />

Entity as lessee<br />

Finance leases are recognised as assets and liabilities at amounts equal to the fair value of the lease property or, if lower, the<br />

present value of the minimum lease payment, each determined at the inception of the lease. The lease assets under the PPP<br />

arrangement are accounted for as a non-financial physical asset and is depreciated over the term of the lease. Minimum<br />

lease payments are apportioned between reduction of the outstanding lease liability, and the periodic finance expense which<br />

is calculated using the interest rate implicit in the lease, and charged directly to the Comprehensive Operating Statement.<br />

Contingent rentals associated with finance leases are recognised as an expense in the period in which they are incurred.<br />

Leasehold Improvement<br />

The cost of leasehold improvements are capitalised as an asset and depreciated over the remaining term of the lease or the<br />

estimated useful life of the improvements, whichever is the shorter.<br />

Borrowings<br />

All borrowings are initially recognised at fair value of the consideration received, less directly attributable transaction costs.<br />

Subsequent to initial recognition, borrowings are measured at amortised cost with any difference between the initial<br />

recognised amount and the redemption value being recognised in the net result over the period of the borrowing using the<br />

effective interest method. Fair value is determined in the manner described in Note 7.1.<br />

114 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 6.2: Cash and Cash Equivalents<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Cash on Hand 74 74<br />

Cash at Bank i 160,858 115,935<br />

Total Cash and Cash Equivalents 160,932 116,009<br />

Represented by:<br />

Cash as per Cash Flow Statement 145,888 103,390<br />

Cash for Monies Held in Trust (refer to Note 5.3)<br />

- Cash at Bank 15,044 12,619<br />

Total Cash and Cash Equivalents 160,932 116,009<br />

i<br />

$7.6m (<strong>2017</strong>: $7.9m) relates to funding from the Commonwealth Department of <strong>Health</strong> and Human Services for the <strong>Monash</strong><br />

<strong>Health</strong> Translation Precinct.<br />

Cash and cash equivalents recognised on the Balance Sheet comprise cash on hand and in banks,<br />

deposits at call and highly liquid investments (with an original maturity date of three months or less),<br />

which are held for the purpose of meeting short term cash commitments rather than for investment<br />

purposes, which are readily convertible to known amounts of cash and are subject to insignificant risk<br />

of changes in value.<br />

For cash flow statement presentation purposes, cash and cash equivalents include any bank overdrafts,<br />

which are included as liabilities on the Balance Sheet.<br />

115


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 6.3: Commitments for expenditure<br />

a) Commitments other than public private partnerships<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Capital Expenditure Commitments<br />

Payable:<br />

Plant and equipment 29,987 37,728<br />

Total Capital Expenditure Commitments 29,987 37,728<br />

Operating Commitments<br />

Payable:<br />

Contracted services 100,074 108,854<br />

Total Operating Commitments 100,074 108,854<br />

Lease Commitments<br />

Commitments in relation to leases contracted for at the<br />

reporting date - cancellable 33,814 36,<strong>18</strong>0<br />

Total Lease Commitments 33,814 36,<strong>18</strong>0<br />

Total Commitments other than Public Private<br />

Partnerships 163,875 <strong>18</strong>2,762<br />

All amounts shown in the commitments note are nominal amounts inclusive of GST.<br />

Commitments for future expenditure include operating and capital commitments arising from contracts. These<br />

commitments are disclosed by way of a note at their nominal value and are inclusive of the GST payable. In<br />

addition, where it is considered appropriate and provides additional relevant information to users, the net<br />

present values of significant individual projects are stated. These future expenditures cease to be disclosed as<br />

commitments once the related liabilities are recognised on the balance sheet.<br />

Service concession arrangements<br />

<strong>Monash</strong> <strong>Health</strong> sometimes enters into certain arrangement with private sector participants to design and<br />

construct or upgrade assets used to provide public services. These arrangements are typically complex and<br />

usually include the provision of operational and maintenance services for a specified period of time. These<br />

arrangements are often referred to as either public private partnerships or service concession arrangements<br />

(SCAs). The State of Victoria is obliged to fund Quarterly Service Payments due under the Project Agreement<br />

for the life of that Agreement, a period of up to 25 years. <strong>Monash</strong> <strong>Health</strong> expects that it will continue to<br />

operate and control Casey Hospital at the expiry of the lease. The building has been componentised into 4<br />

major asset classes, of which their estimated useful lives are between 22 to 70 years.<br />

These SCAs usually take one of two main forms. In the more common form, <strong>Monash</strong> <strong>Health</strong> pays the operator<br />

over the period of the arrangement, subject to specified performance criteria being met. At the date of<br />

commitment to the principal provisions of the arrangement, these estimated periodic payments are allocated<br />

between a component related to the design and construction or upgrading of the asset and components<br />

related to the ongoing operation and maintenance of the asset. The former component is accounted for as a<br />

lease payment in accordance with the lease policy (See Note 6.1). The remaining components are accounted<br />

for as commitments for operating costs which are expensed in the comprehensive operating statement as<br />

they are incurred.<br />

116 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 6.3: Commitments for expenditure (continued)<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

(b) Public Private Partnerships i, ii $'000 $'000<br />

Commissioned Public Private Partnerships - Casey<br />

Hospital<br />

Nominal Value Nominal Value iii<br />

PPP operations and maintenance commitment<br />

Not later than one year 11,211 6,244<br />

Later than 1 year and not later than 5 years 21,597 27,734<br />

Later than 5 years 60,147 65,221<br />

Total PPP operations and maintenance commitment 92,954 99,199<br />

Capital commitments iv<br />

Not later than one year 9,<strong>18</strong>7 8,973<br />

Later than 1 year and not later than 5 years 39,101 38,147<br />

Later than 5 years 70,391 80,531<br />

Total capital commitments 1<strong>18</strong>,678 127,652<br />

TOTAL COMMITMENTS FOR PUBLIC PRIVATE PARTNERSHIPS 211,633 226,850<br />

Amounts shown are exempt from GST.<br />

i<br />

The present values of the minimum lease payments for commissioned Public Private Partnerships (PPP) are recognised on the Balance Sheet<br />

and are not disclosed as commitments.<br />

ii<br />

The year on year reduction in the nominal amounts of the other commitments reflects the payments made.<br />

iii<br />

The prior year amounts have been updated to reflect the Department of Treasury and Finance commitments and are now comparable to the<br />

current year disclosure.<br />

iv The capital commitments include both interest and principle repayments based on the Treasury Corporation of Victoria PPP model as<br />

provided by DHHS. The finance lease liability disclosed in Note 6.1 presents the principle component of the capital commitment, as minimum<br />

future lease payments.<br />

(c) Commitments payable<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Capital Expenditure Commitments<br />

Less than 1 year 23,570 23,175<br />

Longer than 1 year but not longer than 5 years 6,417 14,552<br />

Total Capital Expenditure Commitments 29,987 37,728<br />

Operating Commitments<br />

Less than 1 year 35,701 30,213<br />

Longer than 1 year but not longer than 5 years 64,370 61,766<br />

5 years or more 3 16,875<br />

Total Operating Commitments 100,074 108,854<br />

Lease Commitments<br />

Less than 1 year 7,588 7,612<br />

Longer than 1 year but not longer than 5 years 15,512 15,252<br />

5 years or more 10,714 13,316<br />

Total Lease Commitments 33,814 36,<strong>18</strong>0<br />

Public Private Partnership Commitments (commissioned) i<br />

Less than 1 year 20,398 15,2<strong>18</strong><br />

Longer than 1 year but not longer than 5 years 60,698 65,881<br />

5 years or more 130,537 145,751<br />

Total Public Private Partnership Commitments 211,633 226,850<br />

Total Commitments 375,508 409,612<br />

Less GST recoverable from Australian Tax Office (17,132) (15,562)<br />

Total Commitments 358,376 394,050<br />

117


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 7: Risks, contingencies and valuation uncertainties<br />

<strong>Monash</strong> <strong>Health</strong> is exposed to risk from its activities and outside factors. In addition, it is often<br />

necessary to make judgements and estimates associated with recognition and measurement of items in<br />

the financial statements. This section sets out financial instrument specific information, (including<br />

exposures to financial risks) as well as those items that are contingent in nature or require a higher<br />

level of judgement to be applied, which for <strong>Monash</strong> <strong>Health</strong> is related mainly to fair value determination.<br />

Structure<br />

7.1 Financial instruments<br />

7.2 Contingent assets and contingent liabilities<br />

1<strong>18</strong> <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 7.1: Financial instruments<br />

Financial instruments arise out of contractual agreements that give rise to a financial asset of one<br />

entity and a financial liability or equity instrument of another entity. Due to the nature of <strong>Monash</strong><br />

<strong>Health</strong>'s activities, certain financial assets and financial liabilities arise under statute rather than a<br />

contract. Such financial assets and financial liabilities do not meet the definition of financial<br />

instruments in AASB 132 Financial Instruments: Presentation .<br />

(a) Financial instruments: categorisation<br />

Contractual<br />

Financial<br />

Assets -<br />

Receivables<br />

Contractual<br />

Financial<br />

Liabilities at<br />

Amortised<br />

Cost<br />

Total<br />

Consolidated<br />

20<strong>18</strong> $'000 $'000 $'000<br />

Contractual Financial Assets<br />

Cash and cash equivalents 160,932 - 160,932<br />

Receivables<br />

- Trade debtors 5,490 - 5,490<br />

- Other receivables 34,431 - 34,431<br />

Total Financial Assets i 200,853 - 200,853<br />

Financial Liabilities<br />

Payables - 90,222 90,222<br />

Borrowings - 93,578 93,578<br />

Other financial liabilities<br />

- Accommodation bonds - 14,825 14,825<br />

- Other - 219 219<br />

Total Financial Liabilities i - 198,844 198,844<br />

Contractual<br />

Financial<br />

Assets -<br />

Receivables<br />

Contractual<br />

Financial<br />

Liabilities at<br />

Amortised<br />

Cost<br />

Total<br />

Consolidated<br />

<strong>2017</strong> $'000 $'000 $'000<br />

Contractual Financial Assets<br />

Cash and cash equivalents 116,009 - 116,009<br />

Receivables<br />

- Trade debtors 5,499 - 5,499<br />

- Other receivables 38,500 - 38,500<br />

Total Financial Assets i 160,008 - 160,008<br />

Financial Liabilities<br />

Payables - 81,217 81,217<br />

Borrowings - 89,579 89,579<br />

Other financial liabilities<br />

- Accommodation bonds - 12,408 12,408<br />

- Other - 211 211<br />

Total Financial Liabilities i - <strong>18</strong>3,415 <strong>18</strong>3,415<br />

i The carrying amount excludes statutory receivables (i.e. GST receivable and DHHS receivable) and<br />

statutory payables (i.e. Revenue in Advance and DHHS payable).<br />

119


Note 7.1: Financial instruments (continued)<br />

(b) Net holding gain/(loss) on financial instruments by category<br />

Notes To the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Net Holding<br />

Gain/(Loss) Total<br />

Consolidated<br />

20<strong>18</strong> $'000 $'000<br />

Financial Assets<br />

Cash and Cash Equivalents i 2,807 2,807<br />

Investment - Term Deposit 524 524<br />

Financial Assets - Receivables i (2,713) (2,713)<br />

Total Financial Assets 6<strong>18</strong> 6<strong>18</strong><br />

Financial Liabilities<br />

Financial Liabilities at Amortised Cost ii (54) (54)<br />

Total Financial Liabilities (54) (54)<br />

<strong>2017</strong><br />

Financial Assets<br />

Cash and Cash Equivalents i 1,867 1,867<br />

Investment - Term Deposit 1,038 1,038<br />

Receivables i (2,<strong>18</strong>9) (2,<strong>18</strong>9)<br />

Total Financial Assets 716 716<br />

Financial Liabilities<br />

Financial Liabilities at Amortised Cost ii (378) (378)<br />

Total Financial Liabilities (378) (378)<br />

i For cash and cash equivalents and receivables, the net gain or loss is calculated by taking the movement<br />

in the fair value of the asset, the interest revenue, plus or minus foreign exchange gains or losses arising<br />

from revaluation of the financial assets, and minus any impairment recognised in the net result.<br />

ii For financial liabilities measured at amortised cost, the net gain or loss is calculated by taking the<br />

interest expense measured at amortised cost.<br />

Categories of financial instruments<br />

Receivables and cash are financial instrument assets with fixed and determinable payments that are not<br />

quoted on an active market. These assets are initially recognised at fair value plus any directly attributable<br />

transaction costs. Subsequent to initial measurement, receivables are measured at amortised cost using the<br />

accrual method (and for assets, less any impairment). <strong>Monash</strong> <strong>Health</strong> recognises the following assets in this<br />

category:<br />

· cash and deposits<br />

· receivables (excluding statutory receivables); and<br />

· term deposits<br />

Financial liabilities at amortised cost are initially recognised on the date they are originated. They are<br />

initially measured at fair value plus any directly attributable transaction costs. Subsequent to initial<br />

recognition, these financial instruments are measured at amortised cost with any difference between the<br />

initial recognised amount and the redemption value being recognised in profit and loss over the period of the<br />

interest bearing liability, using the accrual method. <strong>Monash</strong> <strong>Health</strong> recognises the following liabilities in this<br />

category:<br />

· payables (excluding statutory payables); and<br />

· borrowings (including finance lease liabilities).<br />

Offsetting financial instruments: Financial instrument assets and liabilities are offset and the net amount<br />

presented in the consolidated balance sheet when, and only when, <strong>Monash</strong> <strong>Health</strong> has a legal right to offset<br />

the amounts and intends either to settle on a net basis or to realise the asset and settle the liability<br />

simultaneously.<br />

120 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 7.1: Financial instruments (continued)<br />

(b) Net holding gain/(loss) on financial instruments by category<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Some master netting arrangements do not result in an offset of balance sheet assets and<br />

liabilities. Where <strong>Monash</strong> <strong>Health</strong> does not have a legally enforceable right to offset recognised<br />

amounts, because the right to offset is enforceable only on the occurrence of future events<br />

such as default, insolvency or bankruptcy, they are reported on a gross basis.<br />

Derecognition of financial assets: A financial asset (or, where applicable, a part of a<br />

financial asset or part of a group of similar financial assets) is derecognised when:<br />

· the rights to receive cash flows from the asset have expired; or<br />

· <strong>Monash</strong> <strong>Health</strong> retains the right to receive cash flows from the asset, but has assumed an<br />

obligation to pay them in full without material delay to a third party under a ‘pass through’<br />

arrangement; or<br />

· <strong>Monash</strong> <strong>Health</strong> has transferred its rights to receive cash flows from the asset and either:<br />

· has transferred substantially all the risks and rewards of the asset; or<br />

· has neither transferred nor retained substantially all the risks and rewards of the asset,<br />

but has transferred control of the asset.<br />

Where <strong>Monash</strong> <strong>Health</strong> has neither transferred nor retained substantially all the risks and<br />

rewards or transferred control, the asset is recognised to the extent of <strong>Monash</strong> <strong>Health</strong>’s<br />

continuing involvement in the asset.<br />

Impairment of financial assets: At the end of each reporting period, <strong>Monash</strong> <strong>Health</strong><br />

assesses whether there is objective evidence that a financial asset or group of financial assets<br />

is impaired. All financial instrument assets, except those measured at fair value through profit<br />

or loss, are subject to annual review for impairment.<br />

The allowance is the difference between the financial asset’s carrying amount and the present<br />

value of estimated future cash flows, discounted at the effective interest rate. In assessing<br />

impairment of statutory (non-contractual) financial assets, which are not financial<br />

instruments, professional judgement is applied in assessing materiality using estimates,<br />

averages and other computational methods in accordance with AASB 136 Impairment of<br />

Assets .<br />

Reclassification of financial instruments: Subsequent to initial recognition and under rare<br />

circumstances, non-derivative financial instruments assets that have not been designated at<br />

fair value through profit or loss upon recognition, may be reclassified out of the fair value<br />

through profit or loss category, if they are no longer held for the purpose of selling or<br />

repurchasing in the near term.<br />

Derecognition of financial liabilities: A financial liability is derecognised when the<br />

obligation under the liability is discharged, cancelled or expires.<br />

When an existing financial liability is replaced by another from the same lender on<br />

substantially different terms, or the terms of an existing liability are substantially modified,<br />

such an exchange or modification is treated as a derecognition of the original liability and the<br />

recognition of a new liability. The difference in the respective carrying amounts is recognised<br />

as an ‘other economic flow’ in the Comprehensive Operating Statement.<br />

121


Notes To and Forming Part of the Financial Statements<br />

Monas <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/<strong>18</strong><br />

Note 7.2: Contingent assets and contingent liabilities<br />

At 30 June 20<strong>18</strong>, there were no contingent assets (<strong>2017</strong>: $0)<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Contingent Liabilities<br />

Quantifiable<br />

Backdated EBA Awards - 2,900<br />

Total Quantifiable Contingent Liabilities - 2,900<br />

All amounts shown in the contingents note are nominal amounts inclusive of GST.<br />

Contingent assets and contingent liabilities are not recognised in the Balance Sheet, but are disclosed<br />

by way of note and, if quantifiable, are measured at nominal value. Contingent assets and contingent<br />

liabilities are presented inclusive of GST receivable or payable respectively.<br />

122 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 8: Other disclosures<br />

This section includes additional material disclosures required by accounting standards or otherwise, for<br />

the understanding of this annual report.<br />

Structure<br />

8.1 Equity<br />

8.2 Reconciliation of net result for the year to net cash flow from operating activities<br />

8.3 Responsible persons disclosures<br />

8.4 Remuneration of executives<br />

8.5 Related parties<br />

8.6 Remuneration of auditors<br />

8.7 Ex-gratia payments<br />

8.8 AASBs issued that are not yet effective<br />

8.9 Events occurring after the balance sheet date<br />

8.10 Controlled entities<br />

8.11 Economic dependency<br />

123


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 8.1: Equity<br />

(a) Surpluses<br />

Property, Plant and Equipment Revaluation Surplus<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000<br />

$'000<br />

Balance at the beginning of the reporting period 641,545 641,545<br />

Revaluation increment<br />

- Land 35,000 -<br />

Balance at the end of the reporting period* 676,545 641,545<br />

* Represented by:<br />

- Land 158,864 123,864<br />

- Buildings 516,917 516,917<br />

- Cultural assets 447 447<br />

- Motor vehicles 317 317<br />

676,545 641,545<br />

Restricted Specific Purpose Surplus<br />

Balance at the beginning of the reporting period 14,953 8,203<br />

Transfer from accumulated surplus 5,762 6,750<br />

Balance at the end of the reporting period 20,715 14,953<br />

Total Surpluses 697,260 656,498<br />

(b) Contributed Capital<br />

Balance at the beginning of the reporting period 403,093 403,048<br />

Capital contribution received from Victorian Government 827 45<br />

Balance at the end of the reporting period 403,920 403,093<br />

(c) Accumulated Surpluses<br />

Balance at the beginning of the reporting period 133,689 32,982<br />

Net result for the year 15 107,457<br />

Transfers to restricted specific purpose surplus (5,762) (6,750)<br />

Prior year adjustment 36 -<br />

Balance at the end of the reporting period 127,978 133,689<br />

Total equity at end of year 1,229,158 1,193,280<br />

Contributed Capital<br />

Consistent with Australian Accounting Interpretation 1038 Contributions by Owners Made to<br />

Wholly-Owned Public Sector Entities and FRD 119A Contributions by Owners , appropriations<br />

for additions to the net asset base have been designated as contributed capital. Other<br />

transfers that are in the nature of contributions to or distributions by owners that have been<br />

designated as contributed capital are also treated as contributed capital.<br />

Transfers of net assets arising from administrative restructurings are treated as contributions<br />

by owners. Transfers of net liabilities arising from administrative restructures are to go<br />

through the Comprehensive Operating Statement.<br />

Property, Plant and Equipment Revaluation Surplus<br />

The asset revaluation surplus is used to record increments and decrements on the revaluation<br />

of non-current physical assets.<br />

Specific Restricted Purpose Surplus<br />

A specific restricted purpose surplus is established where <strong>Monash</strong> <strong>Health</strong> has possession or<br />

title to the funds but has no discretion to amend or vary the restriction and/or condition<br />

underlying the funds received.<br />

124 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 8.2: Reconciliation of net result for the year to net cash<br />

Flow from operating activities<br />

Consolidated Consolidated<br />

20<strong>18</strong> <strong>2017</strong><br />

$'000 $'000<br />

Net result for the period 15 107,457<br />

Non-cash movements:<br />

Depreciation and amortisation 77,310 67,063<br />

Provision for doubtful debts 533 206<br />

Adjustment Prior year capital contribution 11 -<br />

Share of net results in associates (87) (147)<br />

Net movement in finance lease i (3,198) (2,172)<br />

Government non cash funding for hospital expansion (44,380) (61,905)<br />

Adjustment of non current portion of loan to present value (1,155) -<br />

Movements included in investing and financing activities<br />

Net gain from disposal of non-financial physical assets 342 271<br />

Movements in assets and liabilities:<br />

Change in operating assets and liabilities<br />

(Increase)/Decrease in Receivables 54 (6,963)<br />

(Increase)/Decrease in Prepayments 806 422<br />

Increase/(Decrease) in Payables 9,005 (14,158)<br />

Increase/(Decrease) in Provisions 41,375 24,165<br />

(Increase)/Decrease in Inventories (1,578) (2,617)<br />

NET CASH INFLOW FROM OPERATING ACTIVITIES 79,053 111,622<br />

i Funded by and payments made by the Department of <strong>Health</strong> and Human Services to <strong>Monash</strong><br />

<strong>Health</strong>.<br />

125


Note 8.3: Responsible persons disclosures<br />

Responsible Ministers:<br />

The Honourable Jill Hennessy, Minister for <strong>Health</strong>, Minister for Ambulance Services<br />

The Honourable Martin Foley, Minister for Housing, Disability and Ageing, Minister<br />

for Mental <strong>Health</strong><br />

Governing Boards<br />

Ms Barbara Yeoh (term expired 30 June 20<strong>18</strong>)<br />

Ms Debbie Williams (term expired 30 June 20<strong>18</strong>)<br />

Mr Charles Gillies<br />

Ms Heather Cleland<br />

Mr Dipak Sanghvi<br />

Ms Jorden Lam<br />

Dr Misty Jenkins<br />

Ms Sarah Ralph<br />

Prof. Hatem Salem<br />

Accountable Officers<br />

Mr Andrew Stripp<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

In accordance with the Ministerial Directions issued by the Minister for Finance under the Financial<br />

Management Act 1994 , the following disclosures are made regarding responsible persons for the reporting<br />

period.<br />

Period<br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

1/07/<strong>2017</strong> - 30/6/20<strong>18</strong><br />

Remuneration of Responsible Persons<br />

The number of Responsible Persons are shown in their relevant income bands.<br />

Parent<br />

20<strong>18</strong> <strong>2017</strong><br />

Income Band No. No.<br />

$0 - $19,999 - 3<br />

$20,000 - $29,999 - 2<br />

$30,000 - $39,999 8 5<br />

$70,000 - $79,999 1<br />

1<br />

$420,000 - $429,999 - 1<br />

$460,000 - $469,999 1 -<br />

Total numbers of Responsible Persons 10 12<br />

Total remuneration received or due and receivable by Responsible<br />

Persons from the reporting entity amounted to:<br />

$854,638 $770,504<br />

Amounts relating to the Governing Board Members and Accountable Officer are disclosed in the <strong>Monash</strong><br />

<strong>Health</strong>'s controlled entities financial Statement. Amounts relating to responsible Ministers are reported within<br />

the Department of Parliamentary Services' Financial <strong>Report</strong> as disclosed in Note 8.5 Related Parties.<br />

126 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 8.4: Remuneration of executives<br />

Executive Officers' Remuneration<br />

The number of executive officers, other than Ministers and Accountable Officers, and their total<br />

remuneration during the reporting period are shown in the table below. Total annualised employee<br />

equivalent provides a measure of full time equivalent executive officers over the reporting period.<br />

Remuneration comprises employee benefits in all forms of consideration paid, payable or provided in<br />

exchange for services rendered, and is disclosed in the following categories:<br />

Short-term Employee Benefits<br />

Salary and wages, annual leave or sick leave that are usually paid or payable on a regular basis, as well as<br />

non-monetary benefits such as allowances and free or subsidised goods or services.<br />

Post-employment Benefits<br />

Pensions and other retirement benefits paid or payable on a discrete basis when employment has ceased.<br />

Other Long-term Benefits<br />

Long service leave, other long-service benefit or deferred compensation.<br />

Remuneration of executive officers<br />

Parent<br />

Total Remuneration<br />

20<strong>18</strong> <strong>2017</strong><br />

$ '000 $ '000<br />

Short-term benefits 2,351 2,173<br />

Post-employment benefits 213 202<br />

Other Long-term benefits 74 45<br />

Total remuneration 2,638 2,420<br />

Total number of executives 9 12<br />

Total annualised employee equivalent i 9 8<br />

Remuneration of Kitaya Holding Pty Ltd's executive officers is disclosed in the company's financial<br />

statements.<br />

(i) <strong>Annual</strong>ised employee equivalent is based on working 38 ordinary hours per week over the reporting period.<br />

127


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 8.5: Related parties<br />

<strong>Monash</strong> <strong>Health</strong> is a wholly owned and controlled entity of the State of Victoria. Related parties of the<br />

hospital include:<br />

• All key management personnel (KMPs) and their close family members;<br />

• Cabinet ministers (where applicable) and their close family members; and<br />

• Controlled entities<br />

• All hospitals and public sector entities that are controlled and consolidated into the whole of state<br />

consolidated financial statements.<br />

KMPs are those people with the authority and responsibility for planning, directing and controlling the<br />

activities of <strong>Monash</strong> <strong>Health</strong> and its controlled entities, directly or indirectly.<br />

The Board of Directors and the Chief Executive of <strong>Monash</strong> <strong>Health</strong> and it's controlled entities are<br />

deemed to be KMPs.<br />

Key Management Personnel<br />

<strong>Monash</strong> <strong>Health</strong><br />

Ms Barbara Yeoh (term expired 30 June 20<strong>18</strong>)<br />

Ms Debbie Williams (term expired 30 June 20<strong>18</strong>)<br />

Mr Charles Gillies<br />

Ms Heather Cleland<br />

Mr Dipak Sanghvi<br />

Ms Jorden Lam<br />

Dr Misty Jenkins<br />

Ms Sarah Ralph<br />

Prof. Hatem Salem<br />

Mr Andrew Stripp<br />

Position Title<br />

Board Member<br />

Board Member<br />

Board Member<br />

Board Member<br />

Board Member<br />

Board Member<br />

Board Member<br />

Board Member<br />

Board Member<br />

Chief Executive<br />

Kitaya Holding Pty Ltd's KMPs are disclosed in the company's financial statements<br />

Significant transactions with government-related entities<br />

<strong>Monash</strong> <strong>Health</strong> received funding from the Department of <strong>Health</strong> and Human Services of $1,451<br />

million (<strong>2017</strong>: $1,384 million).<br />

The Department of <strong>Health</strong> and Human Services granted an interest free loan of $10m to <strong>Monash</strong><br />

<strong>Health</strong> during the year ended 30 June 20<strong>18</strong>. The loan is repayable over 10 years with repayments<br />

<strong>Monash</strong> <strong>Health</strong> has two loan agreements with Treasury Corporation of Victoria for $19.6m and<br />

$13.3m with amounts borrowed repayable over 22 and 20 years respectively. At 30 June 20<strong>18</strong>, the<br />

total amount due to the Treasury Corporatiion of Victoria in relation to these loans was $27.2m.<br />

Expenses incurred by <strong>Monash</strong> <strong>Health</strong> in delivering services and outputs are in accordance with <strong>Health</strong><br />

Purchasing Victoria requirements. Goods and services including procurement, diagnostics, patient<br />

meals and multi-site operational support are provided by other Victorian <strong>Health</strong> Service Providers on<br />

commercial terms.<br />

Professional medical indemnity insurance and other insurance products are obtained from a Victorian<br />

Public Financial Corporation.<br />

Treasury Risk Management Directions require <strong>Monash</strong> <strong>Health</strong> to hold cash (in excess of working<br />

capital) and investments, and source all borrowings from Victorian Public Financial Corporations.<br />

The compensation detailed below excludes the salaries and benefits the Portfolio Ministers receive.<br />

The Minister’s remuneration and allowances is set by the Parliamentary Salaries and Superannuation<br />

Act 1968 , and is reported within the Department of Parliamentary Services’ Financial <strong>Report</strong>.<br />

128 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 8.5: Related parties (continued)<br />

Parent Parent<br />

20<strong>18</strong> <strong>2017</strong><br />

$ '000 $ '000<br />

Compensation of Key Management Personnel<br />

Short-term Employee Benefits 779 701<br />

Post-employment benefits 62 59<br />

Other long-term benefits 14 11<br />

Total i 855 771<br />

i KMPs are also reported in Note 8.3 Responsible Persons<br />

Transactions with KMPs and Other Related Parties<br />

Given the breadth and depth of State government activities, related parties transact with the<br />

Victorian public sector in a manner consistent with other members of the public e.g. stamp duty and<br />

other government fees and charges. Further employment of processes within the Victorian public<br />

sector occur on terms and conditions consistent with the Public Administration Act 2004 and Codes<br />

of Conduct and Standards issued by the Victorian Public Sector Commission. Procurement processes<br />

occur on terms and conditions consistent with the Victorian Government Procurement Board<br />

requirements.<br />

Outside of normal citizen type transactions with the Department of <strong>Health</strong> and Human Services, all<br />

other related party transactions that involved KMPs and their close family members have been<br />

entered into on an arm's length basis. Transactions are disclosed when they are considered material<br />

to the users of the financial report in making and evaluation decisions about the allocation of scare<br />

resources.<br />

There were no related party transactions with Cabinet Ministers required to be disclosed in 20<strong>18</strong>.<br />

There were no related party transactions required to be disclosed for <strong>Monash</strong> <strong>Health</strong> Board Members<br />

and Chief Executive in 20<strong>18</strong>.<br />

Controlled Entities Related Party Transactions<br />

Kitaya Holdings Pty Ltd operates Jessie McPherson Private Hospital. <strong>Monash</strong> <strong>Health</strong> is reimbursed by<br />

its controlled entity, Kitaya Holdings Pty Ltd, for the provision of goods and services required to run<br />

the private hospital. The fee includes charges for labour, power, food, cleaning and other services.<br />

All transactions are conducted on normal commercial terms and conditions.<br />

The aggregate amounts brought to account in respect of the following types of transactions were:<br />

20<strong>18</strong> <strong>2017</strong><br />

$ '000 $ '000<br />

Rental income received from its controlled entity 1,149 1,132<br />

Contracted Goods and Services provided to its controlled entity 24,228 24,9<strong>18</strong><br />

Amounts owing at balance date<br />

Amount owing to controlled entity 13,<strong>18</strong>8 14,239<br />

129


Note 8.6: Remuneration of auditors<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

20<strong>18</strong> <strong>2017</strong><br />

$000 $000<br />

Victorian Auditor-General's Office<br />

Audit of financial statement 335 326<br />

TOTAL REMUNERATION OF AUDITORS 335 326<br />

130 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 8.7: Ex gratia payments<br />

There have been no ex gratia payments made during the financial year (<strong>2017</strong>: $0).<br />

131


Note 8.8: AASBs Issued that are not yet effective<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Certain new Australian accounting standards have been published that are not mandatory for the 30<br />

June 20<strong>18</strong> reporting period. The Department of Treasury and Finance assesses the impact of all these<br />

new standards and advises <strong>Monash</strong> <strong>Health</strong> of their applicability and early adoption where applicable.<br />

As at 30 June 20<strong>18</strong>, the following standards and interpretations had been issued by the AASB but were<br />

not yet effective. They become effective for the first financial statements for reporting periods<br />

commencing after the stated operative dates as detailed in the table below. <strong>Monash</strong> <strong>Health</strong> has not and<br />

does not intend to adopt these standards early.<br />

Applicable for<br />

annual<br />

reporting<br />

Standard<br />

Summary<br />

periods<br />

beginning on<br />

Impact on public sector entity<br />

financial statements<br />

AASB 9 Financial Instruments The key changes introduced by AASB 9 1 January 20<strong>18</strong> The assessment has identified that the<br />

include simplified requirements for the<br />

classification and measurement of<br />

financial assets, a new hedging<br />

accounting model and a revised<br />

impairment loss model to recognise<br />

impairment losses earlier, as opposed to<br />

the current approach that recognises<br />

impairment only when incurred.<br />

amendments are likely to result in<br />

earlier recognition of impairment<br />

losses and at more regular intervals.<br />

The initial application of AASB 9 is not<br />

expected to significantly impact the<br />

financial positon however there will be<br />

a change to the way financial<br />

instruments are classified and new<br />

disclosure requirements<br />

AASB 2014‐1 Amendments to Australian<br />

Accounting Standards [Part E Financial<br />

Instruments]<br />

AASB 2014‐7 Amendments to Australian<br />

Accounting Standards arising from<br />

AASB 9<br />

AASB 15 Revenue from Contracts with<br />

Customers<br />

AASB 2014‐5 Amendments to Australian<br />

Accounting Standards arising from<br />

AASB 15<br />

Amends various AASs to reflect the<br />

AASB’s decision to defer the mandatory<br />

application date of AASB 9 to annual<br />

reporting periods beginning on or after<br />

1 January 20<strong>18</strong>, and to amend reduced<br />

disclosure requirements<br />

Amends various AASs to incorporate the<br />

consequential amendments arising from<br />

the issuance of AASB 9.<br />

The core principle of AASB 15 requires<br />

an entity to recognise revenue when the<br />

entity satisfies a performance obligation<br />

by transferring a promised good or<br />

service to a customer. Note that<br />

amending standard AASB 2015‐8<br />

Amendments to Australian Accounting<br />

Standards – Effective Date of AASB 15 has<br />

deferred the effective date of AASB 15 to<br />

annual reporting periods beginning on or<br />

after 1 January 20<strong>18</strong>, instead of 1 January<br />

<strong>2017</strong><br />

Amends the measurement of trade<br />

receivables and the recognition of<br />

dividends as follow:<br />

Trade receivables, that do not<br />

have a significant financing<br />

component, are to be measured at<br />

their transaction price at initial<br />

recognition.<br />

Dividends are recognised in the<br />

profit and loss only when:<br />

o the entity’s right to<br />

receive payment of the<br />

dividend is established;<br />

o it is probable that the<br />

economic benefits<br />

associated with the dividend<br />

will flow to the entity; and<br />

1 January 20<strong>18</strong> This amending standard will defer the<br />

application period of AASB 9 to the<br />

20<strong>18</strong>‐19 reporting period in<br />

accordance with the transition<br />

requirements.<br />

1 January 20<strong>18</strong> The assessment has indicated that there<br />

will be no significant impact for the<br />

public sector.<br />

1 January 20<strong>18</strong> The changes in revenue recognition<br />

requirements in AASB 15 may result in<br />

changes to the timing and amount of<br />

revenue recorded in the financial<br />

statements. The Standard will also<br />

require additional disclosures on service<br />

revenue and contract modifications.<br />

1 January 20<strong>18</strong><br />

The assessment has indicated that there<br />

will be no significant impact for the<br />

public sector.<br />

AASB 2015‐8 Amendments to Australian<br />

Accounting Standards – Effective Date of<br />

AASB 15<br />

o the amount can be<br />

measured reliably.<br />

This standard defers the mandatory<br />

effective date of AASB 15 from 1 January<br />

<strong>2017</strong> to 1 January 20<strong>18</strong>.<br />

1 January 20<strong>18</strong> This amending standard will defer the<br />

application period of AASB 15 for forprofit<br />

entities to the 20<strong>18</strong>‐19 reporting<br />

period in accordance with the transition<br />

requirements.<br />

AASB 2016‐3 Amendments to Australian<br />

Accounting Standards – Clarifications to<br />

AASB 15<br />

This Standard amends AASB 15 to clarify<br />

requirements for identifying<br />

performance obligations, principal versus<br />

agent considerations and the timing of<br />

recognising revenue from granting a<br />

licence<br />

The amendments require:<br />

a promise to transfer to a customer<br />

a good or service that is ‘distinct’ to be<br />

recognised as a separate performance<br />

obligation;<br />

for items purchased online, the<br />

entity is a principal if it obtains control of<br />

the good or service prior to transferring<br />

to the customer; and<br />

for licences identified as being<br />

distinct from other goods or services in<br />

a contract, entities need to determine<br />

whether the licence transfers to the<br />

customer over time (right to use) or at a<br />

point in time (right to access).<br />

1 January 20<strong>18</strong><br />

The assessment has indicated that there<br />

will be no significant impact for the<br />

public sector, other than the impact<br />

identified for AASB 15 above.<br />

132 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 8.8: AASBs Issued that are not yet effective (continued)<br />

Standard<br />

AASB 2016‐7 Amendments to Australian<br />

Accounting Standards – Deferral of<br />

AASB 15 for Not‐for‐Profit Entities<br />

AASB 2016‐8 Amendments to Australian<br />

Accounting Standards – Australian<br />

Implementation Guidance for Not‐for‐<br />

Profit Entities<br />

Summary<br />

This standard defers the mandatory<br />

effective date of AASB 15 for not‐for‐profit<br />

entities from 1 January 20<strong>18</strong> to 1 January<br />

2019.<br />

Applicable for<br />

annual<br />

reporting<br />

periods<br />

beginning on<br />

AASB 2016‐8 inserts Australian<br />

1 January 2019<br />

requirements and authoritative<br />

implementation guidance for not‐for‐profitentities<br />

into AASB 9 and AASB 15.<br />

This Standard amends AASB 9 and AASB<br />

15 to include requirements to assist notfor‐profit<br />

entities in applying the<br />

respective standards to particular<br />

transactions and events.<br />

Impact on public sector entity<br />

financial statements<br />

1 January 2019 This amending standard will defer the<br />

application period of AASB 15 for not‐forprofit<br />

entities to the 2019‐20 reporting period.<br />

This standard clarifies the application of<br />

AASB 15 and AASB 9 in a not‐for‐profit<br />

context. The areas within these standards<br />

that are amended for not‐for‐profit<br />

application include:<br />

AASB 9 Statutory receivables are<br />

recognised and measured similarly to<br />

inancial assets<br />

AASB 15<br />

• The “customer” does not need to be the<br />

recipient of goods and/or services;<br />

• The “contract” could include an<br />

arrangement entered into under the<br />

direction of another party;<br />

• Contracts are enforceable if they are<br />

enforceable by legal or “equivalent means”;<br />

• Contracts do not have to have commercial<br />

substance, only economic substance; and<br />

• Performance obligations need to be<br />

“sufficiently specific” to be able to apply<br />

AASB 15 to these transactions<br />

AASB 16 Leases The key changes introduced by AASB 16<br />

include the recognition of most operating<br />

leases (which are currently not recognised) on<br />

balance sheet which has an impact on net<br />

debt.<br />

1 January 2019 The assessment has indicated that most<br />

operating leases, with the exception of short<br />

term and low value leases will come on to the<br />

balance sheet and will be recognised as right of<br />

use assets with a corresponding lease liability.<br />

In the operating statement, the operating lease<br />

expense will be replaced by depreciation<br />

expense of the asset and an interest charge.<br />

AASB 1058 Income of Not‐for‐Profit<br />

Entities<br />

AASB 1058 standard will replace the<br />

majority of income recognition in relation<br />

to government grants and other types of<br />

contributions requirements relating to<br />

public sector not‐for‐profit entities,<br />

previously in AASB 1004 Contributions.<br />

The restructure of administrative<br />

arrangement will remain under AASB<br />

1004 and will be restricted to government<br />

entities and contributions by owners in a<br />

public sector context,<br />

AASB 1058 establishes principles for<br />

transactions that are not within the scope<br />

of AASB 15, where the consideration to<br />

acquire an asset is significantly less than<br />

fair value to enable not‐for‐profit entities<br />

to further their objective<br />

1 January 2019 The current revenue recognition for grants<br />

is to recognise revenue up front upon<br />

receipt of the funds. This may change under<br />

AASB 1058, as capital grants for the<br />

construction of assets will need to be<br />

deferred. Income will be recognised over<br />

time, upon completion and satisfaction of<br />

performance obligations for assets being<br />

constructed, or income will be recognised at<br />

a point in time for acquisition of assets.<br />

The revenue recognition for operating<br />

grants will need to be analysed to establish<br />

whether the requirements under other<br />

applicable standards need to be considered<br />

for recognition of liabilities (which will have<br />

the effect of deferring the income associated<br />

with these grants). Only after that analysis<br />

would it be possible to conclude whether<br />

there are any changes to operating grants.<br />

The impact on current revenue recognition<br />

of the changes is the phasing and timing of<br />

revenue recorded in the profit and loss<br />

statement.<br />

133


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 8.8: AASBs Issued that are not yet effective (continued)<br />

Standard<br />

AASB 1059 Service Concession<br />

Arrangements: Grantor<br />

Summary<br />

This standard applies to arrangements that<br />

involve an operator providing a public<br />

service on behalf of a public sector grantor.<br />

It involves the use of a service concession<br />

asset and where the operator manages at<br />

least some of the public service at its own<br />

direction. An arrangement within the<br />

scope of this standard typically involves an<br />

operator constructing the asset used to<br />

provide the public service or upgrading<br />

the assets and operating and maintaining<br />

the assets for a specified period of time.<br />

The State has 2 types of PPPs:<br />

1. Social Infrastructure: A PPP that<br />

requires the government to make<br />

payments to the operator upon<br />

commencement of services:<br />

• Operator finances and constructs the<br />

infrastructure; and<br />

State pays unitary service payments over<br />

2. Economic Infrastructure: A PPP that is<br />

based on user pays model:<br />

• Operator finances and constructs the<br />

infrastructure;<br />

• State does not pay for the cost of the<br />

construction; and<br />

• Operator charges asset users and<br />

recovers the cost of construction and<br />

operation for the term of the contract.<br />

Applicable for<br />

annual<br />

reporting<br />

periods<br />

beginning on<br />

Impact on public sector entity<br />

financial statements<br />

1 January 2019 For an arrangement to be in scope of AASB<br />

1059 all of the following requirements are<br />

to be satisfied: be satisfied:<br />

• Operator is providing public services using<br />

a service concession asset;<br />

• Operator manages at ‘least some’ of public<br />

services under its own discretion;<br />

• The State controls / regulates:<br />

o What services are to be provided;<br />

o To whom; and<br />

o At what price<br />

• State controls any significant residual<br />

interest in the asset.<br />

If the arrangement does not satisfy all the<br />

above requirements the recognition will fall<br />

under the requirements of another<br />

applicable accounting standard.<br />

Currently the social infrastructure PPPs are<br />

only recognised on the balance sheet at<br />

commercial acceptance. The arrangement<br />

will need to be progressively recognised as<br />

and when the asset is being constructed.<br />

This will have the impact of progressively<br />

recognising the financial liability and<br />

corresponding asset as the asset is being<br />

constructed.<br />

For economic infrastructure PPP<br />

arrangements, that were previously not on<br />

balance sheet, the standard will require<br />

recognition of these arrangements on<br />

balance sheet. There will be no impact to<br />

net debt, as a deferred revenue liability will<br />

be recognised and amortised over the<br />

concession term.<br />

134 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 8.9: Events occurring after the balance sheet date<br />

Assets, liabilities, income or expenses arise from past transactions or other past events. Where<br />

the transactions result from an agreement between <strong>Monash</strong> <strong>Health</strong> and other parties, the<br />

transactions are only recognised when the agreement is irrevocable at or before the end of the<br />

reporting period.<br />

Adjustments are made to amounts recognised in the financial statements for events which occur<br />

between the end of the reporting period and the date when the financial statements are<br />

authorised for issue, where those events provide information about conditions which existed at<br />

the reporting date. Note disclosure is made about events between the end of the reporting period<br />

and the date the financial statements are authorised for issue where the events relate to<br />

conditions which arose after the end of the reporting period that are considered to be of material<br />

interest.<br />

There have been no significant events after reporting date.<br />

135


Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

Note 8.10: Controlled entities<br />

Name of entity Country of incorporation Equity<br />

Holding<br />

Kitaya Holdings Pty Ltd Australia 100%<br />

(trading as Jessie McPherson Private Hospital)<br />

CONTROLLED ENITITES CONTRIBUTION TO THE CONSOLIDATED RESULTS<br />

20<strong>18</strong> <strong>2017</strong><br />

Kitaya Holdings Pty Ltd 100% 100%<br />

136 <strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>-<strong>18</strong>


Note 8.11: Economic dependency<br />

Notes to the Financial Statements<br />

<strong>Monash</strong> <strong>Health</strong> <strong>Annual</strong> <strong>Report</strong> <strong>2017</strong>/20<strong>18</strong><br />

<strong>Monash</strong> <strong>Health</strong> is wholly dependent on the continued financial support of the State<br />

Government and in particular, the Department of <strong>Health</strong> and Human Services.<br />

The Department of <strong>Health</strong> and Human Services has provided confirmation that it will<br />

continue to provide <strong>Monash</strong> <strong>Health</strong> adequate cash flow support to meet its current<br />

and future obligations as and when they fall due for a period up to September 2019.<br />

The hospital’s current asset ratio improved slightly but continues to be below an<br />

adequate short term position (20<strong>18</strong>: 0.51 and <strong>2017</strong>: 0.48) while cash generated<br />

from operations fell to a surplus of $79m from $112m in <strong>2017</strong>. Cash reserves<br />

increased to $160m from $116m in <strong>2017</strong>. A letter confirming adequate cash flow<br />

was also provided in the previous financial year.<br />

The financial statements have been prepared on a going concern basis.<br />

137


Corporate Office<br />

246 Clayton Road, Clayton<br />

t 03 9594 6666<br />

e info@monashhealth.org<br />

www.monashhealth.org<br />

ABN 82 142 080 338

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!